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Abstract 
There is a need for alternative “treatments” for killing microbes in wound and other body 
surfaces. Antimicrobial Photodynamic Therapy (APDT) and Electrochemically Activated 
Solutions (ECAS) are two recent developments in the field of biocide research that in the 
future may have widespread applications, replacing conventional antibiotics or disinfectants. 
The aims of the work described in this thesis are 5-fold. (1) Develop an in vitro model and 
determine the kill rates of bioluminescent species using bioluminescence light output (2) 
Measure the comparative effects of heavy water and reactive oxygen species (ROS) inhibitory 
agents against appropriate controls for both APDT and ECAS treatment and gain insight into 
general killing mechanisms (3) Develop methods to compare kill rates of target microbe 
(prokaryotic cells) against mammalian eukaryotic cells, by comparison of kill rates under the 
same treatment conditions and thus, assess the likelihood of cytotoxic damage to the host (4) 
Measure the potential of treatments to induce genotoxic damage to mammalian cells using a 
COMET assay (5) Measure the effects of treatments when the target is growing in biofilm 
mode (using a continuous matrix perfusion model) and compare standard treatments for fast 
and slow growing cells. 
A standard assay was developed containing target cell suspensions with killing agent ECAS 
or APDT (methylene blue (MB) combined with polychromatic light) and bioluminescence 
was measured using luminometer and viable count methods. For mechanistic study, the assay 
was repeated in the presence of ROS scavenger molecules. Fluorescence responses by probes 
singlet oxygen sensor green (SOSG), 3’-(p-aminophenyl) fluorescein (APF), 3’-(p-
hydroxyphenyl) fluorescein (HPF) were measured using a fluorimeter to detect ROS in the 
presence or absence of specific ROS inhibitory agents. The potential cytotoxicity of APDT 
and ECAS against keratinocytes (H103) and lymphocytes (Jurkat cell) was measured using 
the neutral red test (for keratinocytes) and MTS assay (for lymphocytes). Trevigen’s comet 
assay kit was used to measure genotoxicity produced by ECAS and APDT towards 
lymphocytes, DNA damage was determined using epifluorescence microscopy. An in vitro 
flat-bed perfusion biofilm model was used to compare the effects of ECAS and APDT against 
biofilms, using a low light camera to measure bioluminescence within the biofilm. All data 
were compared using appropriate statistical analyses.  
The light output from the bioluminescent target species was highly proportional to the viable 
counts with high correlation (R
2
> 0.9). Order of killing susceptibility was S. aureus > E. coli 
> P. aeruginosa > MRSA. Kill rates measured using luminescent light output from lux-
modified target species are more accurate than conventional viable count. The rapid assay 
method, coupled with the use of D2O, ROS-scavengers and fluorescent probes provided key 
insights into mechanisms of APDT and ECAS. It was confirmed that singlet oxygen is the 
main cytotoxic species for ADPT whilst a mixed system (hydroxyl radical plus singlet 
oxygen, and possibly other species) was involved for ECAS. APDT and ECAS are not 
particularly cytotoxic to mammalian cells (keratinocytes or lymphocytes); therefore a large 
safety margin of dose may exist to reduce the microbial cells without harm to mammalian 
cells. APDT is more genotoxic to lymphocytes than is ECAS but both are less toxic compared 
to H2O2 positive control. The in vitro flat-bed perfusion biofilm model was suitable to study 
both APDT and ECAS against biofilm cells. The results showed that biofilm was resistant 
compared to planktonic cells, and was able to recover easily post treatment. Slower growing 
cells take longer to recover following APDT.  
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1.1 Overview 
Antimicrobial resistance across a wide range of micro-organisms, most of which 
can cause a wide spectrum of diseases is now considered to be a growing public 
health threat (Spellberg et al., 2008). This has led major research efforts to 
develop alternative antimicrobial therapeutics (Dai et al., 2009). Infections caused 
by antibiotic resistant bacteria lead to increased morbidity and mortality causing a 
considerable burden on the healthcare systems (de Kraker et al., 2011). Therefore, 
it is essential to develop and apply novel antimicrobial strategies to which 
pathogens will not easily develop resistance. Antimicrobial Photodynamic 
Therapy (APDT) (Hamblin and Hassan, 2004) and Electrochemically Activated 
Solutions (ECAS) are now considered to be possible alternative 
biocide/disinfectant therapies (Thorn et al., 2012). APDT is the application of a 
non-toxic compound, termed a photosensitizer (PS), which can be activated by 
light of appropriate wavelength to produce reactive oxygen species (ROS) (i.e. 
singlet oxygen and free radicals), which can then exert antimicrobial effects 
(Hamblin et al., 2002, Embleton et al., 2005). ECAS is a highly oxidative (OPR 
1,170 to 1,180 mV) and fast acting biocidal solution, generated from electrolysis 
of a dilute salt solution (Robinson et al., 2010). Both agents have a broad-
spectrum of activity against a wide range of microbial species. The ROS 
generated by these agents react with multiple components within the bacterial cell 
structure, leading to cell death (Thorn et al., 2012; Hamblin and Hassan, 2004). 
The general mechanisms of these two agents involve multiple target sites, in 
contrast to antibiotics, which generally involve a single target site. Therefore 
bacteria are less likely to develop resistance against these agents. In order to study 
the efficacy and understand the mechanisms of both APDT and ECAS activities, 
rapid methods of data acquisition are required to monitor survivors at any time 
point and allow calculation of death rate (K) as the basic “unit” of comparison 
between different conditions, including different species, different biocide or 
different physicochemical factors.   
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1.2 Photodynamic Therapy (PDT) 
Photodynamic therapy (PDT) utilizes the combination of non-toxic dyes known as 
photosensitizers and harmless visible light of the correct wavelength to excite the 
PS. In the presence of oxygen, the excited PS transfers energy or electrons to the 
ground state molecular oxygen producing reactive oxygen species (ROS) such as 
singlet oxygen and hydroxyl radical that are able to kill both mammalian and 
microbial cells (Ochsner, 1997). PDT targets cells (whether microbial or 
mammalian) based on the phenomenon that PS accumulate preferentially in the 
target species or, for mammalian systems, hyperproliferative cell populations 
(Hamblin and Newman, 1994). The term PDT is generally used when treatment is 
targeted at cancers. 
 
Photodynamic anti-tumour therapy (PDT) is based on the fact that photosensitive 
substance administered systematically are preferentially incorporated into rapidly 
proliferating tumorous tissue, and after its irradiation the cell structures are 
damaged due to the development of reactive cytotoxic products and subsequent 
apoptosis of tumorous cells. The first successful application of PDT was in skin 
tumour therapy by local application of eosin, which accumulates quickly in the 
proliferating neoplastic cells (Ryskova et al., 2010). Currently PDT is used for the 
treatment of superficial malignancies and localised cancer of the skin (Zhao and 
He, 2010). Various PS have been approved for clinical use, including porfimer 
sodium (photofrin) (chemical structure shown in appendix 1) for treatment of lung 
cancer in USA, Japan and Europe (Brown et al., 2004).  
 
PDT initially has been mainly studied and developed as a cancer treatment, but 
now numerous investigations demonstrates possible applications in diverse 
conditions such as dermatological areas such as psoriasis (Boehnche et al., 2000) 
and acne vulgaris (Hongcharu et al., 2000), rheumatoid arthritis (Hansch et al., 
2008), atherosclerosis (Peng et al., 2011) and re-stenosis  (Mansfield et al., 2001). 
One of the most successful applications of PDT developed so far is for an 
(ophthalmological) treatment of age related macular degeneration, now a Foods 
and Drugs Authority (USA) approved treatment (Bressler and Bressler, 2000). 
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1.3 Antimicrobial Photodynamic Therapy (APDT) 
Similar to PDT, APDT utilizes PS activated by visible light to produce cytotoxic 
reactive oxygen species (ROS) that damage microbial cells via oxidative damage. 
When the cells to be killed are pathogenic micro-organisms the procedure is 
termed APDT. In the literature different terms are used to describe APDT. APDT 
is also known as photodynamic inactivation (PDI), lethal photosensitization 
(LPS), photo activated disinfection (PAD) or photodynamic antimicrobial 
chemotherapy (PACT).  
 
The first demonstration of lethal photosensitization of microbial cells was 
recorded over a century ago by Raab (1900) who showed that low concentrations 
of methylene blue (MB), which does not have any toxicity in the absence of light 
towards Paramecium caudatum, could lead to cessation of motility (that is 
presumption of the killing of the organism) by exposure to ordinary daylight 
(Ryskova et al., 2010). Furthermore, Raab showed that acridine and light were 
also toxic to Paramecium (Daniel and Hill, 1991). The term photodynamic 
therapy was coined by Von Tappeiner in 1904 to describe the involvement of light 
and oxygen in the photodynamic reactions (Tappeiner and Jodlbauer, 1904).  
 
Since the discovery of APDT, applications in this area largely came to an end 
because of the discovery of antibiotics raising the belief that infectious diseases 
would be eradicated (Coates and Hu, 2007). However, because of the overuse of 
antibiotics combined with the ability of micro-organisms to evolve and overcome 
the antimicrobial properties of antibiotics, these drugs are becoming increasingly 
ineffective in treating microbial infections (Levy, 2002).  
 
In a recent report published by the World Health Organisation (WHO) the 
seriousness of the antibiotic resistance problem was stated; “A post-antibiotic 
era—in which common infections and minor injuries can kill—far from being an 
apocalyptic fantasy, is instead a very real possibility for the 21st century”, based 
on a recent survey (Antimicrobial resistance: global report on surveillance, WHO, 
2014). WHO report that antimicrobial resistance now pose serious threat to 
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effective prevention and treatment of infections caused by bacteria, fungi, 
parasites and viruses. This is the first time a comprehensive survey has been 
carried out to find the current status of antimicrobial resistance worldwide based 
on surveillance data submitted by 114 countries. The findings of the report 
showed that for E. coli, K. pneumoniae and S. aureus the proportion resistant to 
commonly used specified antibacterial drugs exceeded 50% in many settings.  The 
report highlighted the increase of K. pneumoniae resistance to carbapenems, 
usually the last line of available treatment, from all regions. In addition, high rates 
of methicillin-resistant Staphylococcus aureus (MRSA) mean that treatments of 
these infections must rely upon second line drugs in many countries. Second-line 
drugs for S. aureus may have severe side-effects and are more expensive; further 
increasing the burden on the healthcare systems especially in under-developed 
countries where resources are limited.  
 
Regarding the real threat of antibiotic resistant micro-organisms to the public 
health in general, it is more urgent than ever to develop alternative therapies.  In 
this case both APDT and ECAS can target skin and wound infections (localised 
infections) by S. aureus or MRSA. In recent years research in APDT has been 
stimulated, due to the emergence of antibiotic resistant strains, such as MRSA and 
vancomycin-resistant Enterococcus faecalis (Jori and Brown, 2004).   
 
The use of APDT against infectious disease is now recognised as a highly 
important emerging area of research (Jori and Brown, 2004; Hamblin and Hassan, 
2004). The most accepted use of APDT is in the sterilization of blood products 
from potential microbial agents and it is approved for this purpose in Germany 
(Mohr et al., 1997; Wainwright, 2000). APDT has been recognised as a new form 
of treatment for infectious agents (Hassan and Hamblin, 2004) and its 
development has been compared to that of the discovery of antibiotics 
(McCaughan, 1999).  
 
There are several advantages of using APDT to treat microbial diseases. The main 
favourable features of APDT can be summarized as follows:  
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 Broad spectrum of action, since one photosensitizer can act on bacteria, 
 fungi, yeasts and parasitic protozoa.  
 Efficacy is independent of the antibiotic resistance pattern of the given 
microbial strain.  
 Lack of selection of photoresistant strains after multiple treatments. 
 Use of low cost light sources for activation of photosensitizing agent.  
 
Because of these favourable features, APDT has the potential to be the treatment 
of choice especially for localised infection and oral cavity conditions (Dai et al., 
2009).  
 
Figure 1.1 shows the general applications of APDT in localised infections. Recent 
research findings strongly supports the hypothesis that APDT can represent a 
viable alternative to antibiotics since the mechanism of action of APDT against 
microbial cells are different from the typical action of most antibiotics 
(Wainwright, 1998). Conventional antibiotics kill bacteria through single site/ 
mode of action and may be specific to single species or groups given sufficient 
exposure to the drug: therefore most microbes are able to evolve resistance to a 
single specific point of attack. Unlike conventional antibiotics, biocides, 
disinfectants and APDT act on a broad spectrum of targets and species 
(Wainwright, 1998).  
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Figure 1-1 Applications of APDT   
 
The technology of APDT may be developed to eradicate pathogens under mild 
irradiation conditions, such as short interaction times or low fluence rates, with 
limited damages to host tissue (Jori et al., 2006). However there are some 
limitations of APDT including the need for external energy from a specific 
radiation source to activate the PS. APDT requires sufficient oxygenation of the 
target in addition to sufficient concentration of photosensitizer drug. Target cells 
must be accessible for the activating radiation energy. Penetration depth of the 
activating radiation is a limiting factor. Thus surfaces can easily be treated but 
deeper layers need longer wavelengths or special delivery systems. The activating 
wavelength must be sufficiently different from the absorption characteristics of 
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surrounding tissue to avoid energy loss and possible side effects from high 
intensity irradiation and APDT may have detrimental effects on mammalian cells 
(cytotoxic or genotoxic).  
1.4 Photosensitizers (PS) 
PS are usually aromatic molecules, which are efficient in the formation of long-
lived triplet excited states. The most frequently used PSs in APDT studies to kill 
micro-organisms are activated by light within the visible part of the spectrum 
(400-700 nm). Photosensitizing agents should have specific features. The ideal 
properties are: 
1. Chemically pure, water soluble, stable in solutions at physiological pH for ease 
of application and rapidly cleared from the body (Sharman et al., 1999). 
2. Minimal skin sensitivity (Sharman et al., 2000). 
3. High yield for generation of long-lived triplet state and the cytotoxic singlet 
oxygen species are both important features, which influence the efficiency of 
PS (Castano et al., 2004). High absorption of light at longer wavelengths (600-
950 nm) is important; they should ideally absorb light in the red wavelength 
(630 nm), which has greater tissue penetration than shorter wavelengths. 
Therefore PS that absorbs in the region of 600-800nm are preferred (Castano et 
al., 2004). 
4. Selective uptake by the target pathogens (Lyon et al., 2011; Wainwright et al., 
2007). 
5. Possession of a broad spectrum of action against bacteria, fungi, yeasts, 
viruses, and parasitic protozoa especially those resistant to conventional 
antibiotics (Wainwright et al., 2007).  
6. Non-specific in terms of biomolecular targeting (Wainwright et al., 2007).  
7.  Efficacy, independent of the antibiotic-susceptibility of the target organism.  
8. Ability to cause extensive reduction in pathogens with low dark toxicity (PS 
toxicity in the absence of light) to human cells and absence of production of 
toxic by-products. Low mutagenic potential in mammalian cells (Lyon et al., 
2011).  
9. Photostable during application (Wainwright et al., 2007). 
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Currently available PSs do not meet all of the above-mentioned properties; 
however with chemical modifications many give active derivatives with 
properties closer to the ideal. There are several groups of PSs that are in current 
use in PDT cancer and, with some modifications can be applied to treat infectious 
diseases. The photosensitizer classes employed to date in APDT include 
phenothiaziniums, acridines, porphyrins, phthalocyanines, cyanines chlorins, 
psoralens and fullerenes. Increasing numbers of studies are now carried out to 
assess effectiveness of these PSs and to increase specificity to micro-organism 
over mammalian cells. Phenothiazinium PSs are close to ideal for APDT since 
they possess many of the ideal properties required of a PS (Wainwright et al., 
2007). The PS employed in this current research is the phenothiazinium PS MB 
and is discussed in section 1.4.3.  
1.4.3 Phenothiaziniums  
Phenothiaziniums are a class of positively charged, aromatic photosensitizing 
molecules. Phenothiaziniums have a core structure consisting of a planar tricyclic 
heteroaromatic ring, with an absorption wavelength range of 600-660 nm 
(Phoenix and Harris, 2003). These ranges of light absorption properties of the 
phenothiazinium dyes are excellent for the local therapy of microbial disease. The 
intense long wavelength absorption in this region 600-660 nm lies outside the 
light absorption by endogenous pigments such as haem that might otherwise 
interfere with the photosensitization process. Several compounds in this group 
have been shown to possess antibacterial properties (Wainwright et al., 2007).  
 
The lead compound of phenothiaziniums is MB. With the increase in research in 
PDT there was a great need for the development of novel analogues. A large 
variety of phenothiazines have been synthesized, of which MB, toluidine blue  O  
(TBO), azure A-C and thionin are the most commonly used (Wainwright et al., 
2007). These novel photosensitizers are now routinely tested against different 
micro-organisms. 
 
MB structure is shown in Figure 1.2. Among the most widely used 
phenothiazinium dyes are MB and TBO. They are efficient producers of singlet 
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oxygen (Wainwright et al., 2007) and the maximum absorption wavelength in 
water is 656nm for MB and 625nm for TBO, respectively (Wainwright et al., 
2007) 
 
  
Figure 1-2: Chemical formula of  MB 
 
One of the most important features for a drug is its selectivity towards the target 
organism and cytotoxicity and genotoxicity towards mammalian cells. Research 
has shown no detectable cytotoxic or genotoxic effects of MB on keratinocytes. 
(Zeina et al., 2002; Zeina et al., 2003).  
 
MB  was initially synthesised in 1876 for use in the textile industry, and was first 
employed in medicine in 1891 as a successful treatment for malaria (Wainwright, 
2005).  MB has been used in histology for over a century. MB was reported for its 
photodynamic action against bacteriophages as early as 1930 (Wainwright, 1998). 
The oxidized phenothiaziniums may be reduced by biological systems. MB is 
utilized as an indicator of bacterial activity in the testing of milk, microbial 
reduction of the MB causing decolorization (Wainwright, 1998). MB  is used in 
surgical identification of organs or tissue structures at a concentration of 1% w/v 
without causing human toxicity (Creagh et al., 1995).  
 
Cationic PSs are more selective for bacterial cells compared with mammalian 
cells as cationic molecules are taken up comparatively slowly by mammalian 
cells, and thus damage to host cells may be limited by carrying out APDT within a 
short time of applying the photosensitizer (Demidova and Hamblin, 2004; Dai et 
al., 2009). 
MB combination with light has been shown to cause damage to membrane lipids, 
essential proteins, DNA and other cellular components, usually leading to 
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bacterial cell death (Phoenix and Harris, 2003). At increasing concentrations, MB  
may aggregate and form dimers, which may cause a shift in the absorption 
maximum of the photosensitizer. It has been proposed that dimerization is further 
induced at the bacterial cell surface due to electrostatic interactions between MB  
and negatively charged polymers on the bacterial cell surface, and that these 
dimers are also involved in cell photo damage, as well as monomeric species 
(Usacheva et al., 2003). 
 
Figure 1.3 shows commonly used phenothiazinium and related PSs. MB and TBO 
are the most extensively studied phenothiazinium based PSs for their antibacterial 
activity. The minimal toxicity of these dyes to human cells, plus their ability to 
produce high quantum yields of singlet oxygen, has evolved a great interest in 
testing the potential of these PSs as photoactivated antimicrobial agents.  
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MB                       H          H          NMe2      NMe2     H         H  
Azure A               H          H          NMe2      NH2         H         H  
Azure B               H          H          NMe2      NHMe    H         H  
 Azure C              H          H          NHMe     NH2        H         H  
Thionin               H          H          NH2         NH2        H          H  
1-MMB               Me       H          NMe2      NMe2    H          H  
1,9 DMMB         Me       H          NMe2      NMe2    H          Me  
NMB                   H          Me       NHEt        NHEt    Me       H  
 
 
Figure 1- 3: Commonly used phenothiazinium and related PSs (source: 
Wainwright, 2005). 
 
Nile Blue A, X=O, R
5
= NH2 
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At physiological pH, these molecules are generally cationic. Most of these 
molecules are also lipophilic (log P > 0) which support partitioning into the 
membrane environment, and have amphiphilic properties (i.e. chemical compound 
possessing both hydrophilic and lipophilic properties). These properties are 
important for interaction with the membrane and enable the molecules to become 
internalized into the cell (Phoenix & Harris, 2003). 
 
Numerous studies carried out so far have shown antimicrobial activities of these 
commercially available phenothiaziniums is high against both Gram-positive and 
Gram-negative bacteria (Wainwright et al., 2007) including MRSA (Wainwright 
et al., 1998) and  vancomycin-resistant Enterococcus spp. (Wainwright et al., 
1998)  thus indicating clinical potential in localised infections.  The 
phenothiazinium PS TBO has been shown to eliminate of periodontopathogenic 
bacteria confirming its application in oral cavity infections (Kömerik et al., 2003). 
Phenothiazinium dyes are the only PS that has been applied in the clinical 
settings: in the photo-decontamination of blood plasma (Mohr et al., 1997; 
Wainwright, 2000).  
 
Currently there are only a relatively small number of analogues, which have been 
prepared to allow proper structure—function and activity properties. Figure 1.4 
shows the relationship between structure function and improved activity of PS. It 
is important to study these PSs in terms of function and structure activity to 
improve their efficacy as PSs while limiting their phototoxicity to healthy cells. 
This is a major part of on-going research, which will allow increased 
photosensitizer screening both in the antimicrobial and oncological fields. As with 
conventional drug discovery, the use of the substitutions/alterations will lead to 
development of optimized PSs (Wainwright, 2005).  
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Figure 1- 4: Structure—function relationships for phenothiazinium PSs 
(source: Wainwright, 2005). 
 
1.5 Light Sources  
The use of light and light-sensitive compounds to treat diseases goes back 
thousands of years since the healing properties of sunlight were known (Daniell 
and Hill, 1991). In Egypt, India and China therapeutic effect of the sunlight was 
used to treat diverse diseases including vitiligo, rickets and psoriasis (Ackroyd et 
al., 2001). 
 
The application of light for the treatment of diseases is known as heliotherapy or 
phototherapy. The ancient Greeks used sunlight as treatment of disease in the 
second century BC (Moan and Peng, 2003). At the end of the 19
th
 century the 
Danish physician, Neils Finsen (Nobel prize, 1903) used red light to treat 
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smallpox and ultraviolet light to treat cutaneous tuberculosis (Moan and Peng, 
2003). Another well-known application of phototherapy is the treatment of 
hyperbilirubinemia (jaundice) in new born babies using blue light. The light 
converts the overproduced bilirubin to isomers that can be more readily excreted 
by the liver (Moan and Peng, 2003).  
 
In PDT, the photosensitizer will only be activated by the correct wavelength and 
once the photosensitizer gets activated the photosensitization reaction is initiated 
in the presence of oxygen. The PSs used in PDT are activated by visible light. 
Visible light has a wavelength range of 400-760nm. Therefore the choice of light 
to use in PDT is dependent on the photosensitizer used and the depth of the 
targeted tissue into which light should penetrate. The depth of light penetration 
increases in the visible and near- Infrared (NIR) spectral regions. For clinical 
applications of PDT it is very important for sufficient light to reach the target area 
in order to activate enough photosensitizer molecules. The penetration of light is 
limited due to both absorption and scattering that occur in tissue structures 
(Dougherty and Marcus, 1992). In human tissue, water and oxygenated 
haemoglobin are two important absorbers. Below 600nm the absorption 
coefficient for haemoglobin increases strongly while above 1100 nm the 
absorption for water becomes quite large. Therefore for these reasons wavelength 
regions that can be used for the clinical application in PDT roughly lies between 
600 and 1100 nm. This is called the phototherapeutic window, which is a trade-off 
between sufficient energy (i.e. lower wavelengths) and sufficient penetration 
depths (i.e. longer wavelengths). Moreover the beam of longer wavelength is less 
scattered than that of a shorter one (Niemz, 2007). 
 
There are different types of light sources that have been used to photo-activate the 
photosensitizing agents in use. For APDT, coherent and non-coherent light and 
ultraviolet light sources have been used. In PDT a wavelength ranging from 600-
800nm is widely used (Wainwright, 1998). APDT like PDT uses mainly low 
power light rather than laser light (Wainwright, 1998). Microbial photodynamic 
killing also have been shown with natural sunlight (Zeina et al., 2001).  
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Research into improving the light technology is important to increase the 
efficiency of both PDT and APDT. In this regard developments in optical fibre 
technology promise to be a more targeted approach to delivering the light to 
nearly all body cavities and foci of infection (abscesses). Optical fibre technology 
can benefit both PDT and APDT.  
 
The characteristic of light source on the efficacy of both PDT and APDT is 
essential and therefore requires development for its use in clinical applications. 
Comparative studies are devised to show efficiency on both Gram positive and 
Gram negative bacteria using the same photosensitizer and different light sources, 
along with knowledge of the killing behaviour across a wide range of target 
physiochemical condition. The majority of these studies can be most usefully 
developed in vitro. 
 
The light source is measured by power density, which is normally given in 
mWcm
-2 whereas the light dose is mJ cm
-2   which is the total energy received. The 
total energy is calculated as the power density multiplied by the illumination time 
(in seconds) that is mWcm
-2 x s = mJcm
-2
. The power density, the illumination 
time or both can be varied to give the same light dose. Despite the equivalent dose 
the microbial kill from the exposure to low power density over a long time 
compared to high power density over a short time period is not equivalent 
(Wainwright 1998).  
   
Incoherent light 
Natural light is incoherent, polychromatic consisting of light of different 
wavelengths and is divergent, typically radiating in all directions (Wilson, 1993). 
Sunlight has been used in APDT as source of light to activate PSs. Zeina et al. 
(2001) showed sunlight with photosensitizer MB (100 g/ml) was highly effective 
in killing S. aureus and S. epidermidis. In a study carried out to show inactivation 
of micro-organisms in the environment it was shown that V. fischeri in 
aquaculture water was inactivated by sunlight (Alves et al., 2011). The use of 
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solar energy as an alternative to the other illumination systems could be 
economically viable for regions with a high degree of sunlight radiation and could 
be used for the treatment of contaminated wastewaters as well as for the 
disinfection of drinking water and of aquaculture water (Alves et al., 2011).  
 
Incoherent light sources include lamps with continuous spectrum (incandescent 
lamps, xenon arc lamps) or sources with the spectrum in discrete bands (gas 
discharge lamps or metallic vapour lamps) (Calin and Parasca, 2009). 
Photodynamic inactivation of micro-organisms has been demonstrated using 
incoherent light sources such as (some) light-emitting diodes and tungsten, 
halogen and xenon lamps (Calin and Parasca, 2009). Incoherent light sources are 
easy to use and comparatively cheap (Ackroyd et al., 2001). Incoherent light has 
several advantages as a light source for PDT: the polychromatic nature of the light 
means that different PSs with different absorption maxima may be used, and large 
illumination fields may be achieved for use over large areas, which is particularly 
relevant to dermatological indications. Incoherent light sources are also relatively 
cheap, easy to operate and are readily available (Pervaiz and Olivo, 2006). 
However, the disadvantages of incoherent light are low intensity of the required 
wavelengths, difficulties in management of light dose, and significant thermal 
effects (Pervaiz and Olivo, 2006). The low intensity of incoherent light means that 
long exposure times are generally required for a therapeutic effect to be achieved 
(Wilson, 1993). However, incandescent lamps have proven useful in APDT, 
especially for Staphylococcus aureus and Escherichia coli (Calin and Parasca, 
2009).  
 
Ultraviolet 
Light with wavelength less than 300 nm is absorbed by proteins and nucleic acids 
and induces bacterial killing due to dimerization of DNA (Wilson, 1993). 
However ultraviolet (UV) is rarely used as a source of light in killing of micro-
organism in human infections due to its potential to cause mutagenic effects 
(Wilson, 1993). 
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Coherent Light (Laser) 
Laser is an acronym of light amplification by stimulated emission of radiation. 
Lasers produce high-energy monochromatic light. Monochromaticity permits 
irradiation with the exact wavelength at which a certain PS has its absorption 
maximum (Pervaiz and Olivo, 2006). Laser is seen as an ideal light source for the 
photodynamic inactivation of bacteria, due to its monochromaticity and coherence 
(Calin and Parasca, 2009). The high power of laser light makes it ideal since 
shorter exposure times can be employed to kill microbes by APDT (Wilson, 
1993). In addition the laser light is easily coupled into fibers for highly controlled 
delivery of light to the location of treatment (Calin and Parasca, 2009). These 
characteristics make laser light an appropriate candidate for clinical applications. 
In addition to activation of PS by the laser light, laser light alone may have other 
photobiological effects within the body tissue such as bactericidal, regenerative 
and vasodilative effects (Vladimirov et al., 2004).  
 
A variety of lasers have been used over the years; these are described in terms of 
the lasing medium used to generate the beam, which may be a gas, dye, and 
crystal or semiconductor diode. Examples include the helium/neon (He-Ne), 
carbon dioxide, gallium aluminium arsenide (GaAlAs), Argon dye and 
neodymium yttrium aluminium garnet (Nd : YAG) lasers (Wilson, 1993). For 
APDT studies the most frequently used lasers are the helium–neon (He-Ne) laser 
and the semiconductor laser (diode laser). These have the advantage of being 
relatively cheap, of smaller size, portable and reliable. The use of He-Ne laser 
light has been well documented in APDT in particular inactivation of S. aureus 
and P. aeruginosa (Calin and Parasca, 2009).   
1.6 Mechanism of APDT  
The antimicrobial photo damage at the molecular level in many cases is well 
established (Wainwright, 1998). The PDT or APDT reaction starts when a light of 
appropriate wavelength to activate the PS molecule to the excited singlet state that 
ultimately leads to production of cytotoxic species damaging bacterial cells 
(Wainwright, 1998). Figure 1.5 shows diagrammatic illustration of the light 
absorption and energy transfer processes that takes place during APDT.  
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Figure 1-5: Schematic illustration of photophysical and photochemical 
mechanisms of APDT (adapted from Castano et al., 2004). 
Mechanisms of ROS generation by combination of light, photosensitizer (PS) and 
ground state triplet oxygen (
3
O2). Ground state photosensitizer (
1
PS) is irradiated 
with visible light generating excited singlet state PS (
1
PS*). 
1
PS* can relax back 
to excited triplet state photosensitizer (
3
PS*) generating superoxide radical (type I 
mechanism) and/or excited state singlet oxygen (
1
O2) (type II mechanism). 
   
A photodynamic reaction starts with the absorption of light (photons) by the 
ground state PS. The ground state PS has two electrons with opposite spins (this is 
known as singlet state) in the low energy molecular orbital. Following the 
absorption of light, one of these electrons is boosted into a high energy orbital but 
keeps its spin (first excited singlet state). This is a short-lived species, lasting nano 
seconds (Phillips, 1997), which is a very short time for any significant interaction 
to take place with the surrounding molecules. The excited singlet species therefore 
loses its energy by emitting light (fluorescence) or by internal conversion to heat. 
The excited singlet state PS may also undergo the process known as intersystem 
crossing whereby the spin of the excited electron inverts to form the relatively 
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long-lived (microsecond) excited triplet-state that has parallel electron spins 
(Castano et al., 2004). The long lifetime of the triplet state PS is due to the fact 
that loss of energy by emission of light (Phosphorescence) is a spin-forbidden 
process. This triplet state is long lived enough to take part in chemical reactions 
and therefore most of the photodynamic reactions take place when in triplet state. 
Therefore it is recognized that triplet state of the photosensitizer is responsible for 
the generation of cytotoxic species produced during PDT and APDT (Jori and 
Spikes, 1990). Interaction of the triplet excited PS with surrounding molecules 
results in two types of photo-oxidative reaction, type I and type II (Foote, 1991; 
Castano et al., 2004). 
 
Type I reaction  
In type I reactions the excited triplet state PS (S*) reacts directly with a local 
substrate R, via electron or hydrogen transfer. This leads to the production of 
radicals or ion radicals (Sharman et al., 2000). Equation 1 and 2 shows the two 
possible electron transfer reactions between an excited photosensitizer and 
substrate R. Subsequent redox reactions and oxygenation products rely on close 
proximity of the photosensitizer and the biomolecular target. A type I reaction 
with water in the microbial milieu can give rise to hydroxyl radicals (HO•) which 
can also react with biomolecules or combine to give hydrogen peroxide in situ 
with subsequent cytotoxic results (Wainwright, 1998).  
3
S* + R  S .-  + R .+            (1)  
3
S* + R  S .+  + R .-                   (2)   
The PS and substrate radicals produced in turn react with other substrate 
molecules. If PS reacts with ground state oxygen it leads to formation of cytotoxic 
oxidation products (Wainwright, 1998). Type I reactions frequently involve initial 
production of superoxide anion by electron transfer from the triplet PS to 
molecular oxygen (Castano et al., 2004). PS radicals ideally react in a way that 
regenerates the ground state PS to enable another reaction cycle continuing the 
process.  The excited PS (S*) can also directly transfer an electron to molecular 
oxygen producing superoxide (Sharman et al., 2000) (equation 3).  
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3
S* + 
3
O2  S 
.+  
+ O2
.-             
(3)  
Equation 4 to 6 shows chain reaction induced by hydrogen transfer (Sharman et 
al., 2000).  
3
S* + RH  SH.  + R.                              (4)  
R
.
 + O2  ROO
.                                          
(5)  
ROO
.
 + RH  ROOH + R.          (6)  
 
Type II reaction  
A type II photodynamic reaction is an energy transfer reaction where the excited 
triplet state PS (
3
S*) transfers its energy directly to a ground state oxygen 
molecule (
3
O2), generating the reactive oxygen species, singlet oxygen  (
1
O2) 
(Sharman et al., 2000) equation 7, that in turns react with various substrates 
(Sharman et al., 2000).   
3
S* + 
3
O2  
1
S + 
1
O2
                                 
(7)  
Singlet oxygen is thought to play the key role in APDT (Maisch et al., 2007). 
Singlet oxygen is electrophilic and is able to oxidise a variety of electron rich 
substrate molecules, such as polyunsaturated lipids, cholesterol, proteins and 
nucleic acid bases, especially guanine (Agnez-Lima et al., 2012). Singlet oxygen 
readily reacts with amino acids containing double bonds (Wainwright, 1998).  
The type-I and type-II reactions shown above are described as the primary 
processes in PDT and APDT. Superoxide (O2
.-
), singlet oxygen (
1
O2) and 
hydroxyl radical (HO•) interact to produce peroxy-radical (RO*2) alkoxy-radical 
(RO*), hydroperoxides and peroxide (ROOR) (Singh, 1982). Superoxide can react 
with a variety of compounds including hydroxyl radical to form singlet oxygen, or 
nitric oxide radical to produce peroxynitrite, another highly reactive oxidising 
molecule.  
   
One of the important reactions of superoxide is the production of hydrogen 
peroxide in the presence of the enzyme superoxide dismutase that catalyses this 
reaction; also known as dismutation. Hydrogen peroxide is important in biological 
systems because it can readily pass through cell membranes (Gutteridge and 
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Halliwell 1990). Another important reaction is the Fenton reaction, which occurs 
in the presence of Fe
2+
 ions. In this reaction Fe
2+
 ions acts as a catalyst to convert 
hydrogen peroxide into hydroxyl radical. This reaction is important in biological 
systems because most cells have some significant levels of iron and is an 
important source of highly reactive species such as superoxide, hydroxyl and 
alkoxy radical. The highly reactive hydroxyl radicals undergo three main types of 
reactions. The first is addition to double bonds to give secondary radicals. There 
are many types of molecules in the cell containing double bonds such as an 
unsaturated fatty acid could form hydroxylated adduct. The second type of 
reaction is where hydroxyl radical can oxidize a substrate by abstraction of an 
electron from it, for example it could react with oxygen to produce peroxyl 
radical. The third type of reaction is the transfer of electrons where hydroxyl 
radical can cause electron transfer reactions with organic and inorganic 
compounds. This type of reaction produces highly reactive species, resulting in 
chain reactions responsible for oxidative damage of fatty acids and lipids. This 
demonstrates why radicals such as hydroxyl radicals can cause so much damage 
(Wainwright, 1998). 
   
These further reactions are free radical secondary processes, which depend on the 
particular chemical environment in which the reactions are occurring. All these 
species have the potential to cause cellular damage.  Hence both type I and type II 
pathways can lead to damage to cellular proteins or cell death (Wainwright, 
1998).  Both type I and II can occur simultaneously and which pathway is 
dominant depends on the concentration of PS and on environmental factors such 
as oxygen supply. A low oxygen concentration or more polar environments will 
favour a type I reaction (Wainwright, 1998; Sharman et al., 1999).   
1.7 Methods used to study the mechanism of APDT  
The evidence supporting the involvement of singlet oxygen in APDT by detection 
of singlet oxygen is confirmed using different techniques. The evidence to support 
the formation of singlet oxygen in a system is obtained when that system produces 
light (distinctive monomol luminescence) at approximately 1270nm (Sharman et 
al., 2000). The direct method of detecting singlet oxygen and free radicals include 
22 
 
electron spin paramagnetic resonance (ESR or EPR) and spin-trapping methods 
(Hadjur et al., 1997).  Singlet oxygen is not commonly studied with the electron 
spin resonance (ESR) technique in biological systems; because there are few 
suitable detecting agents and the detection of singlet oxygen in vivo is difficult 
due to its short lifetime in cells (Moan and Berg, 1991). Also because of the rapid 
rate of singlet oxygen consumption and low luminescent quantum yields of singlet 
oxygen (only 200 singlet oxygen molecules per billion undergo irradiative decay) 
luminescence emission cannot be detected from the cell (Gorman and Rodgers, 
1992).  
  
Other methods of evidence for involvement of singlet oxygen are obtained 
through indirect methods using competitive quenchers.  Indirect method of using 
quenchers supports the hypothesis of involvement of singlet oxygen and other 
reactive oxygen species in APDT. Quenchers of singlet oxygen inhibit the photo-
damage caused during APDT.  There are a variety of scavengers and quenchers of 
specific reactive oxygen species, which provide protection against APDT 
cytotoxic effects.  Reagents such as 1,4-diazabicyclo-2,2,2-octane (DABCO), 
methionine, tryptophan, propylgallate, mannitol and cysteine have proved to 
reduce the microbial killing due to quenching effects by these scavengers and 
quenchers under APDT conditions in the presence of PS and light (Nitzan et 
al.,1989; Bhatti et al.,1998).  
   
Another method of testing the involvement of singlet oxygen is seen by the 
variation in the lifetime of singlet oxygen in heavy water (D2O). Singlet oxygen 
has normally a lifetime of 3 s which increases to 65 s in heavy water (Gorman 
and Rodgers, 1992). This increase in the lifetime of singlet oxygen results in more 
time for singlet oxygen to cause cytotoxic damage to the cell. Therefore in the 
presence of heavy water the kill rate by PDT and APDT is increased.  Heavy 
water is considered a specific singlet oxygen identification substance. However, in 
the presence of D2O the quantum yield of triplet state formation for the PS is also 
greater, which will favour both the type I and type II reaction pathways (Phillips, 
1997; Rosenthal and Ben-Hur 1995). Moreover, structural variations in cell target 
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proteins may occur in presence of D2O environments compared to H2O, making 
proteins more susceptible to oxidative damage via type I and type II mechanism. 
Heavy water may also have a negative effect on the ability of the cell repair 
system, thus increasing the damaging effects of PDT (Rosenthal and Ben-Hur, 
1995). The use of other quenchers to study the mechanism of APDT is also 
limited because these quenchers are not entirely specific to singlet oxygen and can 
cross react with other reactive oxygen species produced during PDT processes.  
For example, azide is an effective quencher of singlet oxygen but is also known to 
react with hydroxyl radical but at a much slower rate. Tryptophan is a quencher of 
singlet oxygen, but has been shown to react under certain circumstances via a 
mixed type I/type II mechanism (Shopova and Gantchev, 1990). Therefore 
identifying the mechanism of APDT processes with quenchers and D2O requires 
careful examination of the reaction products and understanding the limitations of 
each method.   
1.8 Mechanism of APDT damage to bacteria  
The overall mechanism of photodynamic therapy takes place in two distinct steps. 
The first step is the photophysical and photochemical properties of the PS and its 
ability to generate cytotoxic agents. The second step is the biological response of 
the cell to the cytotoxic agents (Wainwright, 1998). The efficiency of step one is 
determined by the activity of the photosensitizing drug, which is governed by both 
the lifetime and yield of the triplet state of the PS, which in turn have an effect on 
the quantum yield of singlet molecular oxygen formation. Singlet molecular 
oxygen is regarded as the main mediator of phototoxcity in APDT (Wainwright, 
1998). The ROS and singlet oxygen produced are oxidising agents that can 
directly react with many biological molecules. One of the damaging reactions is 
when radical species react with oxygen producing lipid hydroperoxide. Lipid 
hydroperoxide is detrimental to membrane integrity, leading to loss of fluidity 
allowing leakage of cellular contents and increased ion permeability (Wainwright, 
1998) or inactivation of membrane transport systems and enzymes (Hamblin and 
Hassan, 2004).  
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Type II processes are known as the major pathways in photooxidative microbial 
cell damage. Singlet oxygen reacts with molecules involved in the maintenance 
and structure of cell wall membrane such as phospholipids, peptides and, for 
yeasts sterols (Wainwright, 1998). Reactions of other molecules with singlet 
oxygen also occur. Amino acids in proteins are known to be important targets and 
these include cysteine, methionine, tyrosine, histidine and tryptophan (Grune et 
al., 2001; Midden and Dahl, 1992). Tryptophan undergoes cycloaddition with 
singlet oxygen. Also methionine reacts with singlet oxygen producing methionine 
sulphoxide   (Bonnett, 1995; Wainwright, 1998).   
 
The photodynamic processes can also damage DNA at both nucleic acid bases and 
sugars that link the DNA by oxidation or cross-linking of DNA to protein 
(Wainwright, 1998). One of the main reactions of nucleic acids is the reaction, 
which results in production of guanosine residue (Hamblin and Hassan, 2004). Of 
the four bases in the nucleic acid guanine is the most susceptible to oxidation by 
singlet oxygen (Foote, 1991).  Cells are known to have some capability of fixing 
oxidative damage caused to proteins and DNA. However DNA cross-linking and 
strand breakage are particularly difficult for the cell to repair and excessive 
damage can cause mutations or cell death (Wainwright, 1998) 
 
It has been shown that, although DNA damage occurs, it may not be the prime 
cause of bacterial cell death as Deinococcus radiodurans, which is known to have 
a very efficient DNA repair mechanism and is very tolerant to UV or radiation, 
is easily killed by APDT (Hamblin and Hassan, 2004). Photodynamic treatments 
have been shown to result in the alteration of cytoplasmic membrane proteins 
(Valduga et al., 1999; Bertoloni et al., 1990).  Therefore APDT works by 
targeting multiple components of the cell. 
1.9 Photodynamic Inactivation of Microbial Cells  
The cellular structural differences between different micro-organisms is an 
important factor affecting the way in which photosensitizing agent can interact 
with the cell targets and influence both the efficiency of photosensitizing agent 
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and the mechanism of action. Bacteria are grouped into two main categories 
Gram-positive and Gram-negative organisms, based on their cellular structure and 
organization. The main differences in these two groups are the differences in their 
outer cell wall structure as shown in Figure 1.6. This difference in structure 
influences the permeability of the cell wall of the targeted micro-organism to the 
PS which is an important factor that determines antimicrobial activity of 
photodynamic processes (Bertoloni et al., 1992; Wainwright, 1998). Whilst the 
majority of the PSs are effective against Gram positive bacteria, many have 
exhibited low efficacy against Gram negative bacteria, due to the extra barrier 
posed by the negatively charged outer membrane of the Gram negative species 
(Minnock et al., 2000; Nitzan et al., 1992).  
 
To overcome this intrinsic resistant feature of gram-negative organisms, different 
approaches have been used. These include administration of membrane 
permeabilising agents in conjugation with PS (Bertoloni et al., 1990), stimulating 
the endogenous synthesis of bacterial porphyrins as endogenous PSs (Hamblin et 
al., 2005) and the use of PSs chemically modified to possess a positive charge 
(Malik et al., 1992), to target the outer membrane. In a study carried out on the 
Gram-negative species E. coli and Klebsiella pneumonia, pre-treatment of bacteria 
with EDTA allowed a significant concentration of the PS to penetrate to the 
cytoplasmic membrane killing the organisms; this supports the importance of the 
cytoplasmic membrane as a critical target for bacterial cell photo-inactivation 
(Bertoloni et al., 1990). Using outer wall membrane disrupting agents such as 
EDTA allows PS to penetrate and to overcome the negative charge barrier of the 
Gram-negative cells. The cell wall structure of the target micro-organism is 
important to antimicrobial PDT. In order to efficiently inactivate a micro-
organism, the PS has to reach the cytoplasmic membrane and thus has to pass 
through the cell wall. However, it is more desirable in a clinical setting to have an 
effective PS without a need for additional chemicals. Therefore, it is more 
favourable to use cationic PSs such as MB, which bind to a broad spectrum of 
microbial species and is light-active in itself without the addition of further 
chemicals (Jori et al., 2006).  
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Figure 1- 6: Diagrams illustrating differences in membrane structure between  (a) The 
Gram-positive and (b) Gram-negative bacteria. (diagram adapted from Jori et al., 2006) 
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APDT has also been demonstrated to destroy virulence factors associated with 
bacterial infections. PDT with TBO were shown to affect the potency of two key 
bacterial virulence factors, lipopolysaccharide (LPS) and proteases (Komerik et 
al., 2000). The target species for photoinactivation are mainly bacteria although 
other micro-organisms (yeasts, protozoan) are sensitive to APDT (Zeina et al., 
2001). The possibility of bacterial photoinactivation in vitro by APDT has been 
experimentally proven many times with various combinations of PSs and different 
light doses and table 1.1 shows a summary of previous research carried out 
against a number of different micro-organisms. From these studies it can be 
concluded that APDT may be effective in killing microbial organisms in 
infections, for sterilisation and as a disinfectant. Also these studies show the 
effectiveness of APDT is dependent on the concentration of PS, light dose and the 
microbial species. However from the APDT studies carried out so far, it is 
difficult to compare one study with the other since either may be carried out under 
different conditions even for the same combinations of PS and light. 
28 
 
 
Table 1- 1 Use of PSs and light to inactivate micro-organisms 
Reference  Micro-organism 
and 
concentration 
(CFU/ml) 
PS and PS 
concentration 
 
Irradiation protocol  Fluence 
rate 
(W/cm2) 
Radiation 
time 
(Minutes) 
Total 
light 
dose 
(J/cm2) 
Killing effect 
Embleton et 
al., 2002 
Epidemic 
meticillin-resistant 
Staphylococcus 
aureus-16 
(EMRSA)  
1x10
9
-1x10
10
 
SnCe6-IgG 
4.2 mg/ml 
Helium-neon laser 
Wavelength 632.8 nm 
(measure light output 35 
mW) 
- 5 21 Growth phase of bacteria   
lag-70% 
Exponential-99.9% 
Stationary phase-99.7% 
Gross et al., 
1997 
S. aureus Cowen  
1x10
5
 
 Bacteriochlorophyllide 
IgG conjugate (10 μM) 
140 5 42 99.9% 
Wilson and 
Yanni, 1995 
S.aureus MRSA 
strain 
1.3x10
10
 
TBO  (12.5 μg ml−1) 
Helium-neon laser 632.8 
nm wavelength (light 
output 35 mW) 
- 
1 43 99.99% 
 
 
Alves  et 
al., 2009 
Enterococcus 
faecalis  
10
7
 
 
5,10,15,20-tetrakis 
(1-
methylpiridinium4-
yl) porphyrin tetra-
iodide (Tetra-Py+-
Me) 1 μM 
White light (380-700 nm) 40  270 64.8 PS concentration- 1 μM 
7.33 log reduction 
(99.7%) 
PS concentration- 0.5 
μM 5.07 log reduction 
(93.23%) 
Alves et al., 
2009 
E. coli 
10
7
 
5,10,15,20-
tetrakis(1-
methylpiridinium4-
yl) -porphyrin tetra-
iodide (Tetra-Py+-
Me) 1 μM 
White light (380-700 nm) 40  270 64.8 
> 7 log reduction of 
survivors (99.999%) 
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Banfi et al.,  
 
2006 
Pseudomonas 
aeruginosa 
10
8
 
5,15-Di (N-(4-meth 
oxybenzyl)-4-
pyridyl) -10,20-di(4-
pyridyl) porphyrin 
dichloride 
(dicationic 
porphyrin)  
8 µM 
Visible light 
 
 60 
 
266   > 7 log reduction of 
survivors 
 
 
 
 
Foschi et 
al., 2007 
 
E. faecalis (ATCC 
29212) 
10
9
 
MB 
16.75 M 
 
Diode laser 
 
 
100 
 
10 
 
60 
77.5% reduction 
Souza et al., 
2010 
C.albicans 
10
6
 
TBO, MB, malchite 
green (concentration  
0.1 mg/ml) 
Light source GaAlAs laser 
with a wavelength of 660 
nm, output power 0.035 W 
Illuminated area 0.38 cm
2
. 
  
428 sec (15 
J) 
 
39.5 
TBO- 3-log reduction 
 
MB- 2.71-log reduction 
 
Malachite green-2.25 log 
reduction 
Zolfaghari 
et al., 2009 
EMRSA-16 in 
excision wound 
model- wounds 6 
mm (28 mm
2
); 25 
μl of cell 
suspension (10
8 
cfu)  
25 mm
2 
square 
shaped wounds by 
scarification. 10 μl 
of the suspension 
placed on wound 
(4×10
7 
cfu). 
MB 
100 μg ml−1 
The light source used was 
a 665 nm diode laser  
 
200 
 
30 
 
360 
25-fold reduction in 
number of viable 
EMRSA- 16 (1.4 
logCFU/ wound- in 
excision wounds) 4 fold 
reduction (1.15 log CFU/ 
wounds- in superficial 
scarified wounds 
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Zeina et al., 
2001 
S. aureus , S. 
epidermidis, 
Strep pyogenes , 
C. minutissimum, 
P. acnes, 
Candida albicans  
Bacterial cells 10
8
-
10
9
 
 
C. albicans 10
7 
 
MB 
100 μg ml−1 
Polychromatic visible 
light 
42 10-60 25.2-
151J 
Staphylococcus aureus –
kill rate 0.9 log cfu/ml, D 
value 72s 
 
Staphylococcus 
epidermidis -kill rate 
1log cfu/ml , D value 66s 
 
Streptococcus pyogenes -
kill rate 1.15 log cfu/ml,  
D value 48s 
 
Corynebacterium 
minutissimum – kill rate 
0.7log cfu/ml, D value  
120s  
Propionibacterium acnes 
-kill rate 1.85log cfu/ml, 
D value  30s 
 
Candida albicans -kill 
rate 0.09 log cfu/ml, D 
value 660s  
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To show the killing effect of antimicrobial agents, kill kinetics are derived and 
expressed as kill rate and corresponding D values which make it easier to 
understand the effectiveness of the agent and to compare it under different 
conditions. Figure 1.7 shows a model graph of ideal kill kinetics depicting a 
survival curve showing potential variations in pattern. In some studies, key 
information about the kill rate (K) is not given or presented; merely “before and 
after” measurements, thus making it difficult to accurately assess the efficacy of 
treatments or compare results from different studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-7: Ideal first order kill kinetic survival curve with examples of non-
ideal behaviourThe solid line shows an ideal representation of first order kill 
kinetics. Non-ideal curves commonly encountered include (1) Multi-phasic; 
there is an apparent delay and slow rate of kill before the reaction accelerates 
to maximum rate. (2) Multi-phasic; the reaction rate decelerates slowly with 
time. (3) Multi-phasic; the reaction abruptly ends, marking the end of the 
killing phase. 
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Figure 1.7 shows the ideal first order kill kinetics survival curve and non ideal 
mulitipahsic curves. Likely reasons for multiphasic curves include a multi-hit 
process, where agent molecules must hit many targets in the cell before killing 
commences. If the target cells are mixed species with a range of susceptibilities 
(e.g. Bacillus vegetative cells plus a proportion of endospores), then a rapid rate of 
kill will be followed by a much slower rate; depending on the ratio of vegetative 
cells to spores. Some killing agents at low concentrations can be neutralised by 
the chemical environment (especially with additions like serum), and if the target 
population is high, the agent rapidly runs out of killing power. This is true of 
agents that decay, or are specifically neutralised by other components. It should be 
noted that assay systems have a minimum level of detection, below which 
reductions of the target cells may still be occurring but cannot be detected. For 
viable count, the minimum detection level is typically 10
2
 cfu ml
-1
. For 
bioluminescence, the background readings remain constant at the minimum 
detection level. An apparent deceleration will occur, but this is dependent on the 
detection system rather than the reality of the reactions.  
 
If multiphasic, but without a significant shoulder, the initial kill rate is analogous 
to an initial reaction rate in enzyme kinetics, and (within limits) is proportional to 
the concentration or magnitude or flux of killing molecules or particles (photons) 
depending on the type of agent. A well-standardised assay system can thus be 
used to determine the strength or efficacy of the treatments in question. 
 
Kill rates: A reduction of a population is equivalent to a negative growth rate (-μ). 
The specific growth rate in batch culture with unrestrained growth conditions is: 
 μ = (lnNx – lnN0)/tx-t0 ……………… (Eq 1) 
Where  is the specific growth rate, and Nx and N0 are numbers of cells at zero 
time (t0) and later time (tx). The equivalent for kill rate (-μ) is given by: 
−μ = (lnSx – lnS0)/tx-t0 ……………… (Eq 2) 
Where Sx and S0 are numbers of survivors at zero time (t0) and later time (tx). 
However, in many studies kill rates are more often reported in log10 units (log-fold 
reduction per time unit). This is given as: 
33 
 
Κ = (log10Sx – log10S0)/tx-t0  (Eq 3) 
From this is derived the decimal reduction time (D) 
D = 1/K = tx-t0/(log10Sx – log10S0)  (Eq 4) 
In this thesis, all kill rates are reported as K or its reciprocal, D, the time it takes to 
achieve a 90% kill. 
1.10 Electrochemically Activated Solutions (ECAS) 
APDT and ECAS are proposed as alternative methods of clearing microbial load 
in both clinical and environmental settings. These treatments have the potential to 
be applied to various settings. Figure 1.8 shows possible applications of ECAS. 
 
Figure 1-8: Applications of ECAS (showing a broad spectrum) 
   
Electrochemically activated solutions (ECAS) are produced from tap water and 
low-concentration salt solutions (Bakhir et al., 1999) using a flow through 
electrolytic module (FEM), comprising of coated titanium electrodes that are 
separated by electro-catalytic ceramic diaphragm. ECAS are known to exhibit 
high redox potential, contain free radical species and exist in a metastable state 
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(Robinson et al., 2011). The metastable status of ECAS is not permanent. 
However it has been shown that by storing at low temperature the activity can be 
prolonged (Robinson et al., 2012). 
   
Electrochemical treatment of low concentration salt solution in the anode and 
cathode chambers results in synthesis of two types of solutions. Solutions 
produced at the cathode chamber are called catholyte and solution produced at the 
anode chamber is termed the anolyte (Shetty et al 1999; Selkon et al., 1999). It is 
the solution produced at the anode that has bactericidal and sporicidal activity that 
is not toxic to human tissue and essentially non-corrosive for most metal surfaces 
(Shetty et al 1999; Selkon et al., 1999).  Anolyte solutions contain a mixture of 
oxidizing substances and it is this solution that is very effective at killing bacteria, 
viruses, fungi and protozoa (Prilutskii et al., 1996; Bakhir et al., 1999).  
 
The microbicidal activity of ECAS (super oxidised water) have been 
demonstrated against Escherichia coli (including type 0157), Pseudomonas 
aeruginosa, Bacillus subtilis var. niger spores, methicillin-resistant 
Staphylococcus aureus, Clostridium difficile spores, Helicobacter pylori, 
vancomycin resistant Enterococcus species, Candida albicans (Shetty et al 1999; 
Selkon et al., 1999). This microbicidal activity against a variety of organisms is 
very important as ECAS can be used as a very effective disinfectant or as a broad-
spectrum biocide.  
 
The main attractive feature of electrochemically-activated solution is it is highly 
active against micro-organisms killing 99.999% or greater, in 2 minutes or less (D 
values for example MRSA was 2.08s and 1.98 s for P. aeruginosa) (Robinson et 
al., 2010). It is recognised that ECAS are potent microbiocidal agents (Selkon et 
al., 1999, Shetty et al., 1999). They are also non-toxic when in contact with vital 
biological tissues (Shraev et al., 1993). Clinical applications of anolyte and 
catholyte have been reported to be effective (Malakhov et al., 1994). ECAS has 
been used in dermatological washing, cleaning and dressing of wounds and 
disinfection of instruments (Leonov, 1997). It is also widely used as a disinfectant 
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in hospitals and dental clinics in Japan (Al-Haq et al., 2002). ECAS has use in 
environmental decontamination (Marais and Williams, 2001) and within the food 
industry as a disinfectant (Koseki et al., 2004). Therefore ECAS has been 
suggested to have wide range of application from health care setting to broad-
spectrum disinfectant.  
 
Biocides kill micro-organisms through the targeting of several structures or 
macromolecules or biochemical pathways (McDonnell and Russell 1999). It has 
been shown that ECAS anolyte cause bacterial death by complete destruction of 
proteins or by causing oxidative stress resulting in protein fragmentation (Cloete 
et al., 2009), which is similar to APDT killing of microbial cells. Moreover, 
exposure of micro-organisms to the high oxidation reduction potential (ORP) 
environment in ECAS is known to create an unbalanced osmolarity between ion 
concentrations in the solution and that of the unicellular organisms, further 
damaging membrane structure (Thorn et al., 2012). 
   
Despite considerable research in electrochemical processes and its practical 
applications as a disinfectant and its use as a biocide in various environments, the 
killing mechanisms of electrochemically-activated solutions have not been fully 
identified. Some studies have attributed the high bactericidal capacity of 
electrochemical (EC) processes to electrochlorination (Rodgers et al., 1999), 
destruction caused by electric field (Grahl and Markl 1996), and inactivation by 
production of energy rich short-lived intermediate products. Also research has 
shown the critical role of free radicals generated during electrolysis such as O2
-.
, 
OH
-
, ClO2
-. and HClO-. in exerting strong germicidal action (Patermarakis and 
Fountoukidis, 1990; Oturan, 2000). A study on electrochemical disinfection of 
saline wastewater effluent showed that electrochlorination is not the predominant 
disinfective means of EC process. This study concluded that the production of 
more powerful but short-lived killing substances, free radicals, occurs which are 
facilitated by chloride ions to provide the strong disinfecting action within short 
contact time. The study also showed the importance of Cl
- ions and with excess Cl
- 
the chain reaction produces more OH
.  radicals and extends the lifetime of OH
.  by 
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a factor of 10, thus making it more useful in the destruction of cells (Li et al., 
2002). Although these studies explain the mechanism of bactericidal capacity of 
electrochemical processes and ECAS, it does not explain fully how it can kill 
organisms in such a short contact time and therefore it is necessary to find 
evidence for this superior action and to find the predominant killing action.  
1.10 Comparison of APDT and ECAS 
In this present study it is proposed that by using specific scavengers of free 
radicals and singlet oxygen scavengers and stabilisers, the mechanism of ECAS 
could be understood. It is known that the mode of action of APDT is mainly due 
to damage caused by singlet oxygen with an element of free radical damage.  
Singlet oxygen is known to be very potent to cells and is a short-lived reactive 
species. The killing action of ECAS also involves free radical species and may 
have similarities to APDT. 
 The approach in this thesis was to compare APDT to ECAS. It is anticipated that 
this approach of comparing and contrasting these two antimicrobial agents under 
the same standardized conditions will lead to comprehensive understanding of 
these two antimicrobial agents. Previously, different workers have made 
mechanistic studies of both APDT and ECAS but none have studied them in 
tandem together.  
 
ECAS was chosen for comparison with APDT for several reasons. They are both 
known to damage micro-organism due to ROS and hydroxyl radical, and both 
agents can be applied to localised infections. Therefore the first aim of the study 
was to develop a rapid kill kinetic assay based on lux transformed bioluminescent 
species in order to compare the properties and mechanism of the two agents under 
standardised conditions.  
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1.11 Rapid bioluminescence method to evaluate activities of APDT and 
ECAS   
New methods of applying the bioluminescence approach for rapid and simple 
detection activities of bacteria are required for faster development of these 
alternative agents in order to understand their effectiveness and mechanisms of 
action.  
1.11.1 Bacterial Bioluminescence  
Bioluminescence refers to the process of visible light emission, by the enzyme 
catalyzed chemical reactions, in living organisms (Meighen, 1993). 
Bioluminescent organisms are widely distributed in nature (Campbell, 1989). The 
phenomenon of bioluminescence has been observed among bacteria, 
dinoflagellates, fungi, fish, insects, shrimps and squids. This set of organisms 
includes terrestrial, freshwater and marine species (Meighen, 1993).  
Almost all bioluminescent bacteria have been classified into the three genera 
Vibrio, Photobacterium and Photorhabdus (formally Xenorhabdus). 
Bioluminescent bacteria are the most abundant and widely distributed among the 
light emitting organisms and are found in marine, freshwater and terrestrial 
environments as free-living species, saprophytes, parasites, or as light organ 
symbionts in a number of aquatic species (Alves et al., 2011). All naturally 
occurring bioluminescent bacteria that have been characterized are Gram-negative 
rods and can function as facultative anaerobes (Meighen, 1991). The most studied 
group of bioluminescent bacteria include Vibrio harveyi, Aliivibrio fischeri, 
Photobacterium phosphoreum, Photobacterium leiognathi, and Photorhabdus 
luminnescens. 
Light production by bacterial symbionts of higher organism may serve to attract 
prey, in intra species communication or to escape from predators (Martin et al., 
1989).  P. luminnescens has only been found infecting terrestrial organisms acting 
in symbiosis with nematodes in a parasitic infection of caterpillars (Meighen, 
1991). This bacterium has been isolated from human wounds (Meighen, 1991). 
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1.11.2 Bioluminescence systems in bacteria  
Bioluminescence is an enzyme catalyzed chemiluminescence reaction in which 
free energy released ultimately leads to the emission of a photon. The enzymes 
that catalyze the bioluminescent reaction are called luciferases and the substrates 
are known as a luciferin (Hasting, 1996). In all bioluminescence systems oxygen 
is required for light emission (Meighen, 1993). The structures of luciferases and 
luciferins are different from one bioluminescent organism to the other (Meighen, 
1993). Consequently, the light-emitting reactions are quite distinct among 
different organisms.  
The bacterial light emitting reactions catalyzed by luciferase, involves the 
oxidation of reduced riboflavin phosphate (FMNH2) and long chain fatty aldehyde 
(tetradecanal) with the subsequent emission of blue green light at 490 (Meighen, 
1993). The natural aldehyde for the bioluminescence reaction is believed to be 
tetradecanal on the basis of identification of this compound in lipid extract.   
The reaction involves reducing power (FMNH2) and adenylate energy, since it is 
dependent on the metabolic activity of the bacteria (Vesterlund et al., 2004). 
Under conditions in which FMNH2 and ATP is continually supplied in a lux-
expressing bacterium, luminescence remains at a constant level (Meighen, 1993). 
Figure 1.9 shows the light emission by bioluminescent bacteria captured by ICCD 
photon counting camera. The reaction is as follows:  
                                 Luciferase 
FMNH2 +RCHO +O2                              FMN +RCOOH + H2O +light (490nm) 
 
Figure 1-9: (a) Image showing growth of bioluminescent E. coli Nissle 
pGLITE on the surface of nutrient agar plate (b) biolumiescent E. coli Nissle 
pGLITE expressing the lux gene coding for the emission of light image 
captured ICCD photon-counting camera: Red colour represents higher light 
emission and Green, low light emission 
(a) (b) 
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The lux genes, required for bacterial bioluminescence are arranged in a single 
operon luxCDABE, encodes the luciferase and biosynthetic enzymes (for the 
synthesis of the aldehyde substrate) necessary for light production. Bacterial 
luciferase is a heterodimeric enzyme of 77kDa composed of and  subunits with 
molecular masses of 40 and 37 kDa, respectively (Meighen, 1993). The synthesis 
of aldehyde and recycling of fatty acid to aldehyde for bioluminescence reaction 
is catalyzed by a multienzyme fatty acid reductase complex containing three 
proteins, a reductase, a transferase and synthetase (Meighen, 1993). These three 
polypeptides are endoded by luxC, luxD and luxE respectively and found in the 
lux operon of all luminescent bacteria (Meighen, 1993). A number of additional  
lux genes have been identified, but only luxCDABE is essential for light 
production (Meighen, 1993).  
1.11.3 Applications of bioluminescence 
The lux operons of V. fischeri and of P. luminescens (luxCDABE operon) have 
been expressed successfully in a wide range of Gram-negative bacteria and a 
redesigned operon has also been used to transform Gram-positive bacteria 
(Francis et al., 2000). The luciferase gene from P. luminescens has very high 
thermal stability, making the lux operon of this organism ideal to use as a reporter 
system (Meighen 1993). When the luciferase was expressed in E. coli it was 
found to be stable at 42°C (Chatterjee and Meighen, 1995). Consequently, 
transformed organisms with the lux operon from P. luminescens are ideally suited 
for the study of pathogens in mammalian animal models as the enzyme retains 
significant activity at 37°C (Meighen 1993).  
Though Gram-positive cells express bioluminescence the output compared to 
Gram-negative is low. Therefore in the current study Gram-negative 
bioluminescent organisms were used to study the efficacy of APDT and ECAS.  
In the efficacy testing of antimicrobials it is preferred to see at least a 3-log fold 
drop in bacterial number. Because of the low light output by the Gram-positive 
organism it is not possible to use this organism in the current study. Therefore 
traditional viable count methods were used to study the efficacy of APDT against 
Gram-positive organisms.  
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One of main advantages the bioluminescence systems is that when transfected the 
entire lux gene operon encoding both the bacterial luciferase and the biosynthetic 
enzymes for substrate synthesis, generate bioluminescence without the need for 
exogenous administration of luciferin or aldehyde (Rocchetta et al. 2001). 
Indicator strains used the full operon gene (luxCDABE or modifed luxABCDE) as 
a consequence, allowing stable light production (Vasterlund et al., 2004). 
The bioluminescence output from bioluminescent bacteria is a highly sensitive 
reporter of metabolic activity (Marincs et al., 2000) since it is directly dependent 
on the metabolic activity of the organism (Vasterlund et al., 2004) and thus it can 
be used to monitor the real time effects of antimicrobials on bacterial killing 
(Salisbury et al., 1999; Vasterlund et al., 2004).  Bacterial genes cloned into 
Staphylococcus aureus, Escherichia coli and Salmonella enterica serovar 
Typhimurium indicator strains have been used for detection of antimicrobial 
activity without the need for laborious plate counting and overnight incubation 
(Vasterlund et al., 2004). Studies have shown quantifiable use of luminescence as 
a measure of cell viability and reported to show good correlation with standard 
recovery techniques such as viable counting under defined conditions (Jassim et 
al., 1990). However, in vitro studies have shown that, although in general the 
relationship between bioluminescence and viable counts is closely correlated 
(Salisbury et al., 1999; Thorn et al., 2007), sometimes there are disagreements 
between the two methods. This is seen in the case where the given antibiotic 
inhibits multiplication (increase in viable number) or metabolism (Alloush et al., 
2003; Salisbury et al., 1999). The in vivo/in situ detection of bioluminescent 
organism is non-invasive, allowing rapid monitoring of the infective state of cells 
both in culture and animal models (Alves et al., 2011, Contag et al., 1995; Francis 
et al., 2000). Bioluminescence has been utilized to screen new PS and to 
investigate their efficacy of APDT against bacteria, and to evaluate their re-
growth after APDT and to assess the toxicity of PS in the cells of the infected 
tissue (Alves et al., 2011). 
  
Bacterial bioluminescence has also been used in APDT studies focused on the 
application of water disinfection (Alves et al., 2008). In this study a 
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bioluminescent E. coli was used to evaluate APDT by three cationic meso-
substituted porphyrins under artificial (40 Wm/cm
2) and solar irradiation (≈620 
Wm
−2
) (Alves et al., 2008; Alves et al., 2011). Photoinactivation of E. coli was 
detected by a decrease of more than 4 log10 in bioluminescence (the detection 
limit of the method used) using the three porphyrins in 270 minutes of irradiation. 
The authors found that the inactivation patterns previously obtained for these PS 
using conventional methods of viable count (Alves et al., 2008) were closely 
related to when the PS was assessed by the bioluminescence method. The authors 
concluded that the bioluminescence-based method is effective, sensitive, simpler, 
faster, more cost effective, and much less laborious than the conventional method 
as a screening for in vitro studies of photoinactivation (Alves et al., 2008).  
Bioluminescence methods of analysis have also been used in animal models to 
study APDT. In these studies wound infections (Hamblin et al., 2002; Gad et al., 
2004; Demidova et al., 2005) Acinetobacter baumannii infected burn infections in 
mice (Dai et al., 2009) Staphylococcus aureus infected burn wounds in mice  
(Lambrechts et al., 2005) were treated with APDT and the efficacy of the 
treatment was monitored with bioluminescence imaging. It was shown that there 
was a dose-dependent loss of luminescence upon illumination of treated cells with 
light that was related to bacterial killing (Hamblin et al., 2002; Gad et al., 2004; 
Lambrechts et al., 2005). These investigations showed that monitoring 
bioluminescence is a successful method and allowed the monitoring of the 
infection progress in real time with low light imaging charge-coupled device 
(CCD) camera. These studies confirmed the important role of bioluminescence 
target organisms to monitor APDT effects under different conditions.   
 
In a study to compare the effectiveness of APDT, bioluminescence imaging was 
used to study efficacy of standard endodontic treatment and the combined 
treatment to eliminate bacterial biofilms present in infected root canals (Garcez et 
al., 2007). In this study single-rooted freshly extracted human teeth were 
inoculated with stable bioluminescent Gram-negative bacteria, Proteus mirabilis 
and Pseudomonas aeruginosa to form artificial 3-day biofilms in prepared root 
canals. Bioluminescence imaging was used to serially quantify bacterial burdens. 
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The PS employed in this study was a conjugate between polyethylenimine and 
chlorin(e6) as the photosensitizer (PS) and the light source was 660-nm diode 
laser light. Endodontic therapy alone reduced bacterial bioluminescence by 90% 
while APDT alone-reduced bioluminescence by 95%. The combination treatment 
reduced bioluminescence by more than 98%. Bioluminescence imaging is an 
efficient way to monitor endodontic therapy and antimicrobial PDT may be used 
to optimize endodontic therapy.  However in this study the bioluminescent species 
are not oral periodontal pathogens. This study could be improved by carrying out 
the experiment with a bioluminescent strain of a periodontal pathogen. This will 
make the treatment more significant in periodontology.  
1.12 Clinical applications of APDT and ECAS 
With the growing evidence of effectiveness of APDT against a wide range of 
micro-organisms by in vitro studies stimulated clinical applications in vivo. The 
main area of development of APDT is in dental applications, ophthalmology, 
dermatology and infectious diseases.  APDT has been used to clinically treat 
bacterial infections in brain abscesses and non-healing ulcers (Kharkwal et al., 
2011). Clinical trials of APDT for gastric infections caused by Helicobacter pylori 
in 10 patients have been carried out which showed 99% reduction in bacterial load 
in some patients (Ganz et al., 2005). Blue light alone was also tested for reduction 
in Helicobacter pylori infection (Lembo et al., 2009) However, elimination of 
bacteria was not sustained as there was repopulation of bacteria days after 
treatment. In dermatological conditions such as acne, APDT has been used to 
eliminate Propionibacterium acnes using PS 5-aminolevulinate (ALA) and 
methyl aminolevulinate (MAL) (Kharkwal et al., 2011). APDT for dental 
infections represents the largest growth of clinical application in APDT 
(Kharkwal et al., 2011). Commercial application has developed a system called 
Periowave
TM
 (Ondine Biopharma Corporation) marketed as a photodynamic 
disinfection system for use in dentistry. The evidence for clinical use of ECAS has 
also been shown in small scale case studies with positive results. ECAS used 
twice daily to wash infected ulcers (in 15 patients) was shown to reduce bacterial 
infections and aid debridement (Sekiya et al., 1997). ECAS treatment of burn 
wounds infected with P. aeruginosa in rodents significantly improved their 
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survival rates (Nakae and Inaba, 2000). Furthermore one pilot study using 
extracted teeth showed that ECAS was more effective compared to sodium 
hypochlorite as a root canal cleaning solution (Solovyeva and Dummer, 2000). 
These results indicate the potential use of ECAS in sterilisation and disinfection in 
clinical settings. 
 
1.13 Biofilm 
Bacteria occur in nature in two different growth forms, as planktonic cells (free-
floating single cell organism) or as communities of cells known as biofilms 
(Costerton et al., 1999). Biofilms constitute the predominant form of growth in 
nature (Costerton et al., 2003). A microbial biofilm is defined as a structured 
community of bacterial cells enclosed in a self-produced polymeric matrix that is 
adherent to an inert or living surface and exhibiting phenotypic heterogeneity 
(Costerton et al., 1999). The biofilm can consist of one or more type of species 
(bacterial or fungal) cells and the matrix, which consists of polysaccharides, 
proteins and extracellular DNA (Taraszkiewicz et al., 2013). The structure that 
forms the biofilm contains channels in which nutrients can circulate and the cells 
in the different regions of the biofilm exhibit different patterns of gene expression 
(Costerton et al., 1999). This complexity of biofilm structure and metabolism led 
to its comparison to tissue of higher organism (Costerton et al., 1999). The 
biofilm formation is a complex process involving early, intermediate and mature 
stages (Taraszkiewicz et al., 2013). Different species can form biofilms on 
different kinds of surfaces. Figure 1.10 shows stages in the formation of biofilm. 
The cell-to-cell communication is regulated in the biofilm by quorum sensing 
(QS) molecules that enable cell dentistry “sensing” (Taraskiewicz et al., 2013). 
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Figure 1-10 The biofilm formation involves first attachment of planktonic 
cells to the surface followed by microcolony formation, during this stage 
quorum sensing molecule are produced and extracellular polymer matrix is 
formed around the microcolony. The final stage is the maturation of the 
biofilm to form mushroom shaped structures with expansion and 
dissemination. Microbial cells liberated from the mature biofilm can attach 
to another location or surface causing expansion of infection (diagram 
adapted from Taraszkiewicz et al., 2013). 
 
The biofilm mode of growth allows the survival of bacteria in hostile 
environments and also protects the biofilm microbial cells against antimicrobial 
agents and from the host immune system (Costerton et al., 1999; Bjarnsholt et al., 
2008).   Biofilm infections are important clinically because bacteria in biofilms 
exhibit resistance to antimicrobial compounds and persistence in spite of sustained 
host defenses (Hall-Stoodley and Stoodley, 2009; Ammons, 2010). Multiple 
characteristics of the biofilm contribute to the resistance of biofilms to 
antimicrobial agents such as the growth status of the biofilm cells (Lewis, 2001). 
Most antibiotics target metabolically active cells. Therefore slow growing cells in 
the biofilm may contribute to resistance mechanisms. General stress response and 
resistance subpopulation also contribute to resistance (Lewis, 2001). Another 
contributing factor of biofilm resistance is restricted penetration. Biofilms are 
enclosed within an exopolymer matrix that can restrict the diffusion and bind 
antimicrobials thereby preventing the action of the antimicrobial on the biofilm 
cells (Mah and O’Toole, 2001). It is still not fully understood to what extent each 
of these factors contributes to biofilm resistance. 
Cell detachment Microbial cells 
Slow growing cells 
cells 
Quorum sensing 
molecules 
Extracellular polymer 
matrix 
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A recent study has shown that photodynamic therapy could be successful in 
combination with antibiotic action or host defence mechanisms on S. aureus 
biofilms (Di Pota et al., 2009). This study showed that APDT combined with 
vancomycin or phagocytic activity from whole blood, successfully reduced the 
survival of staphylococcal cells within biofilms. This shows another method of 
using photodynamic therapy to treat superficial infections that are accessible to 
light. Moreover, this study describes that in addition to killing bacteria in the 
biofilms, PDT led to microbial cell detachment, and consequent disruption of 
biofilm architecture. In this study it was also shown that the thickness of a biofilm 
is not a hindrance to photsensitizer diffusion and light penetration. This may be an 
advantage because it is known that antibiotic action is hindered because of the 
slow diffusion of drug into the biofilm due to the presence of extracellular 
polymeric substances (EPS). Currently numerous studies have been carried out to 
test effects of APDT against biofilms. Table 1.2 shows a summary of the APDT 
studies carried out on biofilms using different biofilm models. 
 
Methods to study biofilms (in vitro Biofilm Models)  
A single standardised method to study biofilm is not available. To date various 
biofilm models have been developed. Biofilm in vitro models are grouped into 
two categories: closed or static systems or open or dynamic systems. In closed 
systems there are limited nutrients available. Closed systems are simple to use and 
may be sufficient to address basic questions about biofilm formation, physiology 
and architecture (Lebeaux et al., 2013). They offer a number of advantages such 
as a low cost, easy set-up, and high throughput screens. This includes colony 
biofilm model and microtiter plates and Calgary biofilm device. However, all 
batch culture systems suffer from changes over time including changes in 
substrate concentration, product formation, pH, redox, O2 partial pressure and 
production rate of new cells. 
The principle of open or dynamic system models is similar to continuous cultures, 
in which spent culture consisting of wastes, metabolic byproducts, and dispersed 
and dead cells are constantly replaced by fresh medium (Lebeaux et al., 2013). 
The advantage over the closed systems is that they generally allow the control of 
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environmental parameters such as shear forces, and have been therefore 
extensively used to study the physical and chemical resistance of biofilms and are 
also more comparable to biofilm formation in vivo (Lebeaux et al., 2013).  
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Table 1- 2 APDT for biofilms  
Inoculum Microorganims 
(Photosensitizer) 
Treatment protocol Killing effect Model  
Clinical isolates of 
mutlidrug-resistant 
Pseudomonas aeruginosa 
and methicillin-resistant 
Staphylococcus aureus 
MB 
Biofilm grown discs treated with 100 μL of the 
photosensitizer and incubated for 5 minutes in the dark. 
 Two treatment groups. 
 
Group 1 
 300 μg/mL were exposed to 664 nm light at a dose rate 
of 150 mW/cm
2
 and a light dose of 60 J/cm
2
 for 400 
seconds.  
Group 2  
500 μg/mL group were exposed at a dose rate of 76 
mW/cm
2
 and two light doses of 55 J/cm
2
 separated by a 
5 minutes dark time between each light dose. Control 
groups of no treatment, light alone and MB alone were 
also performed 
APDT reduced the CRS polymicrobial 
biofilm by >99.9% after a single 
treatment. 
Group 1 
300 μg/mL MB Mean log reduction of 
6.67  
Group 2 
500 μg/mL MB Mean log Reduction  of 
7.39 
 
 
FC 270 dual flow 
system 
Biofilm grown  
Beil et al.,  2011 
(a) 
Enterococcus faecalis 
TBO 
MB 
APDT commercial sytems (Denfotex and Helbo)  
Denfotex system- each disc was placed in a well 
containing 1 mL of photosensitizer [i.e. TBO at 12.7 mg/ 
L), pH 5]. After a 2min-pre-irradiation time), discs were 
uniformly irradiated for 150 s at 100 mW with a soft 
diode laser emitting at 635nm,  
The antimicrobial action of the second a PDT system 
(Helbo) (MB at a concentration of 10 mg/mL) After 3 
min pre-incubation time, excess dye was removed and 
discs were irradiated for 2 min with a soft laser (Helbo 
Theralite Laser) with a wavelength of 660 nm, an output 
power of 75 mW  
Denfotex system 
Mean log reduction 0.84  
 
 
 
 
 
 
Helbo system- 
Mean log reduction 1.9  
biofilms were 
grown on dentine 
discs in a 
microtiter plate,  
Meire et al., 2012 
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Clinical isolates of 
mutlidrug-resistant 
Pseudomonas aeruginosa 
and methicillin-resistant 
Staphylococcus aureus 
MB 
After the photosensitizer solution was sprayed into the 
lumen of the biofilm coated endotracheal tube, the 
photosensitizer pre-incubation was 5 minutes. 
Treatment parameters included: 500 μg/mL of MB, a 
fluence rate of 150 mW/cm of catheter length and a total 
light dose of 12 minutes on, 5 minutes off and 12 
minutes on again. 
Mean log reduction of 3 biofilm coated 
endotracheal tube 
Beil et al., 2011 
(b) 
Candida spp. Trichosporon 
mucoides . Kodamaea 
ohmeri 
zinc 2,9,16,23- tetrakis 
(phenylthio)- 29H, 31H- 
phthalocyanine (ZnPc) 
 
The biofilm formed by each strain was immersed in 250 
μl of a solution of ZnPc for 5 min (pre-irradiation time) 
in an orbital shaker 
The light source used was a gallium-aluminum-arsenide 
(GaAlAs) laser (Easy Laser, Clean Line, Taubaté, SP, 
Brazil) with a wavelength of 660 nm, output power of 
0.035 W, and illuminated area of 0.38 cm
2
. A fluence of 
26.3 J cm
2
 (energy of 10 J and time of 285 s) and a 
fluence rate of 92 mWcm
2
 were used. 
A mean reduction of 0.45 log was 
achieved for Candida spp. biofilms, and 
a reduction of 0.85 and 0.84, were 
achieved for biofilms formed by T. 
mucoides and K. ohmeri, respectively. 
 
Biofilms formed 
by yeasts after 48 h 
in the bottom of 
96-well microtiter 
plates 
Junqueira et al., 
2012 
P. aeruginosa PAO1 
5,10,15,20-tetrakis(1-
methyl- pyridino)-21H,23H-
porphine, tetra-p-tosylate 
salt (TMP) 
Exposing static biofilms to 5,10,15,20-tetrakis(1-methyl- 
pyridino)-21H,23H-porphine, tetra-p-tosylate salt (TMP) 
followed by irradiation. TMP concentrations of 100 M 
(0.14 mg ml
-1
) and 225 μM  (0.35 mg ml-1). Samples 
were irradiated for various exposure times at an intensity 
of 220– 240 Joules/cm2. 
 Biofilms were visualized using confocal laser scanning 
microscopy (CLSM) and cell viability determined using 
the LIVE/DEAD BacLight viability assay and standard 
plate counts.  
At a concentration of 100 M TMP, 
there was substantial killing of P. 
aeruginosa PAO1 wild-type and pqsA 
mutant biofilms with little disruption of 
the biofilm matrix or structure.  
Exposure to 225 M TMP resulted in 
almost complete killing as well as the 
detachment of wild-type PAO1 biofilms.  
4.1-log10 and a 3.9-log10 reduction in 
viable cells of wild-type PAO1 and pqsA 
mutant strains, respectively. 
Static biofilm 
grown on glass 
slides 
Collins et al., 2010 
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Multi species oral bacteria 
grown from human saliva 
sample 
The biofilms consisted of 
32.8% streptococci, 6.5% 
Veillonella spp., 0.1% 
Actinomyces spp., and 0.1% 
Gram- negative anaerobes. 
TBO 
Biofilm was exposed to 25 g/ml TBO and 31.5 J of 
laser light 
97.4% bacteria killed  Multi-species 
biofilms were 
grown on 5-mm 
diameter discs 
prepared from 
cellulose nitrate  
O’Neill et al., 
2002 
Multi species bacterial 
biofilm developed from 
plaque samples  
MB 
 
The light parameters used in this study for bacterial 
suspensions and biofilms were 100 mW/cm
2
 (power 
density) and 30 J/cm
2 
(energy fluence) at 665nm. The 
MB concentration at  25 g/mL and 50g /mL exposed 
to light for 5 minutes  
8.4% killed at 25 μg/mL and 31% killed 
at 50 μg/mL  
96-well microtiter 
plates 
Fontana et al., 
2009 
Streptococcus mutans 
Erythrosine 
Biofilms exposed to 20 molL-1 erythrosine and light 
from dental halogen curing unit light intensity at 
600mW/cm
2
 for 30s energy dose 18J/cm
2
 
74% bacteria killed 24 well cell culture 
plate 
Lee et al., 2012 
Streptococcus sanguis 
aluminium disulphonated 
phthalocyanine (AlPcS2) 
Biofilms were grown on hydroxyapatite, irradiated with 
up to 12.2J of light from a gallium aluminium arsenide 
laser in the presence of aluminium disulphonated 
phthalocyanine (AlPcS2)  
5 log kill  Biofilm grown on 
hydroxyapatite, 
Wilson et al., 1996 
S.aureus and E.coli 
MB 
Toluidine blue (TBO) 
Malachite green 
Biofilm subjected to PDT using a 600nm diode laser and 
PS concentration 37.5 to 300 M  
300 M MB: 0.8log E. coli kill.  S. 
aureus 1 log kill. 
150 M TBO 0.9 E .coli kill. S. aureus 1 
log kill  
3000 M TBO E. coli 1.6 kill  
S. aureus 4 log kill  
Biofilms grown on 
sample pieces of 
acrylic resin 
Vilela et al., 2011 
Pseudomonas aeruginosa 
PAO1 
350 l of 0, 5, 10, 20, and 40 mM -ALA, respectively, 
in the dark for 1 h. Four disks treated with different 
concentrations of -ALA were exposed to the LED. The 
When treated with 20 and 40 mM -
ALA, about 2-log reduction in biofilm 
density was observed. When exposed to 
Rotating disc 
reactor with 
removable 
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fluence of light delivered was 100 mW cm
2
 for 20 min. 
All of the samples exposed to either light or drug alone 
were put into test tubes containing 10 ml PBS. The test 
tubes were vertexed for 1 min in order to remove the 
biofilms from the disks. The resultant suspension was 
used for both viable and total cell count. 
 
120 J cm
2
, the biofilm density decreased 
with increasing concentrations of -ALA 
treatment. No viable cells were detected 
when 20 and 40 mM of -ALA were 
applied. P. aeruginosa biofilm regrowth 
after - ALA-mediated PACT. After 
biofilm samples were treated with 20mM 
of -ALA and exposed to 120 J cm2 light 
dose, No viable cell was detected on the 
PACT-treated disk until 24 h of 
regrowth. Biofilms appeared to re-
accumulate thereafter. To completely 
eliminate the possibility of re-growth, the 
PACT treated biofilms were allowed for 
recover for 12 h, followed by another 
PACT treatment in a separate 
experiment. The biofilm was completely 
eradicated and not a single viable cell 
was found at the end of experiment. 
stainless steel discs 
Lee et al., 2004 
51 
 
1.13 Aims of the investigation: 
Aim 1: To develop reliable kill curve assays (based on bioluminescence) and 
measure the target microbial kill rate and final populations at the end of the 
treatment period. 
The traditional methods of measuring kill rates following antimicrobial treatments 
by recovering cell survivors (viable count) is impossible to apply when the kill 
kinetics are either rapid, or complex in nature (e.g. biphasic or multiphasic 
survival curves with “shoulders”). 
Aim 2: To use standardised assays to measure the killing effects of ROS-
based biocide treatments 
The second aim was to use the methods and approaches developed in the first aim, 
and apply the developed assay to the study of two different types of ROS-based 
biocide treatments (APTD and ECAS) and compare treatments in terms of their 
likely mechanisms of ROS generation and killing. 
Aim 3: To compare kill rates of target microbes (prokaryotic) with 
mammalian (eukaryotic) cells  
The third aim was to compare the kill rates of target microbes with mammalian 
cells under the same treatment conditions and measure the equivalent of an in 
vitro therapeutic index, to help gauge the likelihood of treatment damaging the 
host in vivo. 
Aim 4: To measure the potential of biocides to induce genotoxic damage to 
mammalian cells by use of COMET assays and compare treatments 
It is insufficient to show that a particular treatment is (or is not) cytotoxic to 
mammalian cells if ROS agents can induce genotoxic damage. 
Aim 5: To measure the effects of treatments on target micro-organisms when 
growing in biofilm mode (using a continuous matrix perfusion model) and 
compare standard treatment on fast growing and slow growing cells. 
In addition to the concentration of ROS species being an important factor in 
determining the kill rate of target species there are also biological variables such 
as growth rate and physiological state of the organisms that must be considered, 
particularly when cells are growing in biofilm mode. 
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2.1 Bioluminescent bacteria and growth conditions  
The two bioluminescent target organism used in this investigation were a 
recombinant bioluminescent strain Pseudomonas aeruginosa MCS5-lite and a 
recombinant bioluminescent strain E. coli Nissle 1917 pGLITE kindly provided 
by UWE microbiology laboratory.  
The Pseudomonas aeruginosa MCS5-lite strain was produced previously by 
transforming Pseudomonas aeruginosa PAO1 SEI (ATCC 15692) with a 
recombinant plasmid containing the luxCDABE gene cassette of Photorhabdus 
luminescens (Marques et al., 2005).   
Pseudomonas aeruginosa MCS5-lite was maintained on nutrient agar (Oxoid Ltd, 
Basingstoke, UK) containing gentamicin (10 mg/l) (Sigma-Aldrich, Dorset, UK), 
the selective agent for the recombinant plasmid.  
E. coli Nissle 1917 was previously transformed with the recombinant plasmid 
pGLITE (method cited in Robinson et al., 2011), encoding the P. luminescens lux 
operon from plasmid pLITE27 inserted into the broad-host-range plasmid 
PBBR1MCS-2. 
The previously transformed E. coli pGLITE Nissle 1917 was cultured on nutrient 
agar (Oxoid Ltd, Basingstoke, UK) supplemented with 10 mg/liter kanamycin 
(Sigma-Aldrich, Dorset, UK), the selective agent for the recombinant plasmid. 
2.2 Growth and maintenance of micro-organisms  
Methicillin-resistant Staphylococcus aureus (MRSA) (methicillin-resistant 
Llewellyn strain SMH 22115) and S. aureus ATCC 6538 kindly provided by 
UWE were maintained from frozen stock on nutrient agar(Oxoid Ltd, 
Basingstoke, UK) and broth cultures were grown using 1% (w/v) tryptone, 0.5% 
(w/v) yeast extract (TYE) (Oxoid Ltd Basingstoke, UK).  
Batch cultures of Pseudomonas aeruginosa MCS5-lite, E. coli Nissle 1917 
pGLITE and S. aureus ATCC 6538 and MRSA (methicillin-resistant Llewellyn 
strain SMH 22115) were grown in 1% (w/v) tryptone, 0.5% (w/v) yeast extract 
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(TYE) (Oxoid Ltd Basingstoke, UK) with the selective antibiotic where 
appropriate.  
For experiments on photodynamic killing, microbial cells were obtained from 
broth cultures. These were produced following inoculation and incubation of test 
species in 10 ml volume of appropriate liquid medium. All species were incubated 
in a shaking incubator (model S 150, Stuart shakers, UK) at 37
 
°C for up to 24 
hours (stationary phase cultures) or for shorter periods of time (4 to 6 hours) to 
obtain mid- or late exponential phase.  
2.3 Bacterial growth curve 
2.3.1 P. aeruginosa MCS5-lite 
Overnight cultures of P. aeruginosa MCS5-lite were grown in 1% tryptone-0.5% 
yeast extract (TYE) broth (with addition of gentamicin (10 mg/l) and used to 
inoculate 50ml of broth of the same composition within 250ml flask to a 
standardized OD540 of 0.02. Flasks were then incubated at 32
 
°C with orbital 
shaking 200rpm (model S 150, Stuart shakers, UK) and 3 replicate cultures were 
used to follow the growth kinetics of both strains. Viable counts were performed 
as previously described. The optical density (OD540) was measured using a light 
photometer (Heios, Thermo Electron Corporation, UK), and bioluminescence 
measured using a single-tube luminometer (Junior LB9509, Bethhold 
Technologies UK Ltd., Harpenden, UK) (method adapted from Thorn, 2009).  
2.3.2 E. coli Nissle 1917/pGLITE 
Overnight cultures of E. coli Nissle 1917/pGLITE were grown in 1% tryptone-
0.5% yeast extract (TYE) broth (with addition of kanamycin (10 mg/l) and used to 
inoculate 50ml of broth of the same composition within a 250ml flask to a 
standardized OD600 of 0.02. Flasks were then incubated at 37
 
°C with orbital 
shaking 250rpm (model S 150, Stuart shakers, UK) and 3 replicate cultures were 
used to follow the growth kinetics of both strains. Viable count, OD600 and 
bioluminescence were measured as previously described (method adapted from 
Thorn, 2009).  
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 2.3.3 Log-fold dilution standards  
An exponential phase cell suspension of P. aeruginosa MCS5-lite and E. coli 
Nissle 1917/pGLITE (broth cultures of organisms grown to known cell density) 
was used to prepare a series of log fold dilutions. The dilutions were used to 
measure both bioluminescence and viable count to assess the correlation between 
the two methods (method adapted from Thorn, 2009).  
2.4 Photosensitizer 
MB (C.I. 52015; Sigma, Poole, U.K) dye content, 85% was used as the PS in all 
experiments. A stock solution was prepared by dissolving MB in deionized water 
to give a 2 mg/ml concentration. This stock solution was filter-sterilized using a 
0.22-μm-pore size membrane filter (Fisher Scientific) and stored in the dark at 
4
0
C until use. The stock solution was diluted to obtain the test solutions of 
appropriate concentration and fresh stock solutions were prepared as required.  
2.5 Light source 
The light source used in all APDT experiments were polychromatic light 
produced from a standard slide projector  (Reflector Diamator 2500 AF, Portugal) 
equipped with a 250 W lamp and built-in infra red filters to produce white light 
(400-700nm). The emission spectrum of the projector light beam was previously 
measured with a diode array spectrophotometer (4851A, Hewlett Packard, 
Blacknell, Berks, UK) with a total power output (white light ) was 2.8 W with 
infrared power less than 1.0% of the total (Zeina, 2001).  The standard distance 
(vertical distance) to target was 12.5 cm. The light intensity was measured using a 
light meter (Skye Instruments Ltd., Llandrindod Wells, Powys, UK) and shown to 
be 9.47 mW/cm
2
 for planktonic cultures.  
The light source used in all biofilm experiments (chapter 7) was white light via a 
fibre optic cable (Thorlabs Limited, Ely, Cambridgeshire) to give 16 mW/cm
2
 for 
biofilm studies. 
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2.6 APDT Studies: Development of standard bioluminescent assay to study 
photodynamic effects 
A 1ml volume of cell culture suspension was prepared by taking 100 l of 108 
cfu/ml log phase culture target organism (target organism grown as described in 
section 2.1), 50 l of MB to give a final assay concentration of 10 g/ml MB and 
850l of Phosphate Buffer Solution (PBS pH 7.4) (In APDT mechanism studies 
(section 2.12) scavenger/enhancer was added into the system). This cell mixture 
tube was exposed to polychromatic light produced by standard slide projector by 
keeping it under the projector at a measured distance of 12.5 cm (standard 
experiments). At each measured time interval the tube was loaded into the 
luminometer to measure the bioluminescence (for bioluminescence target 
organisms) and a 20l sample was removed to enumerate the cells by viable 
count. After measuring bioluminescence and taking samples for viable count, the 
tube (borosilicate glass tube (12 by 75 mm; Fisher Scientific, Loughborough, 
United Kingdom) was put back under the projector to complete the irradiation 
time. For all the experiments bioluminescence was measured using the single-tube 
luminometer (Junior LB9509, Bethhold Technologies UK Ltd., Harpenden, UK) 
and viable counts were carried out by log serial dilutions (10
-1
-10
-5
) and plating 
the appropriate dilutions on nutrient agar count medium.   
The standardised assay (total light dose of 11 J/cm
2
 at light intensity of 9.4 mW/ 
cm
2
 and in the presence of MB (10 g/ml) (when present) was used, and known 
concentrations of target organism for the treatment. The three controls (a) bacteria 
alone (culture diluted in PBS) (b) bacteria alone with light (light control) (c) 
bacteria and MB without light (Dark control).  
The reduction in the number of survivors after APDT treatment was shown by 
reduction in bioluminescence. The data from these experiments (change in 
bioluminescence readings) were plotted on a graph to show reduction in bacterial 
bioluminescence after APDT together with data obtained for the controls. 
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2.6.1 APDT Data analysis  
To show the kill kinetics of APDT for different target organism a graph was 
constructed with log change in light output for bioluminescent species and for 
non-bioluminescent species log change in viable counts against time. For each kill 
curve linear regression analysis was performed. Statistical analyses were carried 
out to determine if the correlation was statistically different from control groups. 
Graph construction and statistical modelling was conducted with the use of 
GraphPad Prism version 5 for windows.  
2.7 ECAS assay: preparation of inoculum  
An overnight culture of E. coli Nissle 1917/pGLITE was grown at 37 °C with 
shaking at 250 rpm in nutrient broth supplemented with 10 mg/liter kanamycin. 
This was subcultured with appropriate dilution into 10 ml fresh prewarmed 
nutrient broth supplemented with 10 mg/liter kanamycin and grown at 37 °C with 
shaking at 250 rpm until an OD600 of 0.6 was achieved. The cells were then 
centrifuged for 20 min at 3000 g, washed twice in an equal volume of sterile 
Ringer’s solution, and then resuspended in 10 ml sterile Ringer’s solution to 
obtain a specified cell density (method adapted from Robinson et al., 2011). 
2.8 Preparation of ECAS  
ECAS was generated according to the manufacturer’s instructions (Purest 
Solutions Ltd., London, United Kingdom) with a pH of 1.826 and a redox 
potential of 1139.3mV and diluted in deionized water where required. 
2.9 ECAS single tube luminometric assay  
A 100 l volume of E. coli Nissle 1917/pGLITE (final concentration 107 cfu/ml) 
and 900l of Ringer’s was added to a borosilicate glass tube (12 by 75 mm; Fisher 
Scientific, Loughborough, United Kingdom) and loaded into a Sirius luminometer 
(Berthold Detection Systems, Pforzheim, Germany). For ECAS mechanism 
studies (section 2.12) scavenger/enhancer was also added into the system). The 
bacterial bioluminescence of the cell culture suspension was recorded by 
automated protocol that was set up to record every 0.2 s for 15 s prior to 
automated injection of ECAS to allow light levels to equilibrate. ECAS (diluted 
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where appropriate) was injected by the automated injection system at 15 seconds 
(this time was recoded as time zero corresponding to the start of ECAS interaction 
with bacteria) and data collected every 0.2 s until the end of the experiment. 
Control light levels were established by replacing the ECAS with Ringer’s 
solution, and background light levels were established by replacing the inoculum 
with Ringer’s solution (modified method from Robinson et al., 2011). 
2.9.1 ECAS Data analysis  
To show the kill kinetics of ECAS for target organism a graph was constructed 
with log change in light output. For each kill curve linear regression analysis was 
performed. Graph construction and statistical modelling was conducted with the 
use of GraphPad Prism version 5 for windows.  
2.10 Photodynamic and ECAS mediated effects on bioluminescence output in 
the presence of reactive oxygen species inhibitors/enhancer 
Stock solutions of the inhibitor were prepared immediately before use and filter 
sterilised using a 0.22-μm-pore size membrane filter (Fisher Scientific) prior to 
their addition to the reaction mixture at the required concentration. All the 
inhibitors were obtained from Sigma Aldrich. The inhibitors used in the assays 
were DMTU, DMSO, mannitol, tryptophan, histidine, sodium azide. The 
enhancer D2O was substituted for H2O in buffers (PBS).  
Into the standard APDT and ECAS assay (procedure described above were used 
for APDT (section 2.6) and ECAS (section 2.10) appropriate test inhibitors was 
added at the required concentration.  In APDT the cell mixture was exposed to 
light from a standard slide projector by keeping it under the projector at a 
measured distance of 12.5 cm light and at set time intervals the tube was loaded 
into the single-tube luminometer (Junior LB9509, Bethhold Technologies UK 
Ltd., Harpenden, UK) and bioluminescence readings measured (for 
bioluminescence target organisms). For non-bioluminescent target cells a 20l 
sample was removed to enumerate the surviving cells by viable count. After 
measuring bioluminescence and taking samples for viable count the tube 
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(borosilicate glass tube (12 by 75 mm; Fisher Scientific, Loughborough, United 
Kingdom) was put back under the projector to complete the irradiation time. 
In ECAS assay the bioluminescence of bacterial suspension with or without the 
inhibitor was recorded by automated protocol every 0.2 s for 15 s prior to 
automated injection of ECAS for light levels to equilibrate, after this delay period 
ECAS (diluted where appropriate) was injected by the automated injection system  
(this time was recoded as time zero corresponding to the start of ECAS interaction 
with bacteria) and data collection every 0.2 s until the end of the experiment. 
Appropriate controls were carried out by replacing ECAS with the control 
solution.  
2.11 The evaluation of the role of ROS and 
1
O2 in APDT by detection of 
formation by SOSG, APF and HPF Assay 
2.11.1 Chemicals 
The fluorescent probes SOSG, HPF and APF were obtained from Invitrogen as 
solutions in methanol (SOSG) or dimethylformamide (APF and HPF). 
2.11.2 Procedures for the florescent probe (SOSG, APF and HPF) assay in 
APDT  
To detect the generation of singlet oxygen in a cell-free system were carried out in 
1 × 1 × 3 cm glass cuvettes. The cuvettes containing the solutions of MB and the 
probe was exposed to visible light from a projector placed at 12.5 cm vertically. 
The light intensity at this distance was measured to be 9.4 mW/cm
2
. The total 
light dose applied to the samples was in the range of 0-11 J/cm
2
 (over 20 minutes 
period), by varying the irradiation time. The fluorescence was monitored by 
acquisition of the fluorescence signal by fluorimeter. The measurements were 
then expressed as fluorescence over time for solutions containing: APDT: 5 μM 
SOSG and 10 μg/mL MB exposed to light (light dose 0-11 J/cm2), dark control: 
SOSG and 10 μg/mL MB in the dark for 20 minutes, control: 5 μM SOSG on its 
own. To measure the fluorescence 5 μM APF/HPF the same procedure was 
repeated replacing the SOSG probe with 5 μM APF or HPF.  
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2.11.3 Procedures for the florescent probe (SOSG, APF, HPF) assay in ECAS 
In a  1 × 1 × 3 cm glass cuvettes fluorescent probe (5 μM SOSG, APF, HPF) and 
a diluted solution of ECAS (1% v/v or 5% v/v) was mixed and was immediately 
loaded into fluorimeter and the fluorescence signal was measured 5 minutes.  
2.11.5 Quenching studies with florescence probes (SOSG, APF, HPF) 
Using the procedure described in the above sections the interaction between 
fluorescent probes 
1
O2 and •OH specific inhibitors or enhancers were assessed for 
APDT or ECAS in the presence of inhibitors (tryptophan, histidine, NaN3 
mannitol, DMSO, enhancer (D2O) using SOSG, APF or HPF in the systems  
2.12 Methods to determine the cytotoxic effects of APDT on keratinocytes 
and lymphocytes   
2.12.1 Keratinocytes culture conditions  
The human keratinocyte cell line, H103 (kindly donated by UWE, Bristol, UK) 
was cultured in 75cm
2
 tissue flasks in 20 ml volumes DMEM:F12 (1:1) 
containing 2.5 mM L-glutamine, 0.5 g/ml hydrocortisone (all Sigma Aldrich) 
and heat inactivated 10% FBS (FBS Gold, PAA Laboratories Ltd. Termare Close, 
Houndstone Business Park, Yevil Sommerst). Cells were incubated at 37
 
°C, 95% 
air, 5% CO2 in a humidified incubator for 3 days until the cell monolayer became 
confluent. The growth medium was replaced every 3 days as required if indicated 
by change in pH. Upon reaching 70% confluence, the cells were washed with 
phosphate buffered saline (PBS) and trypsinized for 3 minutes at 37
0
C with 0.25% 
trypsin. Cells were passaged and re-seeded at 1.5 x10
5
 cells/ml.  
2.12.2 T lymphocytes culture conditions  
The human T lymphocytes cells line Jurkat cells (cells in suspension), (kindly 
donated by CRIB, UWE, Bristol, UK) was cultured in 75cm
2
 tissue flasks in 20ml 
volumes of RPMI 1640 medium supplemented with heat inactivated 10% FBS 
(FBS Gold, PAA Laboratories Ltd. Termare Close, Houndstone Business Park, 
Yevil Sommerst), 10U/ml penicillin (Sigma Aldrich) and 100g/ml streptomycin  
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(all Sigma Aldrich). When cells were 70% confluent (6 x10
5
 cells/ml), they were 
split 1:4 with fresh media.  
2.12.3 Photosensitizer and light source 
MB (dye content approximately 85%, Sigma, UK) solution were prepared fresh 
for each experiment in sterile PBS (pH 7.4), filter-sterilized and kept in the dark. 
The source of light placed at 12.5cm giving 9.47 mW/cm
2
 (as described in section 
2.5). 
2.12.4 Antimicrobial Photodynamic treatment of keratinocytes  
Aliquots of 20 mL suspension containing 1.5 × 10
5
 cells/ml H103 culture were 
seeded in 96 well plates (100 μl in each well) and incubated for 24 hours for the 
cells to attach to the bottom of the 96 well plates at 37
◦
C in 95% air, 5% CO2. 
After 24h of cell incubation, the growth medium was removed from all wells and 
the cells were washed with PBS. For APDT treatments into each well (n=6), 100 
μl MB to give a final concentration of 10 μg/mL (diluted in PBS) was added and 
were irradiated with light (20 min). Following treatment the MB solution mixture 
was removed and washed cells 4 times in PBS to remove any residual MB 
solution; to test the immediate cytotoxicity effects of APDT on H103 cells, 
viability tests were carried out immediately. To test for the recovery of the cells 
after treatment the cells were re-supplied with growth medium and incubated 
overnight at 37
◦
C for 24-hour recovery period before viability tests were carried 
out. For both immediate and following 24h recovery period, controls were 
included in the 96 well plate (for each condition n=6 was repeated 3 times): (a) 
cells not treated with MB or light (cells exposed to same procedure with PBS (the 
untreated control)), (b) cells treated with MB but not exposed to light (dark 
control cells incubated 10 μg/mL MB (diluted in PBS) for 20 minutes in the dark), 
(c) cells exposed to light (20 min) in the absence of MB (light control cells in PBS 
exposed to light (same irradiation dose as the treatment). After treatment was 
completed the viability of cells were assessed using the neutral red method 
described in section 2.12.11. 
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2.12.5 Antimicrobial Photodynamic treatment of keratinocytes in the 
presence of FBS 
Aliquots of 20 mL suspension containing 1.5 × 10
5
 cells/ml H103 culture were 
seeded in 96 well plates (100 μl in each well) and incubated for 24 hours for the 
cells to attach to the bottom of the 96 well plates at 37
◦
C in 95% air, 5% CO2. 
After 24h of cell incubation, the growth medium was removed from all wells and 
the cells were washed with PBS. FBS (FBS Gold, PAA Laboratories Ltd. Termare 
Close, Houndstone Business Park, Yevil Sommerst) was added into the cell 
mixture in 96 well plate at different concentrations (10%, 25%, 50% v/v) for each 
treatment conditions. The conditions tested were (a) treatment MB final 
concentration 10 μg/mL diluted in PBS with different concentration of FBS and 
exposed to light dose (total light dose 11 J/cm
2
) (b) dark control with MB final 
concentration 10 μg/mL diluted in PBS with different concentration of FBS and 
incubated for 20 minutes (c) light control cells exposed to light only (total light 
dose 11 J/cm
2
) (d) untreated cell as control. After treatment was completed the 
viability of cells were assessed using the neutral red method described in section 
2.12.11. 
2.12.6 Antimicrobial Photodynamic treatment Co-mix assay 
The co-mix assay was carried out by first growing adherent keratinocytes in 96 
well plate until 70% confluence (1.5 × 10
5
 cells/ml) and the cell culture media was 
removed just before the treatment and E. coli Nissle 1917 pGLITE (1.5 × 10
7
 
cells/ml) added and the treatment containing the MB (10 μg/mL) diluted in PBS 
was added in to the mammalian cell mixture and exposed to light for 20 minutes 
(total light dose 11 J/cm
2
). During the experiment, every 5 minutes, samples were 
taken to measure the light output by the bacterial cells using a bench luminometer. 
After treatment was completed, the bacterial cell mixture was removed and the 
adherent keratinocytes were washed twice with PBS and neutral red viability test 
was carried out as described in section 2.12.11.   
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2.12.7 ECAS treatment of keratinocytes  
Aliquots of H103 culture suspension (1.5 × 10
5
 cells/ml) were seeded in 96 well 
plates (100 μl in each well) and incubated for 24 hours for the cells to attach to the 
bottom of the 96 well plates at 37
◦
C in 95% air, 5% CO2. After incubation from 
each well of 96 well plate the media was removed and different concentration of 
ECAS diluted (5%, 10%, 25%v/v) in ringers solutions was added and for the 
control wells the media was replaced by ringers solution and incubated for 30 
minutes. After treatments the cells were washed twice with PBS. In one group of 
treated cells and controls the viability tests were carried out immediately and in 
the other group the fresh media was added and incubated for 24 hours before 
neutral red viability tests as described in (section 2.12.11) were carried out.  
2.12.8 ECAS treatment of keratinocytes in the presence of FBS 
Aliquots of keratinocyte (H103) culture suspension (1.5 × 10
5
 cells/ml) were 
seeded in 96 well plates (100 μl in each well) and incubated for 24 hours for the 
cells to attach to the bottom of the 96 well plates at 37
◦
C in 95% air, 5% CO2. 
After incubation the media from each well was removed and different 
concentration of ECAS (diluted 5%, 10%, 25%v/v) in ringers solutions and 
supplemented with different concentration of FBS (final concentration 1%, 5, 
10% v/v) was added. For the control well the media was replaced by ringers 
solution and incubated for 30 minutes. After treatments the cells were washed 
twice with PBS. Then neutral red viability tests (as described in section 2.12.11) 
were carried out.   
2.12.9 Antimicrobial Photodynamic treatment of T-lymphocytes 
Aliquots of T-lymphocytes culture suspension (8 × 10
5
 cells/ml) were centrifuged 
at 1,200 rpm for 5 minutes to pellet cells. The media was discarded and the pellet 
gently resuspended in 10 ml warm medium, and the cell concentration adjusted to 
1 × 10
5
 cells/ml. This suspension was dispensed into 96 well plate (100 μl in each 
well). For APDT, MB final concentration 10 μg/mL was added into the cell 
suspension in media and exposed to light for 20 minutes (total light dose 11 
J/cm
2
), for dark control MB final concentration 10 μg/mL was added into the cell 
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suspension in media and kept in the dark for 20 minutes. For light control the cell 
suspension was exposed to light only for 20 minutes (total light dose 11 J/cm
2
) 
and the control untreated cells. After the experiment cells were centrifuged at 
1,200 for 5 minutes and resuspended in fresh media and then viability tests 
(section 2.12.11 MTS) were carried out immediately to determine the immediate 
cytotoxic effects and at 24h to test for recovery of cells after treatment. For each 
condition (n=6) the experiment was repeated 3 times.  
2.12.10 ECAS treatment of T-lymphocytes  
Aliquots of T-lymphocytes culture suspension (8 × 10
5
 cells/ml) were centrifuged 
at 1,200 rpm for 5 minutes to pellet cells. The media was discarded and resuspend 
pellet gently in 10 ml warm medium cell and concentration adjusted to 1 × 10
5
 
cells/ml. This suspension was dispensed into 96 well plate (100 μl in each well) 
and into each well, ECAS (5,10,25 v/v) or positive control, bleach (0.5% v/v) was 
added to the required concentration and incubated for 30 minutes at 37
◦
C in 95% 
air, 5% CO2. After 30 minutes incubation the cells were centrifuged and 
resuspended in fresh media. In one group of the treated cells viability tests 
(section 2.12.11 MTS) were carried out immediately after treatment and in the 
second group the cells were resuspended in fresh media and incubated for 24 
hours at 37
◦
C in 95% air, 5% CO2 to measure 24h recovery 
2.12.11 Cell viability tests  
Trypan blue test  
The percentage of viable cells was determined using trypan blue dye exclusion. 
The cell suspension (200l) was mixed with an equal volume of filter sterilised 
0.4% (w/v) trypan blue (Sigma-Aldrich), in PBS and cells observed under the 
microscope. As a non-vital dye, trypan blue is excluded from living cells but 
stains dead cells.  
Neutral red assay  
Neutral red method was employed to test viability of keratinocytes cells after 
exposure to different treatment conditions. 
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Neutral red (3-amino 7-dimethylamino-2-methylphenazine-hydrochloride) is a 
water-supravital dye that passes through intact plasma membranes of viable cells 
and is accumulated in the lysosomes (Repetto et al., 2008). After experiments 
(APDT and ECAS) the supernatant in the 96 well plates was removed and 
replaced with PBS containing 50g mL neutral red (Sigma-Aldrich). The cells 
were incubated for 2 h at 37 °C to allow for the uptake of neutral red. After 
removal of the dye solution, the cells were washed gently with PBS, and the 
residual dye was extracted from the cells by the addition of 100 L of extractant 
solution (51% H2O, 48% ethanol and 1% acetic acid). Optical densities were then 
read at 550 nm using a spectrophotometer (Cecil Instruments Ltd, Cambridge, 
U.K.). The mean optical density of extract from untreated control cells was set to 
represent 100% viability. 
MTS assay 
The MTS was performed using the commercially available kit The CellTiter 96® 
AQueous Non-Radioactive Cell Proliferation Assay (Promega). The instruction 
was followed CellTiter 96® Non-Radioactive Cell Proliferation Assay Technical 
Bulletin #TB112, Promega Corporation.  
The reagent (20μl of CellTiter 96® AQueous One Solution) was added into each 
well of the 96 well assay plate containing the samples in 100 μl of culture medium 
to detect the viability of lymphocytes (treated and untreated cells). The 96 well 
assay plate were then incubated for 4 hours at 37°C in a humidified, 5% CO2 
atmosphere. During a 4-hour incubation, living cells convert the tetrazolium 
component of the dye solution into a formazan product. After the incubation 
period the absorbance of the formazan product at 490nm was measured directly 
from 96-well assay plate. The quantity of formazan product measured by the 
amount of 490nm absorbance is directly proportional to the number of living cells 
in culture. 
The CellTiter 96® AQueous Assay is composed of solutions of tetrazolium 
compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron coupling reagent, 
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phenazine methosulfate (PMS). MTS is bioreduced by cells into a formazan 
product that is soluble in tissue culture medium. The conversion of MTS into the 
aqueous soluble formazan product is accomplished by dehydrogenase enzymes 
found in metabolically active cells (CellTiter 96® Non-Radioactive Cell 
Proliferation Assay Technical Bulletin #TB112, Promega Corporation). 
2.13 Methods for genotoxic effects of APDT and ECAS on T lymphocytes 
(Jurkat cells) (Comet assay) 
Comet (alkaline condition) assay 
Before comet assay was carried out the cells were exposed to treatments (APDT 
and ECAS as follows and each experiment repeated 3 times. The comet assay was 
carried out using the commercially available kit from Trevigen (4250-050-K-
CometAssay® Kit (25 X 2 well slides)) 
Materials Supplied: Lysis Solution, Comet LMAgarose (LMA), Trevigen 
CometSlideTM, 200 mM EDTA, pH 10 
APDT 
Aliquots of T-lymphocytes culture suspension (1 × 10
5
 cells/ml) were prepared 
for treatment. This suspension was dispensed into 96 well plate (100 μl in each 
well). For APDT MB final concentration 10 μg/mL was added into the cell 
suspension in media and exposed to light for 20 minutes (total light dose 11 
J/cm
2
), for dark control MB final concentration 10 μg/mL added into the cell 
suspension in media and kept in the dark for 20 minutes. For light control the cell 
suspension was exposed to light only for 20 minutes (total light dose 11 J/cm
2
) 
and the control untreated cells. After the experiment cells were centrifuged at 
1,200 for 5 minutes and resuspended in fresh media. Samples were prepared 
immediately for the comet assay and another prepared following a 6h and 24h 
incubation period at 37°C in a humidified, 5% CO2 atmosphere.  
ECAS 
The T-lymphocytes cell suspension (concentration to 1 × 10
5
 cells/ml) was 
dispensed into 96 well plate (100 μl in each well) into each well ECAS (5 % v/v) 
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was added to the required concentration and incubated for 30 minutes at 37
◦
C in 
95% air, 5% CO2. After 30 minutes incubation the cells were centrifuged and 
resuspended in fresh media. Samples were prepared immediately for the comet 
assay and another prepared following a 6h and 24h incubation period at 37°C in a 
humidified, 5% CO2 atmosphere. 
After treatment (APDT and ECAS) for each sample cells were resuspended in cell 
culture medium (immediately, 6h and 24h), cell suspensions were harvested by 
centrifugation (200x g for 5 min). The cells were suspend at 1 x 10
5
 cells/ml in ice 
cold 1X PBS (Ca
2+
 and Mg
2+
 free). Extra care was taken to remove any residual 
media used for cell culture as it can reduce adhesion of LMAgarose to the 
CometSlideTM. A series of steps were followed as instructed in the protocol 
(http://www.trevigen.com/docs/protocol_4250-050-K.pdf)  
1. The lysis solution provided in the kit was cooled at at 4°C for 20 minutes 
before use. 
2. The low melting (LM) Agarose melted in a beaker of boiling water for 5 
minutes, with the cap of the bottle loosened. Before use the agarose was cooled  in 
a 37°C water bath for at least 20 minutes. Care was taken with agarose to make 
sure it is cooled before mixing with the cells as the correct temperature is critical 
or the cells may undergo heat shock. 
3. The cells (1 x 10
5
/ml) were carefully mixed with with molten LMAgarose (at 
37°C) at a ratio of 1:10 (v/v) and immediately pipetted 50 μl onto CometSlideTM. 
Using the pipette tip to spread agarose cells mixture over sample area to ensure 
complete coverage of the sample area.  
4. The slides were placed flat at 4°C in the dark for 30 minutes.  
5. The slide was immersed in 4°C Lysis Solution for 60 minutes.  
6. After draining the excess buffer from slides and the slides were then immersed 
in freshly prepared Alkaline Unwinding Solution, pH>13 (Alkaline Unwinding 
Solution, pH>13 (200 mM NaOH, 1 mM EDTA) for 1 hour at 4°C, in the dark. 
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Alkaline Unwinding Solution preparation: 50 ml of Alkaline Solution combined: 
0.4 g NaOH Pellets, 250 μl 200 mM EDTA, 49.75 mldistilled H2O. The solution 
was stirred until dissolved and cooled as the solution became warm during 
preparation.  
8. For electrophoresis 850 ml 4°C Alkaline Electrophoresis Solution filled into the 
slide tray and slides were placed in electrophoresis slide tray (slide label adjacent 
to black cathode) slides aligned equidistant from electrodes and covered with 
Slide Tray Overlay. Electrophoresis carried at 4°C, in the dark. The voltage set to 
about 1 Volt/cm and the current was set is approximately 300 mA, and 
electrophoresis performed for 25 minutes. 
9. The excess electrophoresis solution was gently drained, then gently immersed 
twice in dH2O for 5 minutes each, then in 70% ethanol for 5 minutes.  
10. The samples were dried at 37°C for 10-15 minutes.  
11. 100 μl of diluted SYBR® Gold was placed onto each circle of dried agarose 
and stained 30 minutes (room temperature) in the dark. The excess SYBR 
removed by gently tapping the slide and rinsing briefly in water. The slides were 
then allowed to dry completely at 37 °C. 
12. The slides were viewed by using epifluorescence microscopy (Nikon TE300 
inverted epifluorescence microscope).  
Samples stained with SYBR gold (SYBR® Gold’s maximum excitation/emission 
is 496 nm/522 nm) when excited emits green light. The images were captured 
using a high resolution video camera attached to a microscope (epifluorescence 
microscope) and the software Comet Assay IV single cell electrophoresis assay 
quantification software was used to score the samples.  
 
69 
 
2.14 Flat-bed biofilm perfusion model 
Flat-bed biofilm perfusion (Biofilm growth chambers and removable biofilm 
growth matrix) 
The apparatus and system for growing biofilm in continuous culture was 
conceived and devised by Thorn (Thesis, 2009) and Thorn and Greenman (2009). 
A schematic (figure 2a) and images of sterile biofilm chambers (figure 2b) and the 
in vitro flat-bed perfusion biofilm model experimental set up (figure 2c) as shown. 
Microbial biofilms (n = 3) were grown inside individual sterile chambers (Fig. 2b) 
as described by Thorn (Thesis, 2009) that consisted of a glass microscope slide 
cut to 50 mm and tapered to a point using a diamond glass cutter. Rubber supports 
and a surface methylpentene Delnet apertured film (Delstar, Bristol, UK) were 
glued to the microscope slide using extreme temperature-resistant glue (Bostik, 
Strafford, UK), and a 1-cm
2
 hole cut into the surface film. The microbial biofilms 
were grown within 1-cm
2
 cellulose support matrices (Sirane, Telford, UK), which 
comprise of loosely packed interconnecting strands, and these are placed within 
the confines of the rubber and film supports inside an airtight autoclavable growth 
chamber (Fig. 2b). The airtight autoclavable biofilm growth chambers were 
constructed from a  modified 470-ml freezer storage box (Lock & Lock, Amazon, 
UK). The lid of these chambers were fitted with a sterile 0.2 μm air filter (Fisher 
Scientific) facilitating gaseous exchange with the surrounding environment. 
Sterile perfusate growth media to the biofilm support matrix was supplied through 
a hyperdermic needle which was mounted into the corner of each chamber and 
connected to a media reservoir via silicone tubing. A peristaltic pump (model 
205U; Matson & Marlow Bredel Pumps, Cornwall, UK) was used to perfuse 
growth media through the biofilm support matrix and a hole was cut into the 
bottom of each biofilm growth chamber to allow through-flow of fluids (eluate) 
into a 10 or 500 ml volume collection bottle for sample or waste via a thick 
silicone tube (internal diameter 2cm
2
). All components of the biofilm model were 
heat stable and were sterilized by autoclaving prior to use. Multiple models (n = 
3) were set up in parallel, drawing medium from a single reservoir as required. 
The media consisted of 1/5th strength nutrient broth (Oxoid Ltd., Basingstoke, 
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UK) supplemented with 10 mg/L kanamycin (the selective agent required to 
maintain the recombinant plasmids). 
Inoculating the biofilm model  
Microbial target cell inocula were prepared transferring a single colony of  E. coli 
Nissle 1917/pGLITE  from a nutrient agar plate into TYE broth (1% tryptone-
0.5% yeast extract)  supplemented with kanamycin (10 mg/l) in a 250ml flask to 
give an initial standard OD600 of 0.02. Flasks were then incubated at 37
0
C with 
orbital shaking 250rpm (model S 150, Stuart shakers, UK)  until cultures reached 
mid to late exponential phase corresponding to 10
8
 cfu/ml; 0.6 OD600 measured 
using a spectrophotometer (Heios, Thermo Electron Corporation, UK).    
Aliquots of 300l of this culture containing approximately concentration 108 
cfu/ml were deposited onto a 1-cm
2
 cellulose matrix layered onto a nutrient agar 
plate. The inoculated matrices were then incubated for 4 hours in an anerobic 
cabinet before being transferred aseptically into the support matrix of each sterile 
biofilm chamber. The media was perfused immediately after placing the biofilm 
matrix in the chamber. Biofilm experiments were performed within a large 
incubator (model eurotherm 91e, Carbolite Ltd., London, UK) or, for 
bioluminescence measurements a smaller incubator (Sanyo MCO-15 AC CO2) set 
at 37 °C. 
Growth of biofilm within the in vitro flat-bed perfusion biofilm model  
The model was inoculated with target organism bioluminescent E. coli Nissle 
1917 pGLITE and the perfusate output (eluate) sequentially sampled for 48 hours 
to determine the initial growth, development and the establishment of the biofilm 
steady state. Eluate and the total biofilm matrix (TMP) was also sampled from 
three biofilms (n=3) every 4 hours until 24 hours and then at 36 hours and 48 
hours, and these samples were analysed by determining the viable count and 
bioluminescence. It was expected that the biofilm would reach a steady state in 20 
to 24 hours of growth (Thorn and Greenman, 2009). A separate experiment was 
carried out where the photon counts of the developing bioluminescent biofilms 
were continually measured by low light photometry (0-16 hours).   
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Control of biofilm specific growth rate () in the flat bed perfusion biofilm 
model  
The flat-bed perfusion biofilm system was previously shown to be suitable for 
producing biofilm populations with different growth rate by altering the nutrient 
media perfusion rates (Thorn and Greenman, 2009). Therefore in this study the 
model was used to set biofilm growing at 3 different growth rates described as; 
slow, intermediate and fast growth rates. The biofilm matrix was perfused with 
1/5
th
 strength TYE. The flow rate of perfused biofilm systems (n=3) was set up at 
range of flow rates; 1ml h
-1
 (low), 15ml h
-1
 (intermediate), or 50ml h
-1
 (high).  
The TMP and eluate  count were determined by sequential sampling by viable 
count and bioluminescence for low flow rate and photon count of developing 
bioluminescent biofilms were continually measured by low light photometry (0-
16 hours) for low, intermediate and high flow rate. Under quasi steady state 
conditions, the biofilm growth rate () is equal to the production rate which is 
equal to the elution rate of detached daughter cells (cfu/ml
-1
 h
-1
) divided by the 
total attached population in the cellulose matrix (TMP) (Thorn and Greenman, 
2009; Saad et al., 2013). Using this formula the growth rate for each flow 
condition was determined and or derived.  
Visualization of the bioluminescence and measurement of photon count by 
low light photometry after APDT or ECAS treatment  
Escherichia coli Nissle 1917/pGLITE was used to inoculate the cellulose matrix 
(n=3) at time zero and the perfusate pump (Watson Marlow, Cornwall, UK) 
switched on at a slow (1 ml h
−1
) intermediate (15 ml h
−1
) and fast (50 ml h
−1
) flow 
rates. The media consisted of 1/5
th
 strength TYE supplemented with kanamycin 
(10 μg/ml) as selective agent to maintain pGLITE and lux expression. When the 
biofilm had reached quasi-steady state (after 16 to 24 hours of perfusion), APDT 
treatment was applied (MB 100 μg/ml and total light dose 25.2 J/cm2 (30 minutes 
continuous light irradiation (light intensity 14.5mW/cm
2
) for each biofilm (at 3 
different growth rates), and 3 repeat treatments as described below were applied 
on the same biofilm. The first treatment was carried when the biofilm reached 
steady state (light output constant) (MB 100 μg/ml and total light dose 25.2 J/cm2 
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(30 minutes continuous light irradiation (light intensity 14.5 mW/cm
2
) and then 
second treatment was applied when the biofilm reached steady state (biofilm 
recovery to constant light output levels) around 24 hours post first treatment. The 
third treatment was carried out after 1 hour following the second treatment. In all 
cases the APDT treatment was same (MB 100 μg/ml and total light dose 25.2 
J/cm
2
 (30 minutes continuous light irradiation (light intensity 14.5 mW/cm
2
). The 
photon camera was stopped for the duration of the APDT treatment time and the 
flow of media to the biofilm was also stopped, just prior to duration of treatment, 
and was then switched back on, immediately after treatment. When photon 
measurements were re-started and continued for the duration of the experiment.  
The mature quasi-steady state biofilm at a determined growth rate (perfused for 
16-24 h) was treated with ECAS (pH 2.2 and ORP 1143) by taking 300l of 
(5%v/v) ECAS and depositing this on to the matrix by slow injection 300l over 5 
minutes. Experiments were repeated 3 times for each treatment condition.  
Sampling of the biofilm model 
The biofilm matrix was sequentially sampled to determine the total biofilm matrix 
population (TMP), at different time points to construct the biofilm growth curve, 
by removing the cellulose support matrix and dispersing the attached biofilm cells 
into a defined volume of PBS by vortex mixing. Cell suspensions were serially 
diluted (10
-1–10-5) and spirally plated onto appropriate recovery medium to 
determine the number of CFU per biofilm. The corresponding biofilm matrix  
eluates were also periodically sampled by aseptically replacing growth chamber 
output waste bottles (500ml) with sterile small glass sample bottles, and the 
number of biofilm shed cells per ml were quantified by serial dilution, plating and 
counting of recovered cells after incubation.  
Bioluminescence 
Integration of a bioluminescent target organism facilitated real time in situ 
measurements to be made by setting up the biofilm model within a blacked out 
incubator (Sanyo MCO-15AC CO2 incubator) at maintained at 37° C in a dark 
room facility. The ICCD225 (model 225; Photek, UK) photon counting camera 
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controlled by a computer running IFS32 data acquisition and image processing 
software was set up on the top of the blacked out incubator. The photon 
production rate of a given biofilm was continually monitored at sequential time 
points by using photon integration time of 60 s every 5 min. The IFS32 software 
permitted image capture, data acquisition from an isolated area (biofilm matrix 1-
cm
2
 area) of the image.   
Analysis of Results 
Biofilm growth and antimicrobial kill kinetic profiles graphs were produced in 
Microsoft excel program (Microsoft excel 2010). The specific growth rate () of  
the biofilms was calculated using the following formula   
Growth rate ()= Rate of elution of cells (h-1) 
                              Total biofilm population 
 
The specific growth rate ( equals the biofilm production rate of new cells in the 
perfusate output (cfu per ml x flow rate in mlh
-1
) divided by the total attached 
matrix population (total matrix cfu).  
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(a) 
 
 
 
 
 
                                                                                                                                                                                
 
 
 
 
 
 Figure 2-1 (a) Schematic of the flat-bed 
perfusion biofilm model. 1. Growth medium is 
perfused onto the biofilm via needle. 2. Low- 
light photometry is used to monitor growth 
and kill kinetics of bioluminescent biofilms. 3. 
Biofilms can be removed and disrupted to 
determine the total biofilm population density. 
4. Biofilm eluate is collected (at any time 
point) and analysed by viable count to 
ascertain the biofilm growth rate. 5. treatment 
applied APDT 1 ml of MB and light was 
delivered from fiber optic light source (MB 
100 μg/ml and total light dose 25.2 J/cm2 (light 
intensity 14.5mW/cm
2
 or ECAS  was applied 
on to the surface of cellulose membrane (b) 
Photograph of the biofilm growth chamber. (c) 
Photograph of three flat-bed units running in 
parallel 
(c) (b) 
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Chapter 3: Development of bioluminescent target based 
assay to study kill kinetics of APDT and ECAS 
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3.1 Introduction  
The use of APDT as a non-antibiotic approach to inactivate pathogenic micro-
organisms seems to be very promising (Huang et al., 2012). As discussed in 
chapter 1 APDT has various applications as alternative therapies for localized 
infections. Similarly ECAS, a fast acting biocide, may have many important 
applications in health care settings. These therapies are therefore considered to be 
potential alternatives to antibiotics treatments in the future. Therefore in order to 
study and understand their effectiveness, a rapid method of detecting viability is 
important. To monitor the bacterial APDT efficacy, including the APDT 
mechanism, rapid methods are required to replace of the laborious and time-
consuming conventional methods of serial dilutions, plating, overnight incubation 
and counting of colony-forming units (CFU). New approaches are essential to 
accelerate the development of APDT and ECAS. The bacterial bioluminescence 
method, when applied to APDT studies, to monitor the bacterial viability in real-
time, is considered to be a rapid, sensitive and a cost-effective option (Alves et al., 
2008; Tavares et al., 2011; Hamblin et al., 2002). In experimental systems, a 
strong correlation between bioluminescence and viable counts can be 
demonstrated (Rocchetta et al., 2001). The light output is noncumulative, 
reflecting the actual metabolic rate, and can be measured directly, continuously 
and non-destructively in high-throughput screening or continuous-culture models 
(Beard et al., 2002).  
Bioluminescence has been previously employed to study in vitro APDT using 
porphyrins as PS (Alves et al., 2008; Tavares et al., 2011) and to monitor the 
antimicrobial activity of ECAS (Robinson et al., 2011). However a 
bioluminescent assay has not been applied to compare the two biocides using kill 
kinetics. Moreover APDT using MB kill kinetics has not been studied before 
using bioluminescence. Therefore in this study a bioluminescence assay was 
developed to measure the kill kinetics of the two agents under same standardized 
conditions and the kill rates were compared.  
A simple rapid and robust accurate assay development will help better understand 
the effectiveness of these treatments.  
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3.1.2 Applications of bioluminescence to study antimicrobial activity of fast 
acting biocides- ECAS  
ECAS is known to be a fast acting biocide. Traditional microbiological techniques 
are used to provide reliable data on the rate and extent of kill for a range of 
biocides. However, such techniques provide very limited data regarding the initial 
rate of kill of fast-acting biocides over very short time domains.  
3.2 Aims of the chapter  
To develop reliable kill curve assays (based on bioluminescence) from which can 
be measured the target microbial kill rate and final populations at the end of the 
treatment period. The traditional methods of measuring kill rates by recovering 
cell survivors by viable count following antimicrobial treatments is impossible to 
apply when the kill kinetics are either rapid, or complex in nature (e.g. biphasic or 
multiphasic survival curves with “shoulders” (discussed in chapter 1). 
To study the effectiveness of APDT and ECAS it is required to be tested in vitro 
before testing on animal and humans. Therefore to better understand effectiveness 
and killing mechanisms, faster methods of evaluating the PS effectiveness under 
different conditions using methods such as bioluminescence is very important. 
The main aim of this chapter is to study APDT using the rapid methods of 
bioluminescence and comparing the effectiveness of APDT and ECAS. 
3.3 Results 
3.3.1 Correlation between bioluminescence and viable count 
P. aeruginosa MCS5-lite growth was followed for 24 hours by bioluminescence 
output and viable counts. The growth curve (figure 3.1) shows difference in shape 
with either bioluminescence output or viable counts. During the first 2 hours (lag 
phase), viable counts show a slightly lower rate of increase in viable number 
compared to bioluminescence where it shows a rapid increase in bioluminescence.  
In the exponential phase both parameters appear to increase exponentially from 2 
to 5 hours. It is during this exponential phase of growth that there is good 
correlation between the two variables (r
2
 = 0.8433) (Figure 3.2). The 
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bioluminescence starts to plateau earlier than the viable numbers. When the cells 
enter the deceleration phase at the end of exponential growth, the light output of 
the cells plateaus between 3 and 4 hours earlier than observed using viable counts 
and, at late stationary phase the cells give out low but stable light output up to 24 
hours (Figure 3.1).  
The growth pattern of E. coli Nissle 1917 pGLITE followed a similar pattern to P. 
aeruginosa MCS5-lite. The growth of E. coli Nissle 1917 pGLITE (figure 3.4) 
shows the lag phase followed by exponential phase and then stationary phase. 
This is a general growth pattern shared by all species of bacteria in closed batch 
culture system. Lag phase is where the bacteria adjust to the new environment by 
synthesizing enzymes. Exponential phase is where bacteria use the available 
nutrient to increase their number by dividing. Bacteria enter the stationary phase 
when the nutrients run out and/or is due to the accumulation of metabolic waste in 
the system leading to unfavourable conditions. The bioluminescence output 
increases up to 2 hours during the exponential phase and by 3 hours the 
bioluminescence start to decline reaching a steady level at 24 hours. This was not 
the case for viable count which continues to increase up to 5 hours before 
reaching steady levels from 8 hours to 24 hours. It is during this exponential phase 
of growth that there is good correlation between the two variables (r
2
 = 0.8868) 
(figure 3.5). Figure 3.5 shows that a standard culture of E. coli Nissle 1917 
pGLITE in exponential phase gives viable counts that closely correlate with 
bioluminescence in dilutions of the culture.  
The graph of bioluminescence output against viable numbers of series of log fold 
dilution of a suspension of exponential phase culture is shown in figure 3.6 for 
bioluminescent E. coli Nissle 1917 pGLITE and figure 3.3 for bioluminescent P. 
aeruginosa MCS5-lite. The bioluminescence results closely reflect viable 
bacterial number for exponential culture of these target organisms used in later 
experiments to monitor the antimicrobial activity of APDT and ECAS.  
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Figure 3-1 Growth curves of P. aeruginosa MCS5-lite followed by 
bioluminescence and viable count. Symbols represent mean of 3 experiments, 
and error bars ± standard deviation (SD), ●–viable count, ■- 
bioluminescence. 
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Figure 3-2 Correlation between bioluminescence of P. aeruginosa MCS5-lite 
(relative light units) and viable count of bacteria in exponential phase of 
growth (2-6 hours). Symbols represent mean of 3 experiments, and error 
bars ± SD. 
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Figure 3-3 Correlation between bioluminescence (relative light units) and 
viable counting in bacteria in exponential phase of growth of a suspension of 
series of log fold dilutions of P. aeruginosa MCS5-lite. Symbols represent 
mean of 3 experiments, and error bars ± SD. 
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Figure 3-4 Growth curves of E. coli Nissle 1917 pGLITE followed by 
bioluminescence (relative light units) and viable count. Symbols represent 
mean of 3 experiments, and error bars ± SD, ● –bioluminescence, ■- viable 
count.  
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Figure 3-5 Correlation between bioluminescence of E. coli Nissle 1917 
pGLITE (relative light units) and viable count of bacteria in exponential 
phase of growth (1-6 hours). Symbols represent mean of 3 experiments, and 
error bars ± SD.  
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Figure 3-6 Correlation between bioluminescence (relative light units) and 
viable counting in bacteria in exponential phase of growth of a suspension of 
series of log fold dilutions of E. coli Nissle 1917 pGLITE. Symbols represent 
mean of 3 experiments, and error bars the ± SD.  
 
 
 
 
 
R
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3.3.2 APDT kill kinetic assay 
Figure 3.7 shows the kill rates of E. coli Nissle 1917 pGLITE exposed to APDT 
with different concentration of MB and the same dose of light (total light 11 J/cm
2
 
at light intensity of 9.4mW/cm
2
. It shows that as the concentration of MB 
increased while keeping the light dose constant, the kill rate E. coli Nissle 1917 
pGLITE increases up to10 g/ml and thereafter the kill rate decreases as the 
concentration of MB increases. The highest kill rate at was at 10 g/ml of MB and 
lowest kill rate at was observed at 100 g/ml of MB. 
Figure 3.8 shows the reduction in bioluminescence of E. coli Nissle 1917 pGLITE 
exposed to APDT for 20 minutes. MB was used at 10g/ml after optimization 
(data not shown). The graph shows increase in the reduction of bioluminescence 
as the cumulative light irradiation increase over 20 minutes. At the end of the 
treatment there was nearly a 4 log reduction in bioluminescence. A viable count 
measure at the start of the experiment and at the end of the experiment showed a 
similar reduction of nearly a 4-log drop in viable count. This showed that 
bioluminescence closely correlated with viable bacterial number during killing 
phase. The assays revealed that for “cells only” control showed no change in the 
light output by the bacteria, showing that the bioluminescence output was 
constant for the duration of the experiment. To measure the toxicity level of MB 
alone E. coli was incubated with MB in the dark and bioluminescence was 
measured every 2 minutes for 20 minutes. This showed no reduction in 
bioluminescence, and the viable count did not change significantly over the 20 
minutes, showing that MB is not toxic to bacteria in the dark. Both light and 
sensitizer are required for cell killing. 
The results show that APDT is effective in killing E. coli Nissle 1917 pGLITE 
and that this treatment is effective and bioluminescence could be incorporated into 
the assay to enable rapid assessment antimicrobial activity of APDT. The slope of 
the graph gave the reduction in the rate of bioluminescence (table 3.1) which was 
-0.1709 RLU/min and rate of reduction viable numbers -0.2096 log cfu/min; this 
gave the corresponding D values (time required to reduce bioluminescence by 1 
log) 5.85 minutes and 4.98 minutes respectively.  
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The same assay was repeated with other bioluminescent species P. aeruginosa 
MCS5-lite (figure 3.9). When treated with MB 10g/ml and light there was a light 
dose related increase in reduction in bioluminescence.  There was no change is 
bioluminescence in the controls (dark control).  APDT treatment (30 minutes) 
gave nearly a 4-log reduction in both bioluminescence and viable count. The kill 
rate was calculated from the slope -0.121 RLU/min and -0.126 cfu/ml and the D 
values were 7.94 minutes and 7.93 minutes respectively.  
As the bioluminescent strain of S. aureus could not be used in the assay (because 
of its low light output and thus an inability to capture a 3-log reduction) it was 
only possible to use viable count to assess the activity of APDT towards Gram 
positive organisms. Therefore two Gram positive S. aureus species were tested S. 
aureus ATCC 6538 and MRSA stain for their sensitivity towards APDT 
As can be seen from the graph (figure 3.10) MRSA exposed to APDT showed a 
3-log reduction in viable counts over 30 minutes. The kill rate (table 3.1) obtained 
was -0.11 log cfu/min and D value was 9.1 minutes. S. aureus ATCC 6538 strain 
(figure 3.10) was very sensitive and gave 3-log reduction in viable counts in 10 
minutes (K= -0.3244 log cfu/min) and the D value was 3.1 minutes. Both MRSA 
(figure 3.9) and S. aureus ATCC 6538 strain (figure 3.10) shows no change in 
viability when cells were incubated with MB in the dark (dark controls).   
Table 3.1 shows the comparisons of kill rate for each test organism exposed to 
APDT. S. aureus was the most sensitive and the least sensitive organism was P. 
aeruginosa. MRSA gave a similar kill rate to P. aeruginosa. 
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Figure 3- 7 Kill rates of E. coli Nissle 1917 pGLITE exposed to APDT with 
different concentrations of MB. Error bars show means  ± SD (n=3) 
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Figure 3- 8  Reduction of bioluminescence and viable count of E. coli Nissle 
1917 pGLITE exposed to APDT (MB concentration 10g/ml and total light 
11J/cm
2
 at light intensity of 9.4mW/cm
2
) compared to controls. Error bars 
show means ± SD (n=3). 
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Figure 3- 9 Reduction bioluminescence and viable count of P. aeruginosa 
MCS5-lite exposed to APDT (MB concentration 10g/ml and total light 17 
J/cm
2
 at light intensity of 9.4 mW/cm
2
) compared to controls. Error bars 
show mean ± SD (n=3). 
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 Figure 3- 10 Reduction in viable count of MRSA exposed to APDT (MB 
concentration 10g/ml and total light 17 J/cm2 at light intensity of 
9.4mW/cm
2
) compared to controls. Error bars show mean ± SD (n=3). 
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Figure 3- 11 Reduction in viable count of S. aureus exposed to APDT (MB 
concentration 10g/ml and total light dose  5.6 J/cm2 at light intensity of 
9.4mW/cm
2
) compared to controls. Error bars show mean ± SD (n=3). 
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Table 3-1 Rate of change in bioluminescence or viable count of target 
organisms when exposed to APDT 
 
Target 
organism  
Bioluminescence 
Kill rate (log 
RLU/min)  
Viable count 
Kill rate (log 
(cfu/ml/min) 
r
2
 & P value 
Bioluminescence 
r
2 
& P value
 
Viable count  
E. coli Nissle 
1917 pGLITE 
-0.171 ± 0.011 -0.210 ± 0.008 0.926 
< 0.0001 
0.993 
< 0.0001 
 P. aeruginosa 
MCS5-lite 
-0.121 ± 0.009 -0.126 ± 0.008 0.861 
< 0.0001 
0.993 
0.0037 
MRSA  - -0.110 ± 0.008 - 0.925 
< 0.0001 
S. aureus - -0.324 ± 0.027 - 0.900 
< 0.0001 
 
3.6.2 ECAS kill curve  
Figure 3.12 shows E. coli Nissle 1917 pGLITE exposed to different 
concentrations of ECAS for 2 minutes (total assay time) and figure 3.13 shows the 
initial kill kinetics (change in light output for the first 10 seconds). The main 
difference between APDT and ECAS is that ECAS reduces the bioluminescence 
output by the bacteria within seconds. It only takes 4s for the 25% and 50% 
ECAS to reduce the bioluminescence to the limit of detection. Even the low 
concentration of 0.5 and 1% ECAS gave nearly a 1-log reduction in 
bioluminescence.  The kil 
l rate shown in table 3.2, was proportional to the concentration of ECAS up to 
10%, however at higher concentrations the reduction rate in bioluminescence is 
not proportionately any faster. This may be due to inaccuracy in capturing the kill 
rate because ECAS act in milliseconds at high concentration.  
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Figure 3- 12 Reduction in bioluminescence of E. coli Nissle 1917 pGLITE 
when exposed to ECAS at different concentrations for  2 minutes. Error bars 
show mean  ± SD (n=3). 
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Figure 3- 13 Initial reduction (first 10 seconds) in bioluminescence of E. coli 
Nissle 1917 pGLITE when exposed to ECAS at different concentrations. 
Error bars show mean ± SD (n=3).  
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Table 3- 2 Rate of change in bioluminescence of E. coli Nissle 1917 pGLITE 
when exposed to ECAS at different concentrations  
 
 Target organism  
E. coli Nissle 1917 
pGLITE 
50% 
ECAS 
25% 
ECAS 
10% 
ECAS 
1% 
ECAS 
0.5% 
ECAS 
Bioluminescence Kill 
rate (log RLU/min) 
±SD 
-26.28 
±1.38 
-24.72  
 ± 1.32 
-28.8  
±0.48 
-12.38  
± 0.24 
-7.26 
±0.18 
 r² 0.795 0.791 0.978 0.971 0.946 
P value <0.0001 <0.0001 <0.0001 < 0.0001 < 0.0001 
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3.5 Discussion 
The purpose of this part of the study was to develop a rapid kill assay by 
integrating a bioluminescent reporter target species to determine the kill kinetics 
of two ROS generating systems namely APDT and ECAS. First aim of the study 
was to validate the correlation between viable count and bioluminescence during 
cell growth conditions. The growth of both E. coli Nissle 1917 pGLITE and P. 
aeruginosa MCS5-lite was followed by bioluminescence and viable count. The 
growth curves showed three characteristic phases: lag phase, exponential phase 
and the stationary phase. In the lag phase immediately after inoculation of the 
cells into fresh medium, the population remains temporarily constant before any 
cell division occurs. The cell can only divide after the intracellular components 
have been synthesized (e.g ribosomes, cell polymer building blocks and 
precursors, essential coenzymes).  Hence viable count remains constant in this 
phase while the metabolic activity starts to increase. Therefore slight correlation 
between bioluminescence and viable found was found in this phase.  
It was that found for both E. coli Nissle 1917 pGLITE and P. aeruginosa MCS5-
lite there was a strong correlation in the exponential phase of growth giving r
2
 = 
0.8868 (figure 3.5) and 0.8433 (figure 3.2) respectively. Good correlation between 
viable count and bioluminescence in the exponential phase can be explained by 
considering the different properties that the two methods measure. 
Bioluminescence is based on the metabolic activity of the cells and increase 
according to the increase in metabolic activity of the cell population (Nelson et 
al., 2003; Thorn et al., 2007). In the exponential phase the cells are dividing 
regularly by binary fission at a constant rate depending on the growth medium and 
incubation conditions hence the correlation between viable counts and 
bioluminescence. During stationary phase bioluminescence does not correlate 
with viable count. As the cells stopped dividing the metabolic activity of the cell 
starts to decrease.  
In a study carried out to use a bioluminescent P. aeruginosa strain to test 
antimicrobial efficacy of wound dressing (Thorn et al., 2007), it was concluded 
that bioluminescence correlated with viable count in the exponential growth in 
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planktonic cultures (r
2 
= 0.969) and hence in this study exponential cultures were 
incorporated in to the in vitro wound infection model (Thorn et al., 2007). In 
previous studies also workers have shown this growth phase dependent conditions 
in in vitro experiments using bioluminescent bacterial strains (Nelson et al., 2003; 
Marques et al., 2005). Discrepancies between bioluminescence and viable count 
were found when there was a different response by the cell of its metabolic 
activity compared to viability (Marques et al., 2005). The different cell density of 
exponential phase culture of the two bioluminescent organisms (E. coli Nissle 
1917 pGLITE (figure 3.6) and P. aeruginosa MCS5-lite (figure 3.3), showed 
good correlation between viable counts and bioluminescence. Therefore an 
exponential phase planktonic culture of the bioluminescent target organism was 
used throughout the current study to develop and use in the assay.  
Most of the APDT studies carried out to date by other workers do not attempt to 
measure the kill rate as discussed in chapter 1, merely the numbers of survivors at 
the end of the experiment. Measuring the kill rate of an antimicrobial agent is the 
most important parameter for comparing different targets, different treatments and 
different physicochemical conditions of the assay. How long a biocide takes to 
reduce the number of bacteria by >3-log is an important indicator for it to have 
clinical application. The assay used in this thesis used a kinetic approach and 
bioluminescence enabled this kill kinetic of the test agent to be monitored rapidly 
and accurately. This was one advantage of using this method over traditional 
viable count methods. The reduction in bioluminescence was measured in real 
time especially in the case of ECAS where most of the antimicrobial activity 
occurs at the initial stages. 
In this study 10 g/ml was chosen to use in the assay after optimisation studies 
(figure 3.7). It was important to determine the concentration of MB that will give 
a significant kill rate over a 3 log reduction in viable count. As the concentration 
of MB increased, the photodynamic kill rate of bacteria decreased (figure 3.7). 
This is different to what would normally be expected when the concentration of a 
biocide is increased where the expected outcome is to observe a greater killing 
effect rather than less. The explanation for this difference is due to the property of 
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MB to dimerize as the concentration increases. As the concentration of MB 
increases there are more molecular collisions and a higher proportion of dimer to 
monomer. Monomer and dimers may be involved in different kinds of 
photochemical reactions, which may affect the mechanism and efficiency of cell 
kill (Tardivoa et al., 2005). In addition the increase in PS molecules gives an 
optical shielding effect that prevents the absorption of light by the PS. Hence it is 
important to optimise the concentration of PS. 
It was shown that MB alone and light alone is not active against either of the 
Gram-positive or Gram-negative species; both species require both light and 
photosensitizer to inactivate the micro-organism. The results showed that for both 
bioluminescent species there was significant correlation between viable count and 
bioluminescence in the killing phase (figure 3.8 and 3.9). A very similar kill rate 
for APDT was obtained with both bioluminescence and viable methods (table 
3.1). Therefore loss of bioluminescence under these conditions may clearly 
indicate the loss in viability of bacterial cells. This proved that monitoring 
viability and/or bioluminescence appears to be feasible.  
The assay system generated data showing conclusively that E. coli, P. aeruginosa, 
MRSA and S. aureus were susceptible to APDT. A study carried out to test APDT 
with MB and visible light, and a range of microbial species by Zeina et al. (2001) 
showed APDT to be effective in eliminating these microbial species. MB at 
100g/ml and standard light intensity conditions (42 mW/cm2) were used. The 
kill rates and subsequent D-values were determined against Staphylococcus 
aureus, S. epidermidis, Streptococcus pyogenes, Corynebacterium minutissimum, 
Propionibacterium acnes and Candida albicans. D-values for these species were 
1.2, 1.1, 0.8, 2, 0.5 and 11 minutes, respectively. The D value obtained in the 
current study for S. aureus (3.1 mins) is 2.5 times higher than the study by Zeina 
et al. (2001). This is not surprising since the parameters used were different (the 
MB dye (10g/ml) and light intensity (9.4mW/cm2) compared to the above study. 
Of all the target organisms  S. aureus was the most sensitive organism. This is 
also expected as it is known that Gram-positive organism are more sensitive than 
Gram negative species to MB (Tegos and Hamblin, 2006).  
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The kill rate for MRSA when compared with S. aureus kill rate was much lower. 
It has been reported that phenothiaziniums were less effective against the MRSA 
strains than against the standard S. aureus (Wainwright et al., 1998). However the 
decreases in activity were not as great as those for fucloxacillin and vancomycin 
(Wainwright et al., 1998).  This may be an important advantage of APDT as 
MRSA is a major organism associated with nosocomial infection (Chambers and 
Deleo, 2009). There is growing concern due to widespread occurrence of 
infections and limited alternative drug regimens. Moreover the reports on 
vancomycin-resistant S. aureus make this issue more urgent (Wainwright et al., 
1998).  In addition staphylococcal related infections or colonisation sites are 
accessible to topical treatments (e.g. in epidermal wounds or burns) (Wainwright 
et al., 1998) therefore APDT can be applied to these infections in practice.  The 
result of the current study shows that kill rate is high for both these organisms and 
effective killing (3 log reduction) can be seen in less than 30 minutes of treatment. 
This indicates APDT application need require only short treatments and may be a 
feasible treatment option for localised infections.  
The kill rates for E. coli Nissle 1917 pGLITE and P. aeruginosa MCS5-lite were 
0.172 RLU/min (D value of 5.85 mins) and 0.121 RLU/min (D value 7.94 mins) 
respectively. Within this assay system the E. coli kill rate was slightly higher than 
that measured for P. aeruginosa. The kill rates for both the gram negative 
organisms were lower compared to the Gram positive S. aureus 
In a study carried out with MB 10 mol L-1 and light dose of 12 J cm-2 10 minutes 
exposure  at 630 nm showed a decrease of 5 log for P. aeruginosa and 4 log for E. 
coli (Melo et al., 2011) showing that APDT is effective against these organisms as 
was found in the present study. Differences in log reduction in number of cells 
may be due to the differences in the protocol (e.g concentration of PS, light dose, 
pre-incubation time, cell inoculum density).  Several other studies have also 
reported by viable count methods that APDT is effective against a variety of 
organisms using MB and light (Wainwright et al., 2007).  It is difficult to make 
direct comparisons to these studies as different test parameters were used. 
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However, in general this study is in agreement with previous studies that APDT is 
effective in killing the target organism after short treatments. 
In an APDT study a bioluminescent indicator strain was used to assess the activity 
of three cationic meso-substituted porphyrin derivatives.  It was shown that in the 
presence of the PSs under artificial (40 W m
-2
) or solar irradiation (620 W m
-2
) 
that both were effective against bioluminescent E. coli (>4 log bioluminescence 
decrease) (Alves et al., 2008). The results of this study showed that 
bioluminescence analysis is an efficient, sensitive and faster approach to study 
APDT activity. 
Bioluminescence allows only living or viable cells to be detected (Rocchetta et 
al., 2001). The reduction in bioluminescence in a killing environment may not 
directly show the loss in viability. However it is reasonable to assume that, when 
the changes in treated samples are compared with those of untreated samples, the 
relative difference is reflective of changes in cell viability. Therefore 
bioluminescence output by the cells may produce characteristic kill curve relating 
to the inactivation kinetics of APDT under defined conditions.  
Several other studies carried out using bioluminescent organisms have also 
proved the effectiveness of this method of using bioluminescent organisms in 
APDT (Hamblin et al., 2002; Hamblin et al., 2003; Demidova et al., 2005). 
Furthermore, use of bioluminescence as a measure of cell viability has been 
shown to correlate well with standard recovery techniques such as viable counts 
under defined conditions (Beard et al., 2002; Kadurugamuwa et al., 2003). From 
these results it can be concluded that in a killing environment the loss of 
bioluminescence can be a good indicator of loss of viability of bacterial cells. 
The ECAS kill kinetic assay showed that ECAS gave the highest kill rate 
compared to APDT and reduces the bioluminescence level to the limit of 
detection within 10 seconds. The kill rates for 50% v/v, 25%v/v,10% v/v, 1% v/v 
and 0.5% v/v were  -26.28, -24.72 , -28.8, -12.38, -7.26 logRLU/min respectively. 
The kill rates for ECAS were considerably faster than APDT even at the lowest 
dose of 0.5% ECAS.  
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Because it is a very fast acting agent the initial kill by ECAS would not be 
possible to measure easily by traditional viable count method. The 
bioluminescence method enabled full capture of the kill rates of ECAS. Hence 
ECAS kill kinetic assay is a very useful development. Fast action is highly 
desirable if ECAS was to be used as a hand disinfection biocide where short 
contact time is required. Therefore it is very important to develop studies to test 
the efficacy of ECAS, especially by comparing to other known antimicrobial 
agents.  Most importantly this method is more accurate for measuring rates 
because greater number of data points can be achieved compared with viable 
count in a specific time. This is because viable count requires taking a sample, 
diluting and plating out whereas with bioluminescence a measurement gives 600 
data points in a 10 minutes test. However, with viable counts the maximum 
number of data point likely to be obtained would be 10 points. With higher 
number of data points greater knowledge of variation can be seen and more 
accurate results will be achieved. Since bioluminescence can be measured within 
seconds it is also possible to obtain kill curves for microbial agents that kill in a 
short duration in contrast with viable count. This is evident with ECAS used in 
this research, which can reduce the number of bacteria by 2 or 3 logs in a few 
seconds and reading were recorded every 0.2 seconds.  
Bioluminescence technique has been previously used to compare ECAS activity 
with a range of biocides (Robinson et al., 2011). This study reported that 
bioluminescence method was very effective to measure initial kill rates over very 
short time domains and compared ECAS with the range of biocides. It was found 
that 80%v/v ECAS produced the highest kill rate compared to bleach, Virkon, and 
ethanol at matched concentrations. Also it was reported that in the presence of 
fetal bovine serum (FBS) the activity of ECAS was reduced considerably 
(reported kill rates 80%v/v ECAS kill rate -2.336 log10 RLU s
−1
, in the presence 
5% FBS  1.579 RLU s
−1 
and 10% FBS  0.165 RLU s
−1
). Even though the presence 
of organic soiling reduced the kill rate to 0.165 RLU s
−1
 it still produced 9.9 log 
reductions in 1 minute, which is more than the effective range of 3 log.  
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The results of this study confirmed that the developed bioluminescence assay is 
rapid and accurate, and can be used to monitor bacterial inactivation by both 
APDT and ECAS. Therefore this assay may enable further elucidation of their 
mechanism of action of both the agents.  
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Chapter 4: Comparative mechanistic study of APDT and 
ECAS using bioluminescent rapid assay and ROS specific 
fluorescent probes 
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4.1. Introduction 
In chapter 3 a bioluminescent-based assay was developed and using this assay the 
kill rates of APDT and ECAS treatments were accurately determined. The assay 
was rapid and gave real time data on the kill kinetics of the reaction occurring. It 
was shown that the kill rates by both APDT and ECAS were reduced or increased 
in line with the dose of treatment (APDT and ECAS) used. Therefore 
bioluminescence enabled kill kinetics of the reaction to be monitored. The main 
aim of this chapter is to understand the likely killing mechanisms by using the 
bioluminescent assay with or without specific ROS scavengers and other 
compounds that inhibit or enhance killing activity, and also to determine if ROS 
specific fluorescent probes could detect real-time ROS generation in the system.  
A broad definition of free radicals is any chemical species that has one or more 
unpaired electrons. These species are highly unstable, short-lived intermediates 
that stabilize by abstracting hydrogen from another chemical species (Laguerre et 
al., 2007). The term reactive oxygen species (ROS) is a collective term used for 
oxygen free radicals that includes not only oxygen-centred radicals such as OH
•
 
and O2
-
  but also some non-radical derivatives of oxygen, such as hydrogen 
peroxide (H2O2), singlet oxygen 
1
O2  and hypochlorous acid (HOCl)  
Free radical and ROS can be generated in wide variety of biological and chemical 
systems. These ROS display different kinetics and activity in biological systems. 
The effects of superoxide and hydrogen peroxide are less acute than those of 
hydroxyl and singlet oxygen, because superoxide and hydrogen peroxide can be 
detoxified by endogenous antioxidants including enzymes that may be induced by 
oxidative stress. In contrast, no enzyme can detoxify hydroxyl and singlet oxygen 
possibly due to their high capacity to immediately react upon production making 
them extremely toxic and lethal (Vatansever et al., 2013).    
The cytotoxicity effects of APDT are due to the cytotoxic ROS produced by the 
excited triplet state PS upon absorption of light (Wainwright, 1998; Hamblin and 
Hassan, 2004). The ROS produced in type I mechanisms include free radicals 
such as hydroxyl radicals and in type II mechanisms singlet oxygen is produced. 
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Oxygen is required for type II mechanism. Type I and Type II reactions can occur 
simultaneously.  
Although the photophysics behind the photodynamic reaction and the types of 
ROS produced is well understood, the mechanistic details of how the ROS 
generated during APDT lead to microbial killing are not fully understood. Singlet 
oxygen is the main species thought to be involved in APDT (Ergaieg et al., 2008) 
and is a highly reactive molecule that can result in extreme detrimental effects to 
biological systems (Halliwell, 2006). Hydroxyl radical is thought to be the main 
active species produced in ECAS (Thorn et al., 2012) and also produced in type I 
pathway in APDT (Hamblin and Hassan, 2004). It is the strongest oxidising agent 
known, being characterised to react non-selectively with extremely high rate 
constants with almost every type of organic molecule found in living cells. The 
hydroxyl radical is so active that, if formed in living systems, will react with 
whatever biological molecule is in their close vicinity, and can damage virtually 
all types of organic biomolecules, including carbohydrates, nucleic acids, lipids, 
proteins, DNA, and amino acids (Halliwell, 2006).  
ECAS has been reported to have strong antibacterial effects against a range of 
pathogenic micro-organisms (Liao et al., 2007).  In the literature this high 
antimicrobial activity has been attributed to various inherent characteristics of 
ECAS. It has been proposed that high Oxidation Reduction Potential (ORP) 
creates an unbalanced osmolarity which damages the cell membrane. This may 
cause oxidizing moieties present in ECAS to penetrate into the cell cytoplasm 
leading to further damage to intracellular proteins, lipids and nucleic acid, 
ultimately killing the cells (Thorn et al., 2012). In addition to this, chlorine 
concentration and pH has also been shown to play an important role (Park et al., 
2004). Many researchers have concluded the presence of free chlorine species 
such as HOCl as the main primary species responsible for disrupting the microbial 
structure (Thorn et al., 2012).  
In research carried out to study the fungicidal efficacy of ECAS, hydroxyl radicals 
were detected in ECAS, and significantly contributed to fungicide efficiencies 
(Xiong et al., 2010). Therefore it has been concluded that for ECAS a 
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combination of both reactive free radical and ROS may contribute to its 
antimicrobial efficacy (Thorn et al., 2012). However, very few studies have 
attempted to identify the ROS species in ECAS. This may be due to difficulties of 
directly detecting these species due to their low levels and their high reactivity 
and instability. In one study the presence of hydroxyl radical in ECAS was shown 
using the direct method of electron spin resonance spectroscopy (ESR) (Suzuki et 
al., 2002). However no studies have attempted to determine the rate of generation 
of ROS in real-time and how this relates to the kill kinetics of the target organism.  
Many studies conclude that 
1
O2 is in fact the major ROS of importance in APDT 
(Ergaieg et al., 2008; Maisch et al., 2007), while others attribute the killing to 
radicals including OH
•
 (Martin and Logsdon, 1987). Moreover these studies are 
carried out under different conditions with different light sources with different 
PS therefore making it difficult to compare the results. The various factors 
affecting the production of ROS and kill kinetics is dependent on 
microenvironment conditions (Yamakoshi et al., 2003). Therefore it is essential to 
carry out studies using the same experimental conditions to distinguish and 
quantify each type of ROS produced. 
To the author’s knowledge no study has previously been carried out to monitor 
the ROS production kinetics at the same time as monitoring the kill kinetics using 
bioluminescence. In this study the effects of specific scavenger addition was 
monitored in real time using the bioluminescent target organism. In addition, 
fluorescence probes were used to monitor the ROS production kinetics by the two 
agents (APDT and ECAS). The combination of these two methods, addition of 
scavenger  and use of fluorescent probes, will enable a better understanding of the 
mechanism of APDT. Moreover comparative study of APDT to another ROS 
generating system (ECAS) using the same standardised method will enable better 
understanding of the mechanisms behind both antimicrobial agents.  
Previous studies of microbial killing employed viable count recovery and workers 
only monitored the relative survival of the microorganisms in the presence or 
absence of scavenger by comparing the final survival population numbers at the 
end; not by comparing the killing rates (Sabbahi et al., 2008; Wong et al., 2005; 
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Bhatti et al., 1998). Using viable count methods to determine kill would be very 
laborious and probably inaccurate since minimum of five different time points in 
the presence of scavenger with all the relevant controls would be required to 
obtain a rate. For this reason most researchers do a single viable count after fixed 
time interval to show inhibition of the killing in the presence of specific ROS. 
Using the bioluminescence method to measure kill rates rather than mere survival 
numbers at the end of the reaction time is more accurate since a killing may 
deviate from first order kinetics. Bioluminescence method is especially important 
in the case of fast acting biocides since it is the only method to enable the capture 
of the rapid kill kinetics of ECAS (Robinson et al., 2011). Therefore using 
bioluminescence will enable the accurate capture of kill rate changes in the 
presence or absence of scavengers enabling the detection of ROS involvement in 
ECAS or APDT.   
4.2 Indirect method of detecting singlet oxygen and free radicals  
Indirect methods of evaluating the presence of singlet oxygen or other ROS have 
been used to verify the hypothesis of involvement of singlet oxygen and ROS in 
PDT and APDT (Gorman and Rodgers 1992; Nitzan et al., 1989; Bhatti et al., 
1998).  Using this method various studies have confirmed ROS production in 
APDT (Nitzan et al., 1989; Ergaieg et al., 2008; Abe et al., 1997; Wong et al., 
2005). 
Numerous compounds exists that can react competitively with ROS, providing 
protection against its cytotoxic effects. A variety of scavengers and quenchers of 
specific ROS has been employed to assess their relative contributions to cytotoxic 
events in APDT. Table 4.1 shows the type of scavenger molecule and the 
respective ROS inhibited in different systems.  
Tryptophan is a scavenger with reported activity against singlet oxygen 
(Henderson and Miller, 1986) however it is thought to be less specific since it has 
also been reported to inhibit hydroxyl radical (Maskos et al., 1992).  
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Table 4-1 Indirect method of detecting ROS using specific scavengers  
 
Reference  Microbial 
target species 
Singlet 
oxygen 
quenchers  
Free radical 
quenchers 
ROS 
generation  
Effect of 
scavenger  
Ergaieg et al., 
2008 
E. hirae  
E. coli 
Sodium 
azide  
Histidine  
β-carotene  
 
 
Superoxide 
dismutase  
Catalase  
Dimethyl 
sulfoxide  
(DMSO) 
meso-
substituted 
cationic 
porphyrin 
(TMPyP) (114 
M) plus 
0.285W 
polychromatic 
light for 3 min 
Reduction of 
EPR signal 
Both type I 
and type II 
mechanisms  
Sabbahi et al., 
2008 
S. aureus  Sodium 
azide 
Tryptophan
 
Mannitol APDT MB(20 
M) and 10 
minutes light 
exposure  
Inhibition of  
killing 
APDT MB 
occurred in 
part, via a 
Type I 
mechanism in 
which OH
•
 
was produced. 
Tavares et al., 
2011 
bioluminescent  
E. coli 
 
Sodium 
azide (10 
mM) 
 
Mannitol 
(100 mM) 
 
0.5 mMTri-
Py+ -Me-PF, 
5.0 mMTetra-
Py+ -Me or 
5.0 mM Tri- 
SPy+ -Me-PF 
270 min with 
artificial white 
light 
Inhibition in 
reduction in 
bioluminescen
ce activity 
Type I and 
type II 
mechanisms 
(type II 
mechanism 
more 
important 
compared to 
type I 
mechanism)  
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Huang et al 
2012  
S.  aureus,     
E.  faecalis,  
  
E.  coli,  
P. mirabilis,  
P. aeruginosa 
 
 
Sodium 
azide (10 
mM) 
 
 
 
DMT (200 mM) conjugate 
between 
polyethylenim
ine and 
chlorin(e6) 
(PEI–ce6) 400 
nM and 660 
nm light 5 
Jcm
-2 
(PEI–ce6) 2 
M and light 
660 nm 100 
mWcm
-2
 
Inhibition 
killing (viable 
count cfu/ml) 
Inhibition of 
fluorescence 
by HPF(10 
M) 
Gram-negative 
bacteria are 
more 
susceptible to 
HO
.
 (type I 
mechanism) 
while Gram-
positive 
bacteria are 
more 
susceptible to 
1
 O2 (type II 
mechanism 
Nitzan et al., 
1989 
S.  aureus Methionine  
Tryptophan  
 DABCO 
Propylgallate Deutero-
porphyrin 
Both type I 
and type II 
mechanisms 
Omar et al., 
2008) 
S.  aureus Tryptophan  
Deuterium 
oxide 
(enhancer of 
singlet 
oxygen 
- Indocyanine 
green 
Type II 
mechanisms 
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4.2.2 Fluorescence Probes to determine APDT and ECAS mechanisms  
Sensitive and selective detection of ROS is vital for understanding its involvement 
and antimicrobial mechanism in ROS generating systems such as in APDT and 
ECAS. Use of fluorescence and chemiluminescence probes is a rapid and simple 
method exhibiting high sensitivity and desirable selectivity for detecting particular 
ROS species; therefore having great potential for ROS determination (Price et al., 
2009). 
ROS activity and production can be determined using different analytical 
techniques such as high performance liquid chromatography, gas chromatography 
and mass spectrometry by detecting specific biomarker or products from the 
oxidation of protein, DNA, lipid or other biomolecules (Vivekanandan-Giri et al., 
2011). These analytical procedures also provide specific detection, for example 
for, hypochlorous acid species (Winterbourn and Kettle, 2000). However, the 
main disadvantage of these methods is it does not provide for rapid real time 
monitoring (Winterbourn, 2014). It is preferable to detect ROS in real time within 
live cells or in cell free systems as they are generated. Specific fluorescent probes 
with fluorescent imaging techniques allows for real time monitoring and hence 
will give better insight into the mechanisms and role of ROS in systems 
investigated.  
 
The literature contains numerous reports of the use of fluorescent probes for the 
detection of ROS (Gomes et al., 2005). However, most commonly used traditional 
probes (e.g. dihydro-compounds such as dihydrorhodamine 123 (DHR123) and 
2',7'-dichlorodihydrofluorescein (DCFH) reacts with a wide range of ROS (Soh, 
2006). These probes are also highly photosensitive and as a result are autoxidized 
to produce large background fluorescence in the absence of ROS in fluorescent 
measurements that involve irradiation of excitation light (Soh, 2006).  
A new generation of fluorescent probes have been developed to overcome these 
limitations (Setsukinai et al., 2003). These include APF, and HPF, which were 
shown to be stable against autoxidation and specific (or relatively specific) to 
detect OH
•
 and peroxynitrite (Setsukinai et al., 2003). APF also showed 
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fluorescence in the presence of hypochlorite (
−
OCl) while HPF showed no 
activity.  
SOSG is also a recently developed probe to detect 
1
O2 (Ragas et al., 2010). 
Previous work has shown the specificity of SOSG using a range of conditions 
known to involve the production of singlet oxygen. For example it was 
demonstrated that SOSG can be used effectively to detect singlet oxygen in 
diatoms and leaves (Flors et al., 2006). SOSG exhibits weak blue fluorescence 
with excitation peaks at 372 nm and 393 nm and emission peaks at 395 nm and 
416 nm (Molecular Probes, 2005). In the presence of 
1
O2 SOSG emits a green 
fluorescence with excitation and emission peaks at 504 nm and 525 nm, 
respectively, which can be readily detected for singlet oxygen (Flors et al., 2006). 
Even in the presence of mixed oxidants (superoxide and hydroxyl radicals) SOSG 
appears to give specific dose dependent fluorescence in proportion to the 
concentration or production rate of singlet oxygen (Molecular Probes, 2005).  
These fluorescent molecules physically change shape (and brightness) when they 
come into contact with specific reactive molecules. These conformational changes 
enhance or reduce the fluorescence of the indicators at certain given frequencies 
of light. This change in fluorescence is then measured using a fluorospectrometer 
that measures the intensity of the spectrum of light emitted from the indicators. 
The change in fluorescence of these indicators before and after exposure to these 
reactive molecules therefore indicates existence of such reactive molecules and 
their generation in the system. Each of these three indicators (APF, HPF and 
SOSG) is sensitive to specific types of reactive molecules and considered to be 
resistant to false positives and have been well studied and routinely used to detect 
ROS.  
 
Price et al. (2009) assessed ROS production in PDT using APF, HPF and SOSG. 
It was shown that both APF and HPF could be used to monitor the formation of 
OH
•
 as well 
1
O2 in PDT. The portion of the fluorescence quenched by sodium 
azide (NaN3) (scavenger of singlet oxygen) represents the contribution of singlet 
oxygen and the portion quenched by DMSO (quencher of OH
•
) represents the 
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contribution of hydroxyl radical. Using SOSG probe these workers confirmed 
production of singlet oxygen in PDT. SOSG is mainly specific to singlet oxygen 
as the fluorescence was quenched to large extent in the presence NaN3
 
and only 
minor quenching with DMSO. The authors concluded that this procedure could 
represent a useful means for evaluating formation of both ROS in the context of 
PDT (Price et al., 2009).  In another recent study HPF and SOSG was employed 
to examine the relative contributions 
1
O2 and OH
•
 in APDT mediated killing of 
Gram-positive and Gram-negative bacteria (Huang et al., 2012). 
4.4 Aims and objectives of this chapter 
To apply the bioluminescent target based rapid assay in order to determine the 
mechanisms of two oxidative biocides (APDT and ECAS) in the presence or 
absence of ROS specific inhibitors. To develop a fluorescence-based assay using 
ROS specific fluorescent probes in order to detect the real-time production of 
ROS by APDT and ECAS. Both APDT and ECAS have elements of highly 
reactive oxidizing species but with some similarities and differences in their ROS 
profile. To compare the two systems side by side using standardized assays in 
order to understand the relative contribution of 
1
O2 and OH
•
 to the mechanisms of 
killing of target organism in each system.  
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4.5 Results  
4.5.1 APDT kill kinetics of P. aeruginosa MCS5-lite in the presence of 
hydroxyl radical scavengers, singlet oxygen scavenger and D2O 
All assays were run using appropriate controls. Exposure to scavengers invariably 
caused inhibition of killing actions that would have been expected in the light and 
MB treatment. All other controls without light or MB gave flat profile with little 
change in viable numbers or bioluminescence throughout the assay. 
Data presented in figures 4.1 to 4.2 show the effects of hydroxyl radical 
scavengers N,N′-dimethylthiourea (DMTU) and mannitol on Pseudomonas 
aeruginosa MCS5-lite. Both gave significant reductions compared with the 
control kill rate and this may suggest some role for hydroxyl radical in the killing 
mechanism for this microbial species.  It was of interest to note that there was a 
difference in the kill rate when D2O was included in the assay (figure 4.3) 
showing statistically significant enhancement, and thus suggesting a role for 
singlet oxygen in the normal control killing process. However it was interesting to 
note that the initial kill rate (first 8 minutes of exposure) showed a slight increase.  
Figure 4.4 shows the greater inhibition of killing in the presence 10mM 
tryptophan, again suggesting singlet oxygen mediated involvement in the killing 
of the target species. Table 4.2 summarises the kill rates and the percentage of 
protection that is afforded to the target species by the different compounds. It is 
interesting to note that tryptophan at 10mM gave strong protection of killing 
effect (89% reduction in the kill rate), whilst the hydroxyl scavengers gave around 
50% protection suggesting a role for type-1 hydroxyl radical killing mechanisms 
as well as a role for singlet oxygen (type II mechanisms). 
As a significant difference was found between the initial (first 8 min) and later kill 
rate therefore the initial rate was also calculated. Table 4.3 summarise the kill 
rates and relative protection. 
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Figure 4-1 Changes in bioluminescence of P. aeruginosa MCS5-lite       
treated with APDT (MB 10 g/ml and total light dose 17 Jcm-2 (light intensity 
9.47 mWcm
-2
) compared to APDT in the presence of 10 mM DMTU 
(hydroxyl radical scavenger). DC, dark control; LC, light control, error bars 
show mean ± SD (n=3). 
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Figure 4-2 Changes in bioluminescence of P. aeruginosa MCS5-lite,      
treated with APDT (MB g/ml and total light dose 17 Jcm-2 (light intensity 
9.47 mW/cm
2
) compared to APDT in the presence of 10 mM mannitol 
(hydroxyl radical scavenger). DC, dark control; LC, light control, error bars 
show mean ± SD (n=3). 
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Figure 4-3 Changes in bioluminescence of P. aeruginosa MCS5-lite       
treated with APDT (MB 10 g/ml and total light dose 11 Jcm-2 (light intensity 
9.47 mW/cm
2
) compared to APDT in the presence of D2O (singlet oxygen 
enhancer). DC, dark control; LC, light control, error bars show mean ± SD 
(n=3). 
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Figure 4-4 Changes in bioluminescence of P. aeruginosa MCS5-lite        
treated with APDT (MB 10 g/ml and total light dose 11 Jcm-2 (light intensity 
9.47 mW/cm
2
) compared to APDT in the presence of 10 mM tryptophan 
(scavenger of singlet oxygen). DC, dark control; LC, light control, error bars 
show mean ± SD (n=3). 
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Table 4-2 Showing the APDT kill rate over 20-30 minutes assay of 
P.aeruginosa MCS5-lite in the presence or absence of singlet oxygen 
scavengers or hydroxyl radical scavengers  
 
Treatment Kill rate 
(log 
RLU/min) 
r² P value Deviation 
from zero? 
Percentage 
relative kill  
Percentage 
relative 
protection 
APDT  -0.121 ± 
0.007 0.852 < 0.0001 Significant 100 0 
APDT +10 mM 
Tryptophan 
-0.005 ± 
0.001 0.423 0.001 Significant 10.579 89.421 
APDT+ D2O -0.134 ± 
0.005 0.963 < 0.0001 Significant 247.730 -147.730 
APDT +10 mM 
DMTU 
-0.059 ± 
0.007 0.817 < 0.0001 Significant 48.519 51.481 
APDT +10 mM 
Mannitol  
-0.060 ± 
0.010 0.712 < 0.0001 Significant 49.785 50.215 
 
Table 4-3  Showing the APDT kill rate of P. aeruginosa MCS5-lite over the 
first 8 minutes in the presence or absence of singlet oxygen scavengers or 
hydroxyl radical scavengers  
 
Treatment Kill rate 
(log 
RLU/min) 
r² P value Deviation 
from zero? 
Percentage 
relative  kill 
Percentage 
relative 
protection 
APDT  -0.065 ± 
0.07 
0.873 < 0.0001 Significant 100 0 
APDT +10 mM 
Tryptophan 
-0.016 ± 
0.005 
0.546 0.015 Significant 54.549 45.451 
APDT+ D2O -0.097 ± 
0.006 
0.953 < 0.0001 Significant 148.923 -48.923 
APDT +10 mM 
DMTU 
-0.039 ± 
0.008 
0.880 0.018 Significant 59.771 40.229 
APDT +10 mM 
Mannitol  
-0.038 ± 
0.010 
0.809 0.038 Significant 57.632 42.368 
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4.5.2 APDT kill kinetics S. aureus in the presence of hydroxyl radical 
scavengers and singlet oxygen scavenger  
Figure 4.5. shows the effects of tryptophan at 10mM (potentially a singlet oxygen 
scavenger at this concentration), and the hydroxyl radical inhibitors DMTU and 
mannitol; all gave significant reductions in the rate of killing. The kill rate data 
and percentage protection is summarised in Table 4.4 and shows a 97% reduction 
of kill for tryptophan, and 90% and 80% for DMTU and mannitol respectively. 
However, it should be noted that the bioluminescence-based assay could not be 
applied to Staphylococcus (since no suitable lux variant could be sourced) so all 
rate data presented are from viable counts of starting and surviving populations 
through the time of the assay. Accurate kill rates could not be obtained due to the 
lack of sample points for all conditions at all times; a feat that is difficult using 
viable count.   
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Figure 4-5 Changes in bioluminescence of S. aureus treated with APDT (MB 
10 g/ml and total light dose 11 Jcm-2 (light intensity 9.47 mW/cm2) 
compared to APDT in the presence of 10 mM tryptophan, mannitol and 
DMTU. Error bars show mean ± SD (n=3). 
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Table 4- 4  Showing the APDT kill rate of S. aureus in the presence or 
absence of singlet oxygen scavengers or hydroxyl radical scavengers  
 
 
 
 
 
 
 
 
 
 
 
Treatment  kill rate (slope log 
cfu/ml/min) 
Percentage 
Relative 
protection 
Percentage 
Relative kill 
APDT MB -0.203 ± 0.009 0.00 100 
APDT MB10mM DMTU 
(scavenger of hydroxyl 
radical) 
-0.019 ± 0.003 90.69 9.31 
APDT MB10mM Mannitol 
(scavenger of hydroxyl 
radical) 
-0.039 ± 0.006 80.77 19.23 
APDT MB 10mM 
tryptophan (scavenger of 
singlet oxygen) 
-0.004 ± 0.002 97.81 2.19 
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4.5.3 APDT kill kinetics E. coli Nissle 1917/pGLITE in the presence of 
hydroxyl radical, singlet oxygen scavenger and D2O 
Figure 4.6 shows the APDT activity compared to dark control and light only 
control. Figures 4.7, 4.8 and 4.9 show the effects of tryptophan (at 10mM and 1 
mM), mannitol (10mM) and DMTU (10mM) respectively. All showed significant 
reductions in the expected kill rate seen in the treatment control. The kill rate data 
and percentage protection given by the treatments is summarised in table 4.5. 
Figure 4.10 shows the effects of the use of D2O replacement of H2O. The rate of 
kill was markedly increased, strongly supporting the role of singlet oxygen in 
APDT killing. However, the dark control also showed reduction in 
bioluminescence over the first 5 to 7.5 minutes before completion of the treatment 
response at 20 minutes with an overall 1-log drop of light output compared to 
control. It shows later recovery from 7.5 minutes. In comparison, the APDT with 
D2O continued to reduce bioluminescence another two log-fold, showing a clear-
cut difference in effect.  
As with previous findings, tryptophan (10mM) was shown to be the most 
effective overall inhibitor of total APDT killing. Mannitol and DMTU also gave 
protection, supporting the role of hydroxyl radical involvement (type-I 
mechanisms) in cell killing. However the protection effect of mannitol was less 
compared to DMTU.  
Table 4.6 summarises the initial kill rate calculations based on the first 8 minutes 
(5 data points) 
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Figure 4-6 Changes in bioluminescence of E. coli Nissle 1917 pGLITE  
treated with APDT (MB 10 g/ml and total light dose 11 J/cm2 (light 
intensity 9.47 mW/cm
2
) compared to controls. DC, dark control; LC, light 
control, error bars show mean ± SD (n=3). 
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Figure 4-7 Changes in bioluminescence of E. coli Nissle 1917 pGLITE  
treated with APDT (MB 10 g/ml and total light dose 11 J/cm2 (light 
intensity 9.47 mW/cm
2
) compared to in the presence of 0.1 mM or 10 mM 
tryptophan. Error bars show mean ± SD (n=3). 
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Figure 4-8 Changes in bioluminescence of E. coli Nissle 1917 pGLITE  
treated with APDT (MB 10 g/ml and total light dose 11 J/cm2 (light 
intensity 9.47 mW/cm
2
) compared to assay in the presence of 10 mM 
mannitol. Error bars show mean ± SD (n=3). 
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Figure 4-9 Changes in bioluminescence of E. coli Nissle 1917 pGLITE  
treated with APDT (MB 10g/ml and total light dose 11 J/cm2 (light intensity 
9.47 mW/cm
2
) compared to in the presence of 10 mM DMTU. Error bars 
show mean ± SD (n=3). 
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Figure 4-10 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with APDT (MB 10 g/ml and total light dose 11 J/cm2 (light 
intensity 9.47 mW/cm
2
) compared to assay in the presence of D2O. Error 
bars show mean ± SD (n=3). 
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Table 4- 5 Showing the APDT kill rate of E. coli Nissle 1917 pGLITE in the 
presence or absence of singlet oxygen scavengers and/or hydroxyl radical 
scavengers (summary of rate data from figures 4.6 to 4.10) 
 
Treatment Kill rate (log 
RLU/min) 
r² P value Deviation 
from zero? 
Percentage 
relative kill 
Percentage 
relative 
protection 
APDT -0.171 ± 0.011 0.926 < 0.0001 Significant 100 0 
APDT+ 10 mM 
Tryptophan 
-0.009 ± 0.006 
0.069 0.141 
Not 
Significant 5.049 94.951 
APDT+ 0.1 
mM 
Tryptophan 
-0.178 ± 0.006 
 0.966 < 0.0001 
Significant 
104.272 -4.272 
APDT+ 10 mM 
Mannitol 
-0.196 ± 0.009 
0.959 < 0.0001 
Significant 
114.687 -14.687 
APDT+ 10 mM 
DMTU 
-0.055 ± 0.015 
0.599 0.005 
Significant 
32.048 67.952 
APDT+ D2O -0.190 ± 0.033 0.785 0.000 Significant 111.176 -11.176 
 
 
Table 4- 6 Showing the APDT kill rate of E. coli Nissle 1917 pGLITE over 
the first 8 minutes in the presence or absence of singlet oxygen scavengers 
and/or hydroxyl radical scavengers (summary of rate data from figures 4.6 to 
4.10)  
 
Treatment Kill rate (log 
RLU/min) 
r² P value Deviation 
from zero? 
Percentage 
relative 
kill  
Percentage 
relative 
protection 
APDT -0.259 ± 0.018 0.962 < 0.0001 Significant 100 0 
APDT+ 10 mM 
Tryptophan -0.017 ± 0.021 0.045 0.445 
Not 
Significant 6.514 93.486 
APDT+ 0.1 mM 
Tryptophan -0.191 ± 0.015 0.919 < 0.0001 Significant 73.745 26.255 
APDT+ 10 mM 
Mannitol -0.234 ± 0.029 0.884 < 0.0001 Significant 90.386 9.614 
APDT+ 10 mM 
DMTU -0.164 ± 0.051 0.773 0.050 Significant 63.436 36.564 
APDT+ D2O -0.461 ± 0.066 0.942 0.006 Significant 178.147 -78.147 
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4.5.4 ECAS kill kinetics of E. coli Nissle 1917/pGLITE in the presence of 
hydroxyl radical scavengers dimethyl thiourea (DMTU), mannitol and singlet 
oxygen scavenger, tryptophan and enhancer of singlet oxygen, D2O 
Figures 4.11 to 4.16 show the effects of ECAS on bioluminescence output by E. 
coli Nissle 1917 pGLITE in control conditions and with the addition of 
tryptophan (fig. 4.12), azide (fig 4.13), D2O (figure 4.14), mannitol (figure 4.15) 
and DMSO (figure 4.16). Figure 4.11 shows changes in bioluminescence of E. 
coli Nissle 1917 pGLITE treated with ECAS at 50, 25, 10, 5 and 1% (v/v of neat). 
This shows a dose concentration dependency between ECAS and kill rate for this 
species. 
Table 4.7 summarises the effects of free radicals and singlet oxygen scavengers 
on the kill rate of bioluminescent E. coli Nissle 1917 pGLITE by ECAS.  It shows 
that in the presence of tryptophan a strong protective effect is exhibited although 
the azide which is more specific to singlet oxygen does not afford the same 
protection level as tryptophan, suggesting less involvement of singlet oxygen in 
killing mechanism, whilst the majority of putative hydroxyl radical inhibitors 
(mannitol, DMSO) give between 40 to 60% protection, suggesting a role for 
hydroxyl radical. 
Significant differences were found between the initial killing (first 1min) and later 
killing therefore initial kill rates were calculated and shown in table 4.7 and 4.8 
 
123 
 
0 20 40 60 80 100
-8
-7
-6
-5
-4
-3
-2
-1
0
1
50% ECAS
25% ECAS
10% ECAS
1% ECAS
5% ECAS
Cells only control
Time (s)
L
o
g
1
0
c
h
a
n
g
e
 i
n
 l
ig
h
t 
o
u
tp
u
t 
(R
L
U
)
 
Figure 4-11 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with ECAS at 50, 25, 10, 5 and 1% (v/v of neat). Error bars show 
mean ± SD (n=3). 
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Figure 4-12 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with ECAS: effects of tryptophan (10 mM). Error bars show mean ± 
SD (n=3). 
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Figure 4-13 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with ECAS: effects of sodium azide (100 mM). Error bars show mean 
± SD (n=3). 
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Figure 4-14 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with ECAS: effects of D2O. Error bars show mean ± SD (n=3). 
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Figure 4-15 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with ECAS: effects of mannitol (100 mM). Error bars show mean ± 
SD (n=3). 
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Figure 4-16 Changes in bioluminescence of E. coli Nissle 1917 pGLITE 
treated with ECAS: effects of DMSO (128 mM). Error bars show means ± SD 
(n=3). 
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Table 4- 7  The effects free radicals and singlet oxygen scavengers on the kill 
rate of bioluminescent E. coli Nissle 1917 by ECAS (calculations based on the 
total assay times 2 minutes) 
 
Reagents  Kill rate(log 
RLU/min) 
R
2
 Percentage 
relative protection 
Percentage 
relative kill  
5% ECAS -1.5± 0.12  0.847 0 100 
5% ECAS + 10 mM 
tryptophan 
-0.192 ± 0.036 
 0.4844 
 
86.92 13.07 
5% ECAS +100 mM 
azide 
-0.852 ± 0.084 
 0.7834 
 
42.61 57.38 
5% ECAS +100 mM 
mannitol 
-0.57 ± 0.072 
 0.6781 
 
 
61.69 38.30 
5% ECAS + 128 mM 
DMSO 
-0.822 ± 0.096 
 0.7279 
 
44.55 55.44 
 
Table 4- 8  The effects free radicals and singlet oxygen scavengers on the kill 
rate of bioluminescent E. coli Nissle 1917 by ECAS (calculations based on the 
first 1 minute- Initial kill rate)  
 
Treatment 
Kill rate (log 
RLU/min) 
R² P value 
Deviation 
from 
zero? 
Percentage 
relative  
kill 
Percentage 
relative 
protection 
5% ECAS -1.674 ± 0.148 0.889 < 0.0001 Significant 100.000 0.000 
5% ECAS + 10 mM 
tryptophan -0.450± 0.081 0.659 < 0.0001 Significant 26.885 73.115 
5% ECAS +100 mM 
azide -1.352± 0.144 0.845 < 0.0001 Significant 80.681 19.319 
5% ECAS +100 mM 
mannitol -0.923± 0.137 0.741 < 0.0001 Significant 55.125 44.875 
5% ECAS + 128 mM 
DMSO -1.486± 0.137 0.880 < 0.0001 Significant 88.746 11.254 
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4.5.5 ROS detection using SOSG, APF and HPF in APDT  and ECAS   
Fluorogenic interactions involving 
1
O2 and OH
•
 and fluorescent probes were 
assessed against APDT or ECAS in the absence vs presence of inhibitors 
(tryptophan, histidine, NaN3 mannitol, DMSO), enhancer (D2O) using SOSG, 
APF or HPF. The cuvette containing the solutions of MB and the probe was 
exposed to visible light. The fluorescence was monitored by acquisition of the 
fluorescence signal by the fluorimeter. For ECAS studies, the reaction mixture 
consisted of ECAS of appropriate concentration and the probe (APF and HPF at 5 
M). Fluorescent probe assays were repeated in the presence of inhibitors or 
scavengers of ROS or D2O to show inhibition or enhancement of fluorescence. 
 
4.5.5.1 Detection of singlet oxygen, using Singlet Oxygen Sensor Green 
(SOSG) in APDT and ECAS  
Figure 4.17 shows the increasing fluorescence observed when SOSG probe is 
exposed to APDT. The fluorescence intensity of 5 μM SOSG probe containing 10 
μg/mL MB solutions increased linearly as the irradiation time increased. These 
results suggest that the greater the light energy absorbed by the MB dye, the 
greater the extent of 
1
O2.  It should be noted the fluorescence also increased 
slightly in the light only control, indicating that SOSG probe is itself 
photodynamic and autocatalyic in light. There was no significant increase in 
fluorescence in the dark control. Figure 4.18 shows the effects of D2O, which 
increased markedly the production of fluorescence from the probe, indicating 
increased generation of singlet oxygen. Figures 4.19 and 4.20, show the effects of 
the addition of tryptophan and mannitol respectively. Both these compounds 
inhibited fluorescence from the SOSG probe with a large reduction for tryptophan, 
but only a slight reduction with mannitol.  
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Figure 4-17 Fluorescence response by SOSG probe (5M) exposed to APDT 
(10g/ml MB and total light dose 11 Jcm-2 (light intensity 9.47mW/cm2) 
compared to controls. DC, dark control; LC, light control, error bars show 
mean ± SD (n=3). 
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Figure 4-18 Fluorescence response by SOSG probe (5 M) exposed to APDT 
(10 g/ml MB and total light dose 11 Jcm-2 (light intensity 9.47 mW/cm2) 
compared APDT in presence of D2O. DC, dark control; LC, light control, 
error bars show mean ± SD (n=3). 
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Figure 4-19 Fluorescence response by SOSG probe (5 M) exposed to APDT 
(10 g/ml MB and total light dose 11 Jcm-2 (light intensity 9.47 mW/cm2) 
compared APDT in the presence of tryptophan (10 mM). DC, dark control; 
LC, light control, error bars show mean ± SD (n=3). 
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Figure 4-20 Fluorescence response by SOSG probe (5 M) exposed to APDT 
(10 g/ml MB and total light dose 11 Jcm-2 (light intensity 9.47 mW/cm2) 
compared APDT in the presence of mannitol (10 mM). DC, dark control; LC, 
light control, error bars show mean ± SD (n=3).  
 
 
 
 
 
 
 
 
132 
 
Figure 4.21 shows the effects on SOSG fluorescence in the presence of 1% and 
5% (v/v) of ECAS. To determine if the ROS produced in ECAS can be detected 
by the fluorescent probes the cell free solutions were mixed with the probe and 
fluorescence measured. It was found that when SOSG probe was added into 
different concentration of ECAS there was a very slight increase in fluorescence 
compared to SOSG alone. At higher concentrations the fluorescence was lower 
than the background (SOSG alone).  
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Figure 4-21 Fluorescence by SOSG probe (5 M) with ECAS at 1 % and 5% 
(v/v of neat) following 5 minutes incubation. Error bars show mean ± SD 
(n=3). 
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4.5.5.2 Detection of ROS using APF in APDT and ECAS  
Figure 4.22 shows the fluorescence response by the APF probe at 5μM under 
control conditions: APF probe was exposed to increasing amount of irradiation in 
PBS without MB and the effects of D2O was observed. There was a light dose 
dependent increase in fluorescence intensity compared to APF alone in phosphate 
buffer medium (figure 4.24). This highlights that the APF probe itself act as a 
photosensitizer when exposed to light and the increased fluorescence in D2O 
indicates that the probe may be generating singlet oxygen itself when exposed to 
light. APF on its own without light is not active and did not show any change in 
the fluorescence. APF probe in the dark mixed with MB 10μg/ml also showed no 
fluorescence, indicating that in the dark conditions neither MB nor APF produce 
ROS without light. APF probe was used to detect the production ROS in APDT. 
Figure 4.23 shows the fluorescence response of APF exposed to APDT (MB 10 
g/ml and total light dose 11 J/cm2 (light intensity 9.47mW/cm2) compared to 
controls (light control, dark control, APF probe only). For APDT the graph shows 
fluorescence intensity increased linearly as the irradiation time increased.  
To determine the specificity of the APF probe to singlet oxygen APDT was 
carried out with singlet oxygen specific scavengers and enhancers. Figure 4.24 
shows fluorescence response of APF exposed to APDT in the presence of singlet 
oxygen enhancer (D2O) and figure 4.25, 4.26, 4.27 shows effects of APDT 
compared with APDT in the presence of singlet oxygen specific scavengers. 
Figure 4.24 showed that when APDT was carried out in D2O medium compared 
to phosphate buffer the fluorescence intensity by APF was almost doubled and 
reached a steady level at 2 minutes of light exposure. This indicated that the APF 
probe could detect singlet oxygen in APDT. The large drop in fluorescence 
intensity in the presence of 10mM tryptophan (figure 4.26) showed a fluorescence 
drop may be due to competitive reaction of singlet oxygen produced in APDT 
with scavenger. Figure 4.25 and figure 4.27 showed similar reduction in 
fluorescence in the presence of singlet oxygen specific scavengers histidine and 
sodium azide. In the case of tryptophan and sodium azide increasing the 
concentration in solution from 1mM to 10mM (for tryptophan) and 10mM to 
100mM (for azide) further decreased the fluorescence. To determine the extent of 
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fluorescence by APF due to hydroxyl radical the hydroxyl radical specific 
scavenger mannitol was mixed in the solution with APDT. Figure 4.28 showed 
that there was no a reduction in the florescence in the presence of mannitol and an 
increase in concentration of mannitol from (10mM to 100mM) showed no change 
in fluorescence intensity. Table 4.9 summarises the change in the rate of 
fluorescence by APF compared to the absence and presence of scavengers and 
D2O.  
When APF probe was tested with ECAS it showed that there was no deactivation 
of the probe as in the case of SOSG and HPF. Therefore the only probe that could 
be employed to detect ROS in ECAS was with the APF probe. Figure 4.29 shows 
that fluorescence response of APF with 1% ECAS with and without ROS specific 
scavengers. It shows that the APF probe or 1% ECAS on its own does not 
produce any fluorescence. Increase APF fluorescence response is seen when APF 
probe is mixed with 1% ECAS. Therefore APF can be used to monitor the 
production of ROS in ECAS. Singlet oxygen and hydroxyl radical specific 
scavengers were used to determine the fluorescence response by APF attributed to 
singlet oxygen or hydroxyl radical. ECAS and APF probe in heavy water medium 
produced an increase in the fluorescence. Tryptophan reduced the fluorescence to 
nearly background level. Sodium azide (100mM) contributed to 53% reduction in 
fluorescence. These results indicate there may be role of singlet oxygen in ECAS 
and that APF can detect singlet oxygen. The fluorescence response to 1% ECAS 
by APF was reduced in the presence of hydroxyl radical scavengers (DMSO and 
mannitol). DMSO (128mM) showed a greater reduction (97%) compared to 
mannitol (100mM) (42% reduction). The table 4.10 summarises the relative 
change in fluorescence response by APF exposed to 1% ECAS compared to 
different conditions specific to singlet oxygen or hydroxyl radical. The data are 
consistent with the view that D2O enhances the fluorescence intensity, whilst 
tryptophan, DMSO, and to a lesser extent azide and mannitol cause the 
fluorescent intensity to be inhibited, suggesting mixed ROS reactions. Overall the 
results show that APF probe can detect both the singlet oxygen and hydroxyl 
radical in ECAS. 
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Figure 4-22 Fluorescence response of 5 μM APF probe to control conditions; 
(LC; Light control (light dose 3 J/cm
2 
(light intensity 9.47 mW/cm
2
), DC; 
dark control (MB (10 g/ml) only), APF probe only and APF probe in the 
presence of D2O exposed to light (light dose 3 J/cm
2 
(light intensity 9.47 
mW/cm
2
). Error bars show mean ± SD (n=3). 
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Figure 4-23 Fluorescence response of 5 μM APF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
control conditions; (LC; Light control (light dose 3 J/cm
2 
(light intensity 9.47 
mW/cm
2
), DC; dark control (MB (10 g/ml) only), APF probe only. Error 
bars show mean ± SD (n=3). 
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Figure 4-24 Fluorescence response of 5 μM APF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
APDT same conditions in the presence of D2O. DC, dark control; LC, light 
control. Error bars show mean ± SD (n=3). 
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Figure 4-25 Fluorescence response of 5 μM APF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
APDT same conditions in the presence histidine (10 mM). DC, dark control; 
LC, light control. Error bars show mean ± SD (n=3). 
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Figure 4-26 Fluorescence response of 5 μM APF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
APDT same conditions in the presence tryptophan (1 mM and 10 mM). DC, 
dark control; LC, light control. Error bars show mean ± SD (n=3). 
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Figure 4-27 Fluorescence response of 5 μM APF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
APDT same conditions in the presence sodium azide (10 mM and 100 mM). 
DC, dark control; LC, light control. Error bars show mean ± SD (n=3). 
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Figure 4-28 Fluorescence response of 5 μM APF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
APDT same conditions in the presence mannitol (100 mM). DC, dark 
control; LC, light control. Error bars show mean ± SD (n=3). 
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Table 4- 9  Summary of rate change in fluorescence following APDT in the 
presence or absence of ROS inhibitors or enhancers (D2O) using APF (5 μM ) 
 
APDT and 
reagent  
Rate of change in fluorescence 
(fluorescence intensity/mins) in the 
presence of 5M APF 
R
2
 Percentage 
change in 
fluorescence in 
the presence of 
enhancer or 
inhibitors of 
singlet oxygen 
and ROS 
MB alone 85610 ± 5790 
 
 
0.9086 
 
0 
Deuterium 
oxide  
263200 ± 2637 
 
0.9343 
 
 
207.44 
10 mM L-
Histidine  
38530 ± 5388 
 
0.8796 
 
 
-54.99 
10 mM 
Tryptophan  
24390 ± 1066 
 
0.9868 
 
-71.51 
10 mM Sodium 
azide  
61720 ± 3373 
 
0.9882 
 
-27.90 
100 mM 
Sodium azide 
28610 ± 3408 
 
0.9463 
 
 
 
-66.58 
10 mM 
Mannitol 
78280 ± 8083 
 
0.9591 
 
 
-8.56 
100 mM 
Mannitol 
81760 ± 1070       0.9359 -4.50 
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Figure 4-29 Fluorescence response of 5 μM APF with ECAS ( 1% v/v neat) 
and ECAS ( 1% v/v neat)  in the presnce of ROS scavengers (tryptophan, 
sodium azide, DMSO and mannitol) or enhancer (D2O) incubated for 5 
minutes. Error bars show mean ± SD (n=3). 
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Table 4-10  Summary of the data obtained from APF fluorescence study with  
ECAS 
 
 
 
 
 
 
 
 
 
 
Condition Florescence intensity 
signal by 5 M APF 
probe 
Percentagechange in fluorescence in 
presence or absence of enhancers or 
inhibitors of singlet oxygen and ROS 
(compared to probe and 1% ECAS) 
1% ECAS  312776 0 
1% ECAS +  D2O  379553 21.35 (increase) 
1% ECAS + 10 mM 
Tryptophan 3096 -99.01 
1% ECAS + 100 mM 
Azide 147418 -52.87 
1% ECAS + 128 mM 
DMSO 9617 -96.93 
1% ECAS+ 100 mM 
Mannitol 181169 -42.08 
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4.5.5.3 Detection of ROS production using HPF in APDT 
HPF probe was used to measure the production of ROS produced in APDT. 
Figure 4.30 and 4.31 shows the fluorescence response to APDT at 5M and 
10M HPF respectively. At higher concentration of HPF probe greater 
fluorescence was observed compared to the lower concentration. In both cases the 
fluorescence response by HPF increased linearly with increase in light dose in 
APDT. In the light control and dark control there was no significant increase in 
the fluorescence by HPF probe, showing that only if ROS are generated is there 
detection by the HPF probe.  
To determine the fluorescence response by the HPF due to singlet oxygen or 
hydroxyl radical APDT was carried out with specific scavengers of singlet oxygen 
(tryptophan) and specific scavengers of hydroxyl radical, (mannitol). Figure 4.32 
shows that with APDT, tryptophan reduced the fluorescence to nearly background 
levels. Figure 4.33 shows that with mannitol there was no such reduction; indeed 
a slight increase was observed compared to APDT in the absence of mannitol.  
From the graphs the change in fluorescence was linearly correlated with the 
irradiation time and the calculated r
2
 values were significant. Hence the rate of 
change in fluorescence was calculated and showed in table 4.11. The rate of 
change was compared relative to APDT with 5M HPF probe. It showed that that 
at 10M HPF there was 37% increase in fluorescence. The increase may be due to 
more molecules of HPF probe are available to react with ROS produced in APDT 
and produce the fluorescence end product. When APDT was carried out in the 
presence of 10mM tryptophan there was 89% reduction in fluorescence. This may 
be due to the ROS quenched by the tryptophan instead of reacting with the HPF 
thereby preventing formation of fluorescence product. Tryptophan is a known 
singlet oxygen quencher.  When APDT was carried out with the hydroxyl radical 
scavenger mannitol (10mM) there was 4% increase in fluorescence. This indicates 
the ROS produced in APDT is not hydroxyl radical and that under APDT, HPF 
can detect singlet oxygen and not hydroxyl radical.     
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When HPF probe was mixed with different concentrations of ECAS (figure 4.34) 
the fluorescence decreased with increase in concentration of ECAS. It is 
interesting to note that HPF showed a reduction in fluorescent signal with 
increasing concentrations of ECAS, from zero (probe only) up to 1% ECAS. This 
is contrary to the expected results of the fluorescence increase with increase in 
concentration of ECAS. As the concentration of ECAS increases the ROS 
concentration should increase in proportion and therefore it was expected the 
fluorescence response should increase. This indicates the breakdown of the probe 
molecule by ECAS. 
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Figure 4-30 Fluorescence response of 5 μM HPF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
control conditions; (LC; Light control (light dose 3 J/cm
2 
(light intensity 9.47 
mW/cm
2
), DC; dark control (MB (10 g/ml) only), HPF probe only. Error 
bars show mean ± SD (n=3). 
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Figure 4-31 Fluorescence response of 10 μM HPF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
control conditions; (LC; Light control (light dose 3 J/cm
2 
(light intensity 9.47 
mW/cm
2
), DC; dark control (MB (10 g/ml) only), 10 μM HPF probe only. 
Error bars show mean ± SD (n=3). 
 
 
 
 
 
 
 
149 
 
 
 
0 1 2 3 4 5
0
5.0×104
1.0×105
1.5×105
2.0×105
APDT
HPF only
LC
DC
APDT+10mM
tryptophan
Time (mins)
F
lu
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 (
a
.u
.)
 
 
Figure 4-32 Fluorescence response of 10 μM HPF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
in the presence of tryptophan (10 mM). DC, dark control; LC, light control. 
Error bars show mean ± SD (n=3). 
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Figure 4-33 Fluorescence response of 10 μM HPF probe to APDT (MB 10 
g/ml and total light dose 3 J/cm2 (light intensity 9.47 mW/cm2) compared to 
in the presence of mannitol (10 mM). DC, dark control; LC, light control. 
Error bars show mean ± SD (n=3). 
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Table 4- 11 Summary of rate change in fluorescence following APDT in the 
presence or absence of ROS inhibitors using HPF probe 
 
APDT and reagent  Fluorescence 
intensity  
r
2
 Percentage change 
in fluorescence 
intensity 
APDT- 5M HPF 28590 ± 1444 0.9608 
 
0 
APDT- 10M HPF 39060 ± 3754 0.8712 
 
36.62 
APDT- 5M HPF  
10mM tryptophan 
3231 ± 505.5 0.7187 
 
 
-88.70  
APDT- 5M HPF  
10mM mannitol 
29680 ± 3566        0.8124 3.81 
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Figure 4-34 Fluorescence by HPF probe (5 M) with ECAS at 0.2, 0.5 and     
1 % (v/v of neat) compared to HPF (5 M) probe alone incubated for 5 
minutes. Error bars show mean ± SD (n=3). 
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4.6 Discussion  
In order to determine the active species involved and the mechanisms in APDT 
and ECAS mediated killing of target organisms, a range of different compounds 
were incorporated into the standard bioluminescent-based rapid assay. The rapid 
assay mixture contained 1. Bioluminescent Gram-negative species of target 
organism or non-bioluminescent Gram-positive strain 2. Killing agent (APDT or 
ECAS) 3. ROS inhibitors or enhancer. Similarly in the fluorescent probe assay to 
detect ROS production, the killing agent (APDT or ECAS) was combined with 
the fluorescent probe in the presence or absence of ROS specific scavengers.   
In all cases for both APDT and ECAS the treatments showed significant kill in the 
absence of any scavengers. It showed a linear correlation between treatment 
exposure time and killing. The kill curve showed first order kill kinetics without a 
significant shoulder.  In terms of photodynamic killing effect appear to be a single 
hit process in bacteria where all the putative targets in the cell are equally 
susceptible and if damaged can lead to cell death (Zeina et al., 2001). 
Photodynamic treatment against micro-organisms is considered as mainly 
involving singlet oxygen that reacts against a wide range of cell target molecules 
such as cytoplasmic enzymes, membrane lipids and nucleic acids (Zeina et al., 
2001). In the case of ECAS as it has very high antimicrobial activity it reduces the 
bioluminescence output giving a flat line as it reaches the limit of detection. This 
was observed with higher concentrations of ECAS (25% and 50% v/v) where in 
30s the bioluminescence output flattens as it reached the limit of detection giving 
a multiphasic kill curve. However, even if it is multiphasic but without a 
significant shoulder, the initial reaction rate is proportional to the concentration or 
magnitude of flux of killing molecules. Therefore initial kill rate is important in 
ECAS. The kill rates for ECAS increase with the increase in dose of the agent 
(5%-50% v/v ECAS).  
To evaluate the ROS generation kinetics of the specific ROS in the systems the 
assay included: 1. D2O, which is considered to be specific enhancer of singlet 
oxygen. 2. Compounds that are regarded as singlet oxygen or free radical 
scavengers. The generation of specific ROS was inferred by the real time 
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inhibition of bioluminescence (killing) or increase in the viable count in the 
presence of the ROS specific scavengers for either APDT or ECAS. Change in 
bioluminescence of E. coli Nissle 1917 pGLITE and P. aeruginosa MCS5-lite and 
change in viable count for S. aureus  (non lux strain) in the presence or absence of 
scavenger was monitored after APDT. Whilst with ECAS only bioluminescent E. 
coli 1917 pGLITE strain was used. Very interesting results were obtained from 
this line of study especially by comparing the kill kinetic activity of the two 
systems. First in APDT the MB dark control (no light but MB), light control (light 
but no MB) or untreated cells (no light and no MB) showed no change in killing 
or in bioluminescence. Similarly for ECAS the controls (untreated cells suspended 
in PBS, or cells with scavenger only) again showed no change in bioluminescence 
showing a flat line response. This confirms that under control conditions no ROS 
are generated and hence no killing of the target organisms. The only exception to 
this was D2O control, where D2O had a slight inhibitory effect in the first few 
minutes on the bioluminescence but after that the bioluminescence quickly 
stabilises. This difference shows that D2O environment may have slight effects on 
the cells metabolism.   
APDT carried out in the presence of singlet oxygen specific scavenger 10 mM 
tryptophan showed a very high degree of protection for all the three bacterial 
strains. Gram-positive S. aureus was afforded the highest protection of (97%) 
with E. coli (95%) protection and P. aeruginosa (89%) protection. In the presence 
of the hydroxyl radical scavengers it showed different levels of protection 
depending on the bacterial strains and the scavenger. In the presence of 10 mM 
DMTU S. aureus was afforded the highest protection (91%) with E. coli (68%) 
protection and P. aeruginosa (51%). In the presence of 10 mM Mannitol again S. 
aureus was afforded the highest protection (81%), with  P. aeruginosa (50%) 
protection and with E. coli no protection.  By comparing the protection afforded 
by singlet oxygen scavengers and hydroxyl radical scavengers demonstrates that 
in the case Gram-positive S. aureus strain both the type I and type II may be 
equally important in the killing mechanism however with the Gram-negative 
strains E. coli and P. aeruginosa the type II mechanism appears to be more 
significant compared to type I mechanisms of killing. 
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The effect of D2O replacing the H2O in the PBS buffer used in the assay increased 
the kill rate (E. coli and P. aeruginosa strains) several fold in the D2O medium 
when the ROS generation system was APDT. Singlet oxygen has a lifetime of 3s 
in water and is increased to 65s in D2O (Gorman and Rodgers, 1992). The 
increase in singlet oxygen lifetime in D2O presumably increases the biological 
interaction effect of singlet oxygen increasing the damage to the cells.  This 
explains the higher kill rate when D2O was present, suggesting the involvement 
singlet oxygen (type II mechanism) in MB mediated APDT killing of E. coli and 
P. aeruginosa.  
These results suggest the involvement of ROS in cell killing and were in 
agreement with previous findings that showed involvement of both types I and 
type II mechanisms in APDT (Bhatti et al., 1998; Ergaieg et al., 2008; Huang et 
al., 2012; Wong et al., 2005). However, in one study it was shown that tryptophan 
failed to protect S. aureus MB mediated killing (Sabbahi et al., 2008). The authors 
concluded that the bactericidal activity of APDT was mediated in part, via a type I 
reaction in which hydroxyl radical is the dominant species.  
To reveal the underlying mechanism of ECAS (5% v/v) and to compare with 
APDT mechanism, kill kinetics reaction in the presence of singlet oxygen or 
hydroxyl radical scavenger were carried out. The scavengers are considered to be 
specific to singlet oxygen: Tryptophan (10 mM) (less specific to singlet oxygen) 
strongly inhibited the bioluminescence (87%) whilst the sodium azide (100 mM) 
provided 43% protection. The enhancer of singlet oxygen life span (D2O) showed 
no increase in the kill rate. The scavengers considered as specific to hydroxyl 
radical, mannitol (100 mM) gave 62% protection and DMSO (128 mM) showed a 
45% protection. When this data was compared to the initial killing (first 60s) it 
showed that the singlet oxygen scavengers sodium azide and tryptophan gave 
reduced protection whilst mannitol showed only slight reduction in protection. 
This indicates that kill mechanism of ECAS is mainly dependent on hydroxyl 
radical particularly in the initial stages of killing although the contribution of 
singlet oxygen cannot be rejected. Comparing these results to APDT, the clearest 
difference between APDT and ECAS was seen in the kill effect when water was 
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replaced in the PBS with D2O, while APDT showed a several fold increase in kill 
rate ECAS showed no such increase suggesting that singlet oxygen may not be 
important in the ECAS kill mechanisms. In addition to this sodium azide (100 
mM) a specific scavenger of singlet oxygen showed low level protection while 
tryptophan (10 mM) used as a singlet oxygen scavenger in APDT studies (Wong 
et al., 2005) provided higher protection compared to azide. It has been suggested 
that tryptophan is less specific to singlet oxygen and is known to quench hydroxyl 
radical as well (Sabbahi et al., 2008). In APDT (10 mM) mannitol provided no 
protection for E. coli while presented 62% protection ECAS. The overall 
conclusion drawn from this approach of comparative evaluation of protection 
provided by the ROS specific scavengers in these two systems (APDT and ECAS) 
is that the mechanism of APDT is dependent on both singlet oxygen (type II 
mechanisms) and hydroxyl radical (type I) mechanism whilst the mechanism of 
ECAS is mainly hydroxyl radical with only a small contribution by other ROS 
such as singlet oxygen.  
It was found that the effect of scavenger changed as the reactions proceeded with 
the killing agent. For this reason the initial kill rates were also calculated. A very 
interesting finding was made with APDT of P. aeruginosa and E. coli. When the 
initial kill rate for the two organisms were compared it was found that P. 
aeruginosa killing was largely dependent on hydroxyl radical and E. coli was 
largely dependent on singlet oxygen but at the latter half for P. aeruginosa singlet 
oxygen was important. P. aeruginosa killing was overall more dependent on type 
I mechanism compared to E. coli.  
The scavengers work via different mechanisms and are effective at different 
concentrations. The concentrations of scavengers used in this thesis were based on 
those previously used by others reported in the literature. These concentrations 
may not be optimised concentrations for their use. The bioluminescent assay 
developed in this thesis can be rapidly used to optimise the concentrations of the 
scavenger. This will be much easier and accurate to carry out using 
bioluminescence compared to viable count methods. Hence this may be an 
interesting area to carry out further research. 
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Fluorescent probes showed ROS production in both APDT and ECAS. When 5 
μM SOSG was mixed with   10 g/ml MB, the fluorescence   intensity increased 
linearly as the light dose increased while the aqueous solution of SOSG alone or 
SOSG probe and MB in dark showed no increase in the fluorescence. The greater 
the light energy absorbed by MB molecules, the greater the extent of 
1
O2 
formation. However when SOSG alone was irradiated with increasing light doses 
there was slight increase in fluorescence indicating the probe alone could produce 
1
O2. The quenching of fluorescence in the presence of tryptophan and increase in 
fluorescence when PBS was replaced by D2O confirms that the increase in 
fluorescence is due to production of
 1
O2 by MB upon exposure to light. The low 
level of quenching of fluorescence intensity by mannitol (10 mM) compared to 10 
mM tryptophan indicates that the probe is specific to 
1
O2 with little if any activity 
towards hydroxyl radical. These results are in good agreement with a previous 
study that showed SOSG is specific to singlet oxygen in APDT and comparatively 
less reactive to hydroxyl radical (Price et al., 2009; Flors et al., 2006). When 
SOSG probe was mixed with ECAS to detect singlet oxygen production there was 
only slight increase in fluorescence at the lower concentration and at higher 
concentration of ECAS fluorescence was lower than the background (SOSG 
probe only). This may be because the SOSG probe is deactivated by the ECAS 
and its low pH may be a contributing factor. Therefore without further study and 
pH control (by introduction of non-interfering buffer systems and pH 
neutralisation) SOSG probe cannot be used to study ROS production by ECAS.   
Both APF and HPF showed increase in fluorescence following irradiation of MB. 
When H2O was replaced by D2O the fluorescence response by APF increased 
207% while the singlet oxygen scavengers histidine (10 mM) provided 55% 
reduction, tryptophan (1 mM) showed only 0.4% reduction however at 10 mM 
tryptophan supressed fluorescence by 72% similarly sodium azide 10 mM 
supressed fluorescence 28% and 100 mM  sodium azide 67%.  In contrast to 
singlet oxygen scavengers hydroxyl radical mannitol (10 mM) showed only 9% 
reduction in fluorescence and mannitol (100 mM) showed 5% reduction. 
Similarly MB irradiated with HPF (5M) probe showed 87% suppression in the 
presence of tryptophan (10 mM) while only 4% suppression of fluorescence in the 
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presence of mannitol (10 mM). In conclusion these data show that both the probes 
can detect 
1
O2 generated by irradiation of MB which is in agreement with a 
previous study (Price et al., 2009). 
Overall the results confirmed the previously known mechanisms for APDT with 
MB. Further studies may be carried out with Fenton reagent a hydroxyl radical 
generating system or PS that produce exclusively produce singlet oxygen (type II) 
and free radical (type I) to increases the effectiveness of the test with ROS 
scavengers.     
In a study where both the APF and HPF probes were used to detect singlet oxygen 
production it showed that fluorescence by the probes increased with porphine tetra 
(p-phenylsulfonate) (TPPS) irradiation and fluorescence was only quenched in the 
presence of singlet oxygen scavengers (1 mM sodium azide) and no quenching 
was observed in the presence of hydroxyl radical scavengers (1% v/v DMSO). 
The singlet oxygen enhancer (D2O) increased fluorescence response >25-fold in 
D2O when (TPPS) was irradiated. However, the probes showed increase in 
fluorescence with Fenton reagent (a system that reported to generate only 
hydroxyl radical) and 0.02% (v/v) DMSO quenched ~50% fluorescence. A 
concentration of 0.1% DMSO, was found to decrease the fluorogenic response of 
APF to •OH by >90%. It was concluded that the probes APF and HPF represent a 
useful means for evaluating formation of both 
1
O2 and •OH in the presence of 
specific ROS scavengers (Price et al., 2009). 
Unlike SOSG and HPF, APF was not inactivated by ECAS and showed an 
increase in fluorescence response compared to probe only. To confirm the 
fluorescence increase in the presence of ECAS was specific to singlet oxygen or 
hydroxyl, ROS specific scavengers were added into the system and relative 
contribution was compared. These showed that the fluorescence was inhibited by 
tryptophan (10 mM) (99%) and azide (53%) whilst the singlet oxygen enhancer 
(D2O) showed only a small increase in fluorescence (21%). Fluorescence was 
reduced in the presence of DMSO (128 mM) (97%) and mannitol (100 mM)  
(42%). These results indicate that ECAS fluorescence response is due to both 
singlet oxygen and hydroxyl radical generation, but mainly due to latter. These 
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results were consistent with the results of bioluminescence kill kinetic assay 
confirming that ECAS involves mixed ROS mechanism.     
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Chapter 5: Cytotoxicity of APDT and ECAS on 
mammalian cells 
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5.1 Introduction  
The inappropriate use of antibiotics in both clinical and non-clinical settings has 
resulted in the increased threat of infections resulting from micro-organism 
resistant to all the currently available antibiotics (Alanis, 2005). The problem of 
antibiotic resistance is made worse due to decreases in the number of 
developments of new antibacterial agents in the last 10 to 15 years (Alanis, 2005). 
Consequently there is an urgent need to develop potential alternative therapies 
that can be useful in clinical application in the future (Alanis, 2005; Moellering, 
2011).  
Previous studies and work in this thesis have shown that both APDT and ECAS 
are effective antimicrobial agents against a wide range of microbial species. Both 
APDT (Embleton et al., 2002; Kashef et al., 2012) and ECAS (Tanaka et al, 
1996; Tsuji et al., 1999) can effectively kill multi drug resistant bacteria including 
MRSA.  Owing to these and many other favourable features both APDT 
(Kharkwal et al., 2011) and ECAS (Thorn et al., 2012) are now widely accepted 
as potential alternative therapies to localised antibiotics or other biocides. 
One of the important characteristics of an ideal antimicrobial agent is that the 
target pathogenic microbes are selectively inactivated while host cells and tissues 
are preserved. In evaluating the usefulness of new antimicrobial agents it is 
important to determine its cytotoxic effects towards mammalian cells. By carrying 
out in vitro cytotoxicity tests the ability of the test agent to cause damage to 
mammalian cells can be assessed.  
The two agents were compared in both the kill effect and mechanisms because of 
their ability to generate ROS (chapter 3 and 4). In chapter 4 it was shown that 
APDT damages microbial cells mainly by singlet oxygen whereas ECAS involves 
mixed ROS species with mainly hydroxyl radical being the predominant active 
species. To determine the clinical application of these treatments studies have 
been carried out to assess the potential cytotoxicity of APDT and ECAS to 
mammalian cells. 
Due to the high reactivity of ROS and the potential to damage mammalian cells as 
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well as microbial cells it is important to study the cytotoxicity effects of ROS 
producing antimicrobial agents on mammalian cells. One of the reasons for 
restricted application of oxidizing agents is due to the lack of specificity toward 
microbial cells when compared with host mammalian cells causing unacceptable 
damage to normal cells. However, the development of new ROS based 
antimicrobial systems (such as APDT, ECAS and cold atmospheric plasma) may 
be less damaging to mammalian cells and so are leading areas of research from 
which therapies can be considered for localized infections (Vatansever et al., 
2013). 
APDT can be designed to exhibit minimal damage to host cells and high 
selectivity towards the target pathogen (Sharma et al., 2011). APDT studies  
carried out with PS belonging to different classes combined with light source 
where mammalian cells were exposed to the same condition showed that 
mammalian cells were killed at much lower rates compared to the target bacterial 
cells (Vatansever et al., 2013). Phenothiazinum dyes MB and TBO are the lead 
PS compounds most widely investigated in PDT against infectious agents 
(Phoenix et al., 2009). In vitro studies carried out using TBO as PS showed low 
cytotoxicity towards keratinocytes and fibroblast cells compared to microbial cells 
(Soukos et al., 1996). PS such as TBO has been used successfully at 2,000 fold 
higher concentration than required for antibacterial effect in the diagnosis of 
premalignant disease without adverse effects (Mashberg, 1983).  MB has been 
proposed to be safe for endodontic treatments based on its low toxicity towards 
gingival fibroblasts and osteoblasts under conditions similar to what may be 
applied in a clinical setting for endodontic disinfection (Xu et al., 2009). MB has 
been shown in a recent study to have optimal properties for killing bacteria while 
preserving the viability of neutrophils (Tanaka et al., 2012). This is beneficial 
because neutrophils are the primary mediators of host defense to invading bacteria 
and will improve the therapeutic efficiency of APDT, whilst surviving bacteria 
may re-grow if  APDT kills neutraphils as well (Tanaka et al., 2012). 
Cytotoxic effects of APDT and ECAS on different mammalian cells may be 
different. Soukos et al (1996) showed different cytotoxicity levels of 
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photodynamic treatment with TBO on fibroblast cells and keratinocytes. It was 
shown that fibroblasts were susceptible (>5.0 g/ml TBO) whilst keratinocytes 
were more susceptible (>2.0 g/ml TBO). Therefore it is important to compare 
the relative in vitro cytotoxicity of APDT and ECAS to different mammalian cell 
types. Since both APDT and ECAS may be applied in periodontal and wound 
irrigation, it is important to include cell types which may be exposed in these 
environments including leukocytes. Leukocytes are critical cells involved in the 
inflammatory processes of repair of burns or wounds (Eming et al., 2007). 
However, very few studies have been carried out on leukocytes. Therefore in the 
current study cytotoxicity of APDT and ECAS were tested on both keratinocytes 
and lymphocytes (as an example of one type of leukocyte).    
Current studies show ECAS to be safe and non-toxic (Prilutsky and Bakhir, 
1997). ECAS have also been used without any adverse effects on mammalian 
cells (Robinson et al., 2012). Mice given free access to ECAS as drinking water 
for 8 weeks showed no changes in body weight and no abnormalities on visual 
inspections of the oral cavity. Moreover, histopathological tests and 
measurements of surface enamel roughness and observations of enamel 
morphology showed no abnormal findings (Morita et al., 2011). Therefore it was 
concluded ECAS has no systemic toxicity (Morita et al., 2011). ECAS has been 
shown to have high biocompatibility at relatively high exposure levels compared 
to the anticipated low levels that would be necessary in the real clinical situation 
(Marais, 2002). However in the literature in vitro studies where ECAS was 
incubated with mammalian cell lines showed mixed results with some studies 
showing no toxic effect while others have shown significant cytotoxicity (Thorn 
et al., 2012). Therefore further studies are required to determine the levels of 
cytotoxicity to mammalian cells before a therapeutic system suitable for clinical 
evaluation can be developed. To determine the toxicity level of ECAS it is needed 
to carry out in vitro studies on human cell lines specifically on the skin cells if it is 
intended to apply ECAS to a localised infection site. Therefore in this study the 
cytotoxicity of ECAS was also tested against keratinocytes and lymphocytes 
allowing comparison with APDT. It is difficult to compare animal studies, as the 
in vivo response may be different for different animals or even different strains of 
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the same species, whereas cell cultures have advantages over animal studies since 
the culture and treatment conditions can be more tightly defined. The same cells 
grown under standard conditions can be easily subjected to different treatments 
and results can be compared. 
In vitro cytotoxicity studies have been used as suitable method in detecting the 
cytotoxicity potential of different agents and assessing the toxicity and 
occupational health risk of different compounds (Bakand et al., 2006). Both the 
MTS and neutral red uptake assays have been used as a convenient method for 
assessing cell viability (Bakand et al., 2006). MTS (3-[4,5-dimethylthiazol-2-yl]-
5-[3-carboxymethoxyphenyl] 2-[4-sulfophenyl]-2H tetrazolium) assay is based on 
the ability of viable cells to convert a soluble tetrazolium salt to a formazan 
product. This method has been proven to be a highly sensitive, rapid and 
convenient system (Bakand et al., 2006). The Neutral red (3-amino-7-dimethyl-
amino-2-methylphenazine hydrochloride) uptake assay is a cell survival/viability 
technique based on the ability of viable cells to incorporate and bind supravital 
neutral red dye (Borenfreund and Puerner 1985). In the current study both MTS 
and NR assay were used to study in vitro cytotoxicity of APDT and ECAS.  
Most of the cytotoxicity studies reported in the literature involve determining the 
effective dose of the biocide to kill target microbial cells and then (in separate 
assays) re-test at the same dose to see if it is cytotoxic to mammalian cells 
(Soukos et al.,1996; Soukos et al., 1998; Zeina et al., 2002). However, none of 
the previous investigators have compared APDT and ECAS for relative 
cytotoxicity. Moreover, with one exception (George and Kishen, 2007) none of 
the previous workers have attempted to measure cytotoxicity of killing treatments 
against microbes and mammalian cells simultaneously using mixed cell assays. 
George and Kishen, (2007) used cell mixtures to study the cytotoxic effects of 
APDT on both fibroblast cells and Enterococcus faecalis. The results from viable 
counts showed that E. faecalis were killed at a faster rate than fibroblasts. 
APDT and ECAS cytotoxicity effects on the mammalian cells were carried out in 
the presence of different concentration of fetal calf serum (FCS) since serum 
presence may more closely mimic occurrence in vivo (Lambrechts et al., 2005). 
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It is important to show the same dose that are effective for microbes do not have 
any detrimental effect on mammalian cells by studying the in vitro levels of 
cytotoxicity on mammalian cells. By carrying out in vitro cytotoxicity of APDT 
and ECAS the likely cytotoxicity to mammalian cells in vivo could be predicted. 
If it were found that mammalian cells were equally susceptible to APDT and 
ECAS at the doses that are effective for microbial species, it would suggest that 
the treatment would not be safe for use in practice.  
 
For APDT treatments two different photosensitizer doses were used. MB 
concentration of 10 g/ml and 100 g/ml, both combined with the light dose of 11 
Jcm
-2
. A higher concentration of PS was required to be tested for several reasons. 
In chapter 3 it was shown that Gram negative P. aeruginosa required longer 
irradiation time for 3 log reductions with lower concentration of PS. It is generally 
known that Gram-negative bacteria are more resistant to milder treatments and 
may require higher concentration of PS and longer treatment time to produce an 
antimicrobial effect (Nitzan et al., 1992). Similarly fungal cells also required 
longer time to produce effective kill (Zeina et al., 2001). Several studies have also 
shown that when APDT is applied to biofilm it is more resistant and requires 
higher dose of treatment (Lin et al., 2004). By increasing the concentration of PS 
while keeping the light dose the same the antimicrobial outcome may be 
improved, because more PS molecules are available to produce cytotoxic ROS 
when activated by light. Also the effectiveness of the treatment could be modified 
by keeping the PS concentration constant while changing the light intensity or 
irradiation time (Wainwright, 1998). However higher light intensities and longer 
irradiance times are not preferred because high light intensity may cause damage 
to tissue due to heat and a longer treatment time is not convenient to the patient. 
Therefore higher concentrations of the PS are required to be tested to confirm that 
it does not damage mammalian cells significantly. Therefore, both low and higher 
concentration of MB was used in combination with same light dose was tested on 
keratinocytes.  
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5.2 Aims of this chapter  
This study was carried out to compare the cytotoxicity of the two agents, APDT 
and ECAS, against keratinocytes and leukocytes. In addition the effects of post-
treatment incubation and recovery were studied by comparing the cytotoxicity 
levels immediately after treatment and after a 24 hour recovery period. The effects 
of serum addition at a range of concentrations in preventing cytotoxicity to human 
cells for both APDT and ECAS treatments were also determined. Most 
importantly, co-mix assays of bacteria and keratinocytes together were conducted, 
in order to study comparable kill rates in the same assay following simultaneous 
treatments for APDT.  
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5.3 Results 
In this study two types of mammalian cells were used to test the cytotoxicity 
levels after APDT and ECAS treatment. The cells used were keratinocytes (H103) 
and human lymphocytes (Jurkat).  
The cytotoxicity levels of APDT towards keratinocytes were tested using the 
neutral red assay. Neutral red (NR) assay optical density readings were used to 
calculate the relative viability compared to the control without treatments. In 
addition, appropriate light controls where cells were exposed to light irradiation 
only and dark controls where cells were incubated with the PS only, were carried 
out.  
ECAS cytotoxicity was measured using neutral red assay after incubating the 
keratinocytes with different concentrations of ECAS for 30 minutes. Neutral red 
assay optical density readings were used to calculate the relative viability for each 
ECAS treatment compared to the control untreated cells.  
MTS assay was used to measure the cytotoxicity levels of both APDT and ECAS 
to lymphocyte (Jurkat) cells. The recorded optical density values obtained were 
used to calculate the percentage of viability of cells compared to control without 
treatment.   
The formula given below was used to calculate the percentage viability for both in 
vitro assays. 
  
5.3.1 APDT cytotoxicity to keratinocytes (H103) cells 
Figure 5.1 shows the percentage viability of keratinocytes exposed to APDT (MB 
concentration 10 g/ml and total light dose of 11Jcm-2 [intensity 9.4mWcm-2] and 
irradiation time of 20 minutes) compared to cells exposed to higher concentration 
of MB (100g/ml) and the same light dose 11Jcm-2. The recoveries of 
keratinocytes were tested by comparing at which point the NR assay was 
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performed. The NR assay was performed immediately after APDT exposure and 
after after 24 hours incubation of cells with fresh media. Figure 5.1 shows that 
performing the NR assay immediately after exposure to APDT resulted in 
significantly (p value < 0.001) lower percentage viability than when the NR assay 
was perfomed after 24 hour incubation.  
For keratinocytes treated with APDT (at high and low PS dose) the percentage 
viability was reduced for both immediate and after 24 hour recovery and this was 
significantly different (p value < 0.001) when compared to the light only controls 
(cells exposed to light dose of 11Jcm
-2
 only) and untreated controls.   
Keratinocytes exposed to APDT with high and low concentration of PS was 
compared to the respective dark controls (cells incubated with MB at 100g/ml or 
10g/ml for 20 minutes in the dark) and was significantly different (p value 
<0.001), after the immediate viability test but not after 24 hour recovery. The 
graph (figure 5.1) shows that there was no significant difference between 
exposures to high and low concentration of PS following light treatment. 
Likewise there were no significant differences between high and low 
concentration of PS for dark control. However after 24 hour recovery a difference 
was now revealed for both light treatment and dark controls with regard to high or 
low PS. Comparison of viability of keratinocytes immediately, and after 24 hours 
recovery with both the high and low concentration of PS there a was significant 
increase in viability (p value < 0.001).  
In the case of the dark control for high concentration PS after 24 hour recovery 
there was significant reduction in viability of keratinocytes (p value <0.001) but 
for lower concentration PS dark control, there was no significant difference after 
the recovery period.  
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Figure 5-1 Influence of the time point at which the viability test was 
performed, after APDT of keratinocytes on the outcome of the assay. NR 
assay performed immediately after APDT (immediate viability) and after 24 
hours (viability after 24h recovery). HD, high dose (MB 100 g/ml and 11 
Jcm
-2
 light irradiation); LD, low dose (MB 10 g/ml and 11 Jcm-2 light 
irradiation); DC, dark control; LC, light control; Control (cells not treated). 
Error bars represent mean ± SD (n=3). Asterisks indicate the values that 
differ significantly from the control. Lines with asterisks on top compare the 
groups that significantly differ from each other. *** P value < 0.001.      
 
Figure 5.2 shows the effects APDT on the viability of keratinocytes in the 
presence of different concentrations of foetal bovine serum (FBS) compared to 
absence of FBS. Table 5.1 shows the comparison of significance values between 
different treatment conditions. In the absence of FBS, APDT with higher and 
lower concentration of PS was more cytotoxic to keratinocytes and was 
significantly different compared to dark control, light control and untreated 
control. When 10% FBS was present in media, for the higher concentration of PS 
there was no significance difference between treatment and dark control, but there 
was significant difference between treatment and, light control and untreated 
control. However, in the presence of 10% FBS, APDT low dose showed 
significant difference compared to dark control, light control and untreated. When 
the FBS concentration was further increased to 25% and 50% for all conditions 
including the treatments there was a clear protective effect and an increase in 
viability of keratinocytes.  
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Figure 5-2 Influence of FBS on APDT inactivation of keratinocytes in 10% 
FBS, 25% FBS and 50% FBS. For comparison APDT of keratinocytes in 
PBS (absence of FBS) is shown.  HD, high dose (MB 100 g/ml and 11 Jcm-2 
light irradiation); LD, low dose (MB 10 g/ml and 11 Jcm-2 light irradiation); 
DC, dark control; LC, Light control; Control (cells not treated). Error bars 
represent mean ± SD (n=3).      
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Table 5-1  Significance level comparison of keratinocytes exposed to APDT 
or control conditions in the presence or absence of FBS  
 
conditions Significant?  
P < 0.05 
No FBS 
Significant?  
P < 0.05 
10% FBS 
Significant?  
P < 0.05 
25% FBS 
Significant? 
 P < 0.05 
50% FBS 
APDT LD 
vs DC LD 
Yes  
*** 
Yes 
*** 
Yes 
** 
Yes 
*** 
APDT LD 
vs LC 
Yes  
*** 
Yes 
*** 
No No 
APDT LD 
vs Control 
Yes  
*** 
Yes 
*** 
No Yes 
* 
APDT HD 
vs DC HD 
Yes  
*** 
No No Yes 
*** 
APDT HD 
vs LC 
Yes  
*** 
Yes 
*** 
No Yes 
** 
APDT HD 
vs Control 
Yes 
 *** 
Yes 
*** 
No Yes 
*** 
DC LD vs 
Control 
Yes  
*** 
Yes 
*** 
No Yes 
*** 
DC LD vs 
LC 
No 
ns 
No No Yes 
*** 
DC HD vs 
Control 
Yes  
*** 
Yes 
*** 
No No 
DC HD vs 
LC 
Yes 
** 
Yes 
*** 
No No 
LC vs 
Control 
No No No No 
 
          
HD, high dose (MB 100 g/ml and 11 Jcm-2 light irradiation); LD, low dose (MB 10 g/ml and 
11 Jcm
-2
 light irradiation); DC, dark control; Light control, LC; Control (cells not treated), 
FBS, foetal bovine serum. Asterisks indicate significance difference, *** P < 0.001,   **   P < 
0.01,    * P < 0.05. 
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Figure 5.3 shows comparative killing of mammalian cells verses bacterial cells in 
co-mix assays. The graph shows that mammalian cells only reduced by 0.1 log in 
Figure 5.3 shows killing of mammalian cells verses bacterial cells in a co-mix 
assay. The graph shows that keratinocytes are only reduced by 0.1 log in 20 
minutes of APDT whereas a 3 log reduction in E. coli Nissle 1917 pGLITE 
numbers is seen during this time. The log reductions in E. coli Nissle 1917 
pGLITE numbers were calculated by measuring relative change in 
bioluminescence output at every 5 minute interval during the treatment. The log 
reductions in mammalian cells were calculated by measuring the viability of cells 
using the NR assay and were calculated as relative change before and after 20 
minutes treatment. Previous experiment with mammalian cells showed that the 
change in viability was very small therefore viability was measure before and 
after treatment. Previous results showed no significant dark and light toxicity for 
both mammalian and bacterial cells.  
 
Figure 5-3 Measurement of cell cytotoxicity of a co-mixture of mammalian 
(Keratinocytes (♦)) and bacterial cells (E. coli Nissle 1917 pGLITE (♦)) within 
the same reaction mixture exposed to APDT (MB 10 g/ml and light dose 11 
J/cm
2
 (9.4 W/cm
2
). Viability measured by neutral red assay for keratinocytes 
and for bacteria change in bioluminescence (RLU). Error bars represent 
mean ± SD (n=3). 
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Table 5.2 shows the kill rate of mammalian cells compared to bacterial cells 
exposed to APDT.  Table 5.3 shows the kill rate of mammalian cells compared to 
bacterial cells exposed to ECAS. The kill rates for mammalian cells are 
significantly lower compared to bacterial cells for both APDT and ECAS (table 
5.2 and 5.3). 
Table 5-2 Kill rates of mammalian cells compared to bacterial cells after 
APDT 
 
Species Kill rate  (slope- log cell number/min) 
Keratinocytes 0.012  
Lymphocytes  0.022  
E. coli Nissle 1917 pGLITE 0.150 
S. aureus 0.300 
 
Table 5-3 Kill rates of mammalian cells compared to bacterial cells after 
ECAS 
Species Kill rate  (slope- log cell number/min) 
Keratinocytes No kill 
Lymphocytes  5% ECAS  
0.002 
E. coli Nissle 1917 pGLITE 5% ECAS   
1.5 
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5.3.2 ECAS cytotoxicity to keratinocytes (H103) cells  
Figure 5.4 shows keratinocytes incubated with ECAS for 30 minutes at 25%v/v, 
10%v/v and 5%v/v. As positive control keratinocytes were also incubated for 30 
minutes with 5%v/v bleach. The treatments compared to controls showed that all 
the treated cells are significantly different from the control for immediate 
viability. Treatment with 5%v/v bleach was most toxic to the keratinocytes, 
followed by 25%v/v, 10%v/v and 5% v/v ECAS.  
After 24 hour recovery, cells treated with 5%v/v ECAS showed a viability 
increase nearly to the control levels. Cells treated with 10% ECAS showed no 
recovery and nearly 50% reduction in viability. This was significant compared to 
immediate viability. Both 25%v/v ECAS and 5%v/v bleach showed no significant 
recovery after 24 hours. 
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Figure 5-4 Influence of the time point at which the NR assay was performed, 
after ECAS treatment of keratinocytes on the outcome of the assay. NR assay 
performed immediately after ECAS treatment (immediate viability) and 
after 24 hours (viability after 24h recovery). Error bars represent mean ± SD 
(n=3). Asterisks indicate the values that differ significantly from the control 
(cells not treated). Lines with asterisks on top compare the groups that 
significantly differ from each other. *** P < 0.001, ** P < 0.01.  
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Figure 5.5 shows percentage viability of cells incubated with different 
concentration of ECAS (v/v %) in the presence or absence of FBS.  The table 5.4 
shows the significance level for each different condition.  Both 5 and 10% FBS 
gave protection to cells against 5% and 10% v/v ECAS however no protective 
effect was seen with 25%v/v ECAS treatment. There was no significant difference 
when 1% FBS is present compared to absence of FBS. The 5% v/v ECAS was 
least cytotoxic and 25%v/v ECAS was the most cytotoxic to the cells. 
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Figure 5-5 Influence of FBS on ECAS inactivation of keratinocytes in 10% 
FBS, 25% FBS and 50% FBS. For comparison ECAS treatment of 
keratinocytes in PBS (absence of FBS) is shown. Error bars represent mean ± 
SD (n=3). 
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Table 5-4 Significance level comparison of keratinocytes exposed to ECAS 
and/ or control conditions in the presence and absence of FBS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0 FBS 1% FBS 5% FBS 10% FBS 
Tukey's 
Multiple 
Comparison 
Test 
Significant?  
P < 0.05? 
Significant?  
P < 0.05? 
Significant?  
P < 0.05? 
Significant?  
P < 0.05? 
5% ECAS vs 
10% ECAS  
Yes*** Yes*** No Yes* 
5% ECAS vs 
25% ECAS  
Yes*** Yes*** Yes*** Yes*** 
5% ECAS vs 
Control 
Yes** Yes** No No 
10% ECAS vs 
25% ECAS  
Yes*** Yes*** Yes*** Yes*** 
10% ECAS vs 
Control 
Yes*** Yes*** Yes** Yes* 
25% ECAS vs 
Control 
Yes*** Yes*** Yes*** Yes*** 
Asterisks indicate significance difference, *** P < 0.001, **   P < 0.01, * P < 0.05.  
 
177 
 
5.3.2 APDT cytotoxicity to Jurkat (lymphocyte) cell  
Figure 5.6 shows the viability of Jurkat cells exposed to APDT immediately and 
after 24-hour incubation. APDT treated cells immediate viability shows 35.2% 
and after 24 hour incubation gave 43.5% viability. In the controls there was no 
significant change in the percentage viability of cells. The positive control showed 
that 1% bleach is more toxic compared to APDT treatment and after 24 hour 
incubation there was no recovery as seen with APDT. Also it can be seen that on 
incubation for 24 hours the cells are able to recover.  
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Figure 5-6 Influence of the time point at which the MTS assay was 
performed, after APDT of lymphocytes on the outcome of the assay. MTS 
assay performed immediately after APDT (immediate viability) and after 24 
hours (viability after 24h recovery). Error bars represent mean ± SD (n=3). 
Asterisks indicate the values that differ significantly from the control (cells 
not treated). Lines with asterisks on top compare the groups that 
significantly differ from each other. *** P < 0.001, ** P < 0.01. 
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5.3.4 Jurkat cell cytotoxicity and ECAS 
Figure 5.7 shows lymphocytes incubated with different concentration of ECAS 
and cytotoxicity levels tested immediately or after 24-hour incubation. It shows 
that at 5% ECAS there is no change in viability almost identical to control 
conditions. On incubation for 24 hours after 5% ECAS treatment there was slight 
increase in viability. A dose dependent decrease in viability of cells with increase 
in ECAS concentration was then observed. The positive control (0.5% bleach) 
was the most toxic. With each ECAS treatment after 24 hours recovery incubation 
an increase in viability was observed and 5% bleach also showed a slight 
recovery. 
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Figure 5-7 Influence of the time point at which the MTS assay was 
performed, after ECAS treatment of lymphocytes on the outcome of the 
assay. MTS assay performed immediately after ECAS treatment (immediate 
viability) and after 24 hours (viability after 24h recovery). Error bars 
represent mean ± SD (n=3). Asterisks indicate the values that differ 
significantly from the control (cells not treated). Lines with asterisks on top 
compare the groups that significantly differ from each other. *** P < 0.001, 
** P < 0.01. 
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Table 5.5 shows comparison of the effects APDT and ECAS on the viability of 
keratinocytes. It shows that keratinocytes are more sensitive to APDT compared 
to lower concentration of ECAS. The time point at which the NR assay was 
performed has a significant influence on the reduction in viability of 
keratinocytes. It shows that when NR assay was performed 24 hours after APDT 
or ECAS treatment there is an increase in viability compared to when it is carried 
out immediately after treatments. Table 5.6 shows comparison of the effects 
APDT and ECAS on the viability of lymphocytes. It shows that after exposure of 
lymphocytes to APDT there was significantly higher reduction in viability of 
lymphocytes which is in contrast to 5% ECAS that showed very low level in 
reduction in viability. However, increase in the concentration of ECAS increases 
the reduction in viability of lymphocytes. 1% and 0.5 % bleach are cytotoxic to 
lymphocytes. The time point at which the MTS assay was performed shows a 
significant influence on the reduction in viability of keratinocytes. It shows that 
when MTS assay was performed 24 hours after APDT or ECAS the survival value 
increases compared to when the MTS was performe immediately after APDT or 
ECAS treatment. Table 5.7 shows the influence of FBS on the viability of 
keratinocytes after APDT and after ECAS treatment (table 5.8). FBS has a 
significant influence on the viability of keratinocytes for the both APDT and 
ECAS treatments. In the case of APDT (high and low dose) the photoinactivation 
of keratinocytes in FBS compared to in PBS (absence of FBS) is significantly 
lower. Table 5.7 shows that for all treatment conditions of APDT of keratinocytes, 
with the increase in concentration of FBS the percentage viability of keratinocytes 
increases. FBS (50%) gives the highest protection against APDT. Similarly the 
viability of keratinocytes after ECAS treatment in FBS compared to in PBS 
(absence of FBS) shows increase in viability (table 5.8). Increase in the 
concentration of FBS protects the keratinocytes against ECAS. Table 5.9 shows 
the cytotoxicity levels of APDT and ECAS against keratinocytes and 
lymphocytes. ECAS is less cytotoxic to both keratinocytes and lymphocytes 
compared to APDT. Both APDT and ECAS treatment show higher cytotoxicity 
levels to lymphocytes compared to keratinocytes.  
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Table 5-5 Reduction in percentage viability of keratinocytes after exposure to APDT and ECAS                                                     
(data from figure 5-1 and figure 5-4) 
HD, high dose (MB 100 g/ml and 11 Jcm-2 light irradiation); LD, low dose (MB 10 g/ml and 11 Jcm-2 light irradiation); DC, dark 
control; Light control, LC; Control (cells not treated). 
Type of cell Type 
of 
assay 
Treatment Immediate 
reduction 
viability 
SD Reduction in viability after 24h recovery 
(significant difference- 24h recovery 
compared to immediate reduction. s, 
significant; ns, not significant.) 
SD % Recovery 
Keratinocytes 
(H103) cells 
NR APDT HD 60.7 1.04 41.13 (s) 1.36 19.57 
  DC HD 20.86 4.85 39.95 (s) 1.25 -19.09 
  APDT LD 51.09 0.60 19.94 (s) 6.66 31.15 
  DC LD 25.03 3.19 24.57 (ns) 1.30 0.46 
  LC No reduction 
(increase in 
viability 8.89) 
1.72 6.01 (s) 1.45  
  5% ECAS 10.2 4.20 6.38  (ns) 5.62 3.83 
  10% 
ECAS 
58.09 3.13 78.71 (s) 1.98 -20.62 
  25% 
ECAS 
80.21 1.21 85.51 (ns) 0.22 -5.3 
  5% Bleach 87.34 0.24 85.55 (ns) 0.25 1.79 
  Control 0 0.00 0 0.00  
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Table 5-6 Reduction in percentage viability of lymphocytes after exposure to APDT and ECAS  
 
Type of cell Type of 
assay 
treatment Immediate 
reduction 
(viability) 
SD Reduction in viability after 
24h recovery (significant 
difference- 24h recovery 
compared to immediate 
reduction. s, significant; ns, 
not significant.) 
SD % Recovery 
Lymphocytes MTS APDT LD 64.77 0.96 56.47 (s) 1.29 8.3 
  DC LD 23.97 4.13 21.95 (s) 0.51 2.02 
  1% bleach 78.25 1.74 90.64 (s) 0.82 -12.39 
  Light 
control 
8.67 1.25 7.82 (ns) 1.05 0.85 
  5% ECAS +3.00 1.28 +15.41 (s) 2.28 12.41 
  10% ECAS 28.73 0.86 +3.49 (s) 2.16 18.49 
  25% ECAS 15 1.96 +5.03 (s) 2.64 33.76 
  0.5% 
Bleach 
53.62 7.37 40.56 (s) 0.88 13.06 
  Control 0  0   
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Table 5-7 Influence of FBS on the viability of keratinocytes after exposure to APDT   
 
Cell type  Assay Treatment No FBS 
Percentage 
viability 
10% FBS 
Percentage 
viability 
25% FBS 
Percentage 
viability 
50% FBS 
Percentage 
viability 
Keratinocytes  NR APDT LD 48.48 
SD 2.92 
53.65 
SD 2.96 
62.31 
SD 16.30 
86.36 
SD 4.66 
  DC LD 80.88 
SD 3.08 
97.16 
SD 14.40 
108.30 
SD 5.38 
119.92 
SD 9.96 
  APDT HD 31.42 
SD 5.26 
53.90 
SD 17.12 
63.43 
SD 15.02 
92.36 
SD 9.40 
  DC HD 67.10 
SD 5.43 
62.27 
SD 6.87 
69.44 
SD 16.32 
99.78 
SD 5.25 
  LC 88.96 
SD 5.70 
93.89 
SD 4.23 
100.72 
SD 1.82 
104.92 
SD 7.96 
  Control 100 100 100 100 
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Table 5-8 Influence of FBS on the viability of keratinocytes after expsoure to ECAS treatment 
 
Cell type  Assay Treatment No FBS 
Percentage 
viability 
1% FBS 
Percentage 
viability 
5% FBS 
Percentage 
viability 
10% FBS 
Percentage 
viability 
Keratinocytes  NR 5% ECAS 85.20 
SD 4.31 
86.61 
SD 1.38 
99.61 
SD 15.19 
112.81 
SD 6.66 
  10% ECAS 46.12 
SD1.88 
44.68 
SD 2.80 
71.15 
SD 35.78 
120.44 
SD 5.39 
  25% ECAS 23.75 
SD 1.23 
 
22.57 
SD 0.33 
24.46 
SD 3.20 
28.34 
SD 0.39 
  Control 100 100 100 100 
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Table 5-9 Comparison keratinocytes and lymphocytes cytotoxicity levels of APDT and ECAS  
 
Treatment  Lymphocytes (MTS assay) SD Keratinocytes (NR assay) SD 
 Percentage reduction in 
viability relative to the control 
(media supplemented with 
10% FBS) 
 Percentage reduction in 
viability relative to the 
control (media 
supplemented with 10% 
FBS) 
 
APDT (low concentration PS)  64.77 0.96 46.35 2.96 
Dark control (low 
concentration PS) 
23.97 4.13 2.84 14.40 
Light control 8.67 1.25 6.11 4.23 
Control 0 0.00 0 0.00 
5% ECAS +3.00 1.28 +12.81 6.66 
10% ECAS 28.73 1.96 +20.44 5.39 
25% ECAS 15 0.86 71.66 0.39 
0.5% Bleach 53.62 7.37 -  
1% bleach 78.25 1.74 -  
5% Bleach  No live cells (trypan blue test)  14.45 0.25 
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5.4 Discussion 
This study was carried out to find the cytotoxicity levels of APDT and ECAS since both 
ROS generating systems have been proved to be effective against a wide range of 
microbes (Dai et al., 2009; Loshon et al., 2001). The two systems were compared in 
their ability to damage mammalian cells at a dose that that led to >3log10 bacterial 
killing (dose determined in chapter 3). To use these treatments in vivo would require a 
therapeutic window where bacteria could be killed without damage to adjacent normal 
tissue.  
In this study it was demonstrated that lymphocytes were more susceptible to APDT 
compared to keratinocytes. For this reason keratinocytes were exposed to high and low 
PS dose while lymphocytes cells were only exposed low dose PS. There was no 
significant reduction in viability for both cell types after exposure to light only. When 
cells were exposed to MB in the dark (dark control) for lymphocytes there was no 
significant reduction in viability. However, keratinocyte showed reduction in viability 
for both the low and high PS concentration although this was significantly lower 
compared to keratinocytes exposed to APDT. It was found for the higher concentration 
PS there was a significant recovery of keratinocytes after 24 h incubation. This indicates 
that the MB in the dark is not cytotoxic to the cells since the cells can reverse any 
damage caused by PS alone.  
When lymphocytes were exposed to APDT there was reduction in viability by 65%; and 
however upon 24 h incubation there was 8% recovery. Similarly when keratinocytes 
were exposed to APDT there was reduction in viability by 61% and 51% for the high 
and low PS concentration respectively. When the cells were incubated for 24 h after 
treatment for both the high and low PS there was 20% and 31% recovery respectively. 
Keratinocytes exposed to 5% bleach reduced viability to 87% and showed only 0.25% 
recovery after 24 h incubation while lymphocytes exposed to 5% bleach were 
completely destroyed (no viable cells). When lymphocytes were exposed to 1% bleach 
viability was reduced to 78% and upon incubation for 24 h there was delayed 
cytotoxicity with a further 12% reduction in viability. Even 0.5% bleach was cytotoxic 
to lymphocytes, which reduced viability to 54% with only 13% recovery after 24 h 
incubation. APDT for both cell types were several fold less cytotoxic compared to the 
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bleach positive control (5%). These results indicate that to mammalian cells APDT is 
much safer than bleach, which is an agent commonly used in clinical practice (Xu et al., 
2009).  These results are in agreement with a previous study where APDT carried out 
with MB (50g/ml) showed only modest reduction in viability of mammalian fibroblast 
cells and osteoblast cells while 3% bleach completely eliminated these cells (Xu et al., 
2009).  
In another APDT study with test parameters MB PS at 100 g/ml with a light dose 151 
Jcm
-2
 (light intensity 42 mWcm
-2
) cytotoxic levels to keratinocytes were apparent with 
viability reduced to 58% after 60 minutes and 62% after 90 minutes treatments (Zeina et 
al., 2002). The present study showed similar reduction in viability on average but with a 
lower light dose (11 Jcm
-2
 (light intensity 9.4 mWcm
-2
 and 20 minutes treatment was 
used)). The difference in these results from the present study may be explained by 
variation in test parameters and due sensitivity of mammalian cells to variations in 
experimental test conditions. However, overall the data presented in this thesis was 
found to be in agreement with previous work carried out on APDT-MB showing that it 
is not strongly cytotoxic to keratinocytes. Moreover, when the cytotoxicity levels of 
keratinocytes exposed to APDT were measured after 24 hours, recovery of cells was 
evident under all treatment conditions and in the dark controls. This indicated that the 
cells were able to recover after APDT. This is also in agreement with the findings of 
Zeina et al. (2002) who showed recovery after treatments following 6 hours incubation 
in the dark.  
ECAS (5% v/v) was not cytotoxic to lymphocytes and keratinocytes cells. However 
10% v/v ECAS showed reduced viability of keratinocytes and lymphocytes. Similarly 
25% v/v ECAS reduced viability of keratinocytes to 80% while bleach 5% v/v reduced 
viability to 87% in both cases with no recovery and further reduction in viability upon 
24 h incubation. It was found lymphocytes were less cytotoxic to 10 and 25% v/v ECAS 
compared to keratinocytes. These results indicate that 5% v/v ECAS is the safest 
concentration for mammalian cells. Also ECAS was several fold safer to mammalian 
cells compared to APDT.  
 Bleach (5% v/v) compared to same concentration of ECAS was 5 times more cytotoxic 
to keratinocytes and completely eliminated lymphocytes cells. This is an interesting 
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observation since in the literature ECAS has been compared to bleach. ECAS has been 
shown to produce the same active hypochlorite as in bleach but despite this, ECAS is 
far less cytotoxic (Robinson et al., 2011); highlighting that other factors may be present 
contributing to its high antimicrobial activity yet not contributing to any cytotoxicity to 
mammalian cells and specifically targeting the bacterial cells.    
Experiments were carried out to find out whether the presence of serum in the treatment 
media gave protection to the cells from the cytotoxic effects of APDT. It was found that 
the protective role is dependent on the concentration of FBS. For both low and high PS 
concentration, 10% FBS was slightly protective but increasing the concentration to 25% 
and 50% FBS had significant protective effect. The presence of 50% FBS completely 
inhibited any cytotoxic effects of the treatment on the keratinocytes. Similarly FBS was 
protective against ECAS (5% and 10% v/v). However, 25%v/v ECAS FBS provided no 
further protection.  ECAS cytotoxicity effects tested in the presence of FBS may more 
closely represent an in vivo environment.  
Similar results were shown by a study carried out by Lambrechts et al. (2005) the PS 
used in their study was cationic porphyrin. It was shown that fibroblast survival 
increased with increasing fetal calf serum (FCS) concentration. Protective role of serum 
may be due to quenching and scavenging of ROS and PS may have higher affinity to 
serum and bind to it (Lambrechts et al., 2005).  
Recovery suggests that some aspects of both APDT-MB and ECAS treatment may be 
non-lethal and reversible. Moreover the data comparing the addition of higher 
concentrations of serum indicate that it may also protect the mammalian cells 
throughout treatment and aid in cell recovery. 
The longer duration of application of APDT (20 minutes) is not a feature of ECAS 
which kills microbial cells quite rapidly hence reducing cytotoxicity to the surrounding 
mammalian cells. Therefore because the doses that are effective at killing the microbial 
cells are not cytotoxic to mammalian cells it confirms the applicability of this treatment 
to infected environments where mammalian cells may also be present.  
When cytotoxicity effects of both APDT and ECAS treatment on keratinocytes and 
lymphocytes were compared it showed that lymphocytes cells are more sensitive to both 
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treatments compared to keratinocytes. It is important to note that the methods used to 
assess the cytotoxicity of the two types of cells were different although for each test the 
percentage viability was calculated relative to the control. For lymphocytes the viability 
test carried out used MTS which measures the metabolic activity of the cell whereas the 
NR assay used to measure cytotoxicity of keratinocytes is viability based assay. Of the 2 
treatments ECAS had the least cytotoxic effect on both type of cells. However APDT 
was shown to be more cytotoxic to the lymphocytes compared to keratinocytes. 
Cytotoxicity level of ECAS at low concentration of 5% was not toxic to lymphocytes or 
keratinocytes but both cell types were more affected when the concentration was 
increased.  
For APDT, Boehncke et al. (1996) showed that the difference in susceptibilities is 
proportional to the uptake of MB and that this is dependent on the type of the cells. 
Lymphocyte (Jurkat) cells may take up a greater amount of PS compared to 
keratinocytes and when irradiated produce more cytotoxic ROS in close vicinity of cells 
and therefore account for the difference in cytotoxicity levels in this study. However it 
is difficult to compare this precisely because the viability tests employed were different 
for the two types of cells.  
When the co-mix assay containing keratinocytes and bacterial cells was exposed to 10 
g/ml MB and 11Jcm-2 light it was shown that bacterial cells were killed at a higher rate 
compared to keratinocytes. The treatment has lower cytotoxicity effect on the 
mammalian cell compared to bacterial cells when treatment was carried out 
simultaneously. APDT killing of keratinocytes was 12.5 fold lower than E. coli Nissle 
1917 pGLITE and keratinocytes killing was 25 fold lower than Gram positive species S. 
aureus (based on kill rates calculated in separate assays). 
This shows that when the APDT was carried out simultaneously in the same mixture it 
specifically targets to the bacterial cells over mammalian cells. It is known that bacterial 
cells take up cationic PS at faster rate compared to mammalian cells. It is known that 
the process of dye uptake by mammalian cells is by endocytosis whereas bacterial cells 
take up the dye by passive process (Dai et al., 2009). Therefore the short duration of 
treatments means that bacterial cells may take up more dye compared to mammalian 
cells. If illumination is performed with short intervals after PS application (minutes) the 
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APDT mediated damage to mammalian cells will be minimized.  It has been shown that 
the kill rates for keratinocytes after APDT treatment was 18 to 200-fold lower than that 
microbial species under the parameters employed in the study (Zeina et al., 2002).  
In this study it was found lymphocytes are more sensitive to APDT compared to 
keratinocytes and it was found that under conditions of this study APDT was only 7 fold 
lower at killing lymphocytes compared to Gram-negative E. coli Nissle 1917 pGLITE 
strain. In contrast to APDT, ECAS (5%v/v) was found to be even less cytotoxic to 
keratinocytes and lymphocytes. When E. coli Nissle 1917 pGLITE were exposed ECAS 
(5%v/v) a 1.5 log/min kill rate was obtained and only 0.002 log/min kill rate for 
lymphocytes. This indicated that after ECAS (5%v/v) lymphocytes were killed 750 fold 
lower than bacterial cells (Gram-negative strain). No significant kill was observed when 
keratinocytes were exposed to ECAS (5%v/v).  
PDT of cancer requires longer pre-incubation of PS for the cancerous cells to take up 
the dye to effectively kill the cells; however this is not required of APDT because the 
bacterial cells are killed at a faster rate, eliminating the need for long pre-incubation of 
the PS with the cells. This will minimize the cytotoxicity to mammalian cells. In fact 
this is the main difference between APDT and PDT for cancer. For cancer therapy the 
PS is allowed to accumulate in the hyperproliferative cells. Treatments where the kill 
rates for bacterial cells are faster compared to mammalian cells highly desired. This will 
mean that the treatment periods will be shorter and easier for patients to comply and 
duration of the treatment exposure to mammalian cells are also reduced decreasing the 
chances of side effects of the treatment.   
In conclusion it can be said that for ECAS there is wider safe therapeutic window where 
treatments can effectively target microbial cells over mammalian cells. In the case of 
APDT even though bacterial cells are more susceptible compared to mammalian cells 
the treatment may need to be used more carefully. APDT may need further study and 
optimisation to increase the ratio of bacterial cells killed to that of mammalian cells. 
The use of MB is well established in medicine and it is used for the routine staining of 
vital organs and the treatment of septic shock (Wainwright, 2000).  
It has been shown that APDT with MB showed lower level of cytotoxicity to murine 
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peripheral-blood neutrophils compared to the PSs erythrosine B, rose bengal, crystal 
violet and photofrin. In the study it was shown that under conditions for each PS that 
exerted the maximum bactericidal effect on methicillin-resistant Staphylococcus aureus 
most neutrophils were viable (>80%) after APDT using toluidine blue-O (TB) or MB 
while neutrophils viabilities were decreased (<70%) after APDT using other PSs 
(erythrosine B, rose bengal, crystal violet, Photofrin, new MB and Laserphyrin). These 
results indicate that APDT using TB or MB can preserve host neutrophils while exerting 
bactericidal effect (Tanaka et al., 2012). 
One reason that eukaryotic mammalian cells may be protected from the cytotoxic effect 
while prokaryotic cells are damaged is due to the presence of nuclear membrane 
protecting the nucleus and acting as a barrier either to the penetration of PSs or 
cytotoxic reactive oxygen species formed during the treatment (Zeina et al., 2002). It is 
possible that the same reason can account for the resistance to APDT killing of the 
eukaryotic fungal pathogen C. albicans compared to bacterial cells. C. albicans are 
reported to be hardest to kill by APDT when compared with Gram-positive or Gram 
negative strains (Zeina et al., 2001; Demidova and Hamblin, 2005). Moreover it was 
proposed that the large size of C. albicans  compared to bacterial cells, presents more 
targets to be damaged per cell, consequently the amount of ROS necessary to kill yeasts 
is much greater than amount necessary to kill bacteria (Zeina et al., 2001; Demidova 
and Hamblin, 2005).  
The wide applicability of these two ROS generating systems to a wide range of micro-
organisms and the low toxicity against two important mammalian cell lines may 
indicate that these techniques could be applied in vivo as a method to reduce the 
pathogenic organisms in localised infections. The positive safety and efficacy results of 
these treatments warrant further studies. As it is shown that the serum plays a protective 
role from cytotoxic damages to cells also require further study to understand how 
exactly it protects the cells and how it may effect on the efficacy of the treatment in 
vivo.  
In this study it was shown that when the bacterial and mammalian cells are in co-mix 
assay and simultaneously treated considerably higher kill rates were observed for the 
bacterial cells only and only a slight change for mammalian cells.  This faster kill rate of 
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bacterial cells means mammalian cells are not damaged for the duration of the treatment 
and short treatments can be carried without damage of the mammalian cells. If the 
microbial kill rate is slow that means that the mammalian cells will be exposed to longer 
treatments making it more likely to damage the mammalian cells.  
The co-mix assay was a very useful model as it may be more relevant to an in vivo 
assay. As both types of cells are in close proximity. One reason for low toxicity may be 
that PS is taken up at faster rate and it accumulates only in the microbial cells and not in 
the keratinocytes and hence with irradiation the PS molecules are in close proximity to 
microbial cells are damaged sparing the mammalian cells from damage.  The co-mix 
assay shows that the PS is more specific to bacterial cells (greater reduction in bacterial 
cells compared to mammalian cells). This assay indicates a therapeutic index and can 
predict treatment protocols where only microbes are damaged and mammalian cells are 
left undamaged. This assay could be repeated in future work to compare the cytotoxicity 
of PS used in APDT or new PS that are being developed. The use of bioluminescent E. 
coli in the co-culture mixture helped to carry out the test swiftly and effectively.   
It would be very interesting to carry out this co-mix assay with other antimicrobial 
agents. The assay could not be carried out with ECAS as there was technical difficulty 
measuring the bioluminescence change because ECAS is a very fast acting agent and 
the kill rate was not easily determined for bacteria cells and mammalian cells together. 
However this assay can be modified in the future studies.  
The results of this study are significant and indicate that the MB mediated 
photodynamic therapy and ECAS may be two distinct alternatives to conventional 
antibiotic therapy. Both the APDT and ECAS approaches may be of use for creating 
aseptic skin surfaces before surgery. This is more attractive as it shows no toxicity to 
keratinocytes in vitro. Use in treatments could also be of significant potential benefit for 
the future.  
.   
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Chapter 6: Genotoxicity effects of APDT and ECAS on 
lymphocytes (Analysis of DNA damage in lymphocytes using 
the Comet assay) 
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6.1. Introduction  
Several studies have shown both APDT and ECAS are effective biocides against a wide 
range of microbial species including antimicrobial resistant bacteria and bacterial spores 
and is non-toxic to mammalian cells.  Low level of cytotoxicity and genotoxicity on 
mammalian cells would indicate that these alternative treatments could be used as a safe 
alternative to conventional antimicrobial treatments. Therefore it is important to show 
that the treatments do not cause genotoxicity to mammalian cells. 
In chapter 5 it was shown that treatment doses of ECAS and APDT sufficient to 
effectively kill bacteria are not cytotoxic to keratinocytes and lymphocytes. Both were 
found to be several fold less cytotoxic towards mammalian cells compared to bacterial 
cells. Therefore this suggests that both treatments can be used effectively to treat 
microbial infections without damage to host cells. However, prior to testing of these 
agents in vivo, it is important to determine possible genotoxic effects on mammalian 
cells in vitro. A previous study showed that APDT using MB as PS does not cause DNA 
damage to keratinocytes (Zeina et al., 2003). To the best of author’s knowledge no 
previous studies have been carried out to test the potential genotoxic effects of both 
APDT and ECAS on lymphocytic cells at concentrations relevant to microbial killing.  
A previous report showed that MB mediated PDT is genotoxic to human myeloid 
leukaemia cell line (K562) (McNair et al., 1997). The comet assay showed damage to 
DNA immediately after treatment; however no residual DNA damage was present after 
4 hour post treatment “recovery” incubation at 37°C. The method used in their study 
was different to the current study. The treatment protocol involved first, incubating the 
cells with MB for 1 or 16 hours, and then removing any unbound MB before the cells 
were irradiated with 20W argon ion pumped dye laser with light dose of 20 Jcm
-2
. This 
method is more relevant in cancer PDT as it usually involves a long preincubation time 
for PS to be taken up by the cancer cells. This is not necessary in the case of APDT.  
A search of the published literature found no reports on testing for the in vitro 
genotoxicity of ECAS. ECAS is reported to be safe since ECAS failed to induce 
genotoxicity, when tests were carried out to for DNA damage, using either the Ames 
test (Tsuji et al., 2008) or the genotoxicity micronucleus test (Gutierrez, 2006; Thorn et 
al., 2012). Moreover, a recent study showed that ECAS did not degrade nucleic acids or 
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induce oxidative damage in dermal fibroblasts in vitro (Martínez-De Jesús et al., 2007). 
These studies support the view that ECAS does not cause DNA damage and is not 
genotoxic to mammalian cells. However the number of studies carried out is limited. No 
studies have focused on the DNA damage to lymphocytes. Therefore in this study 
genotoxicity of ECAS and APDT were measured at concentration/dose conditions 
known to be highly biocidal to test microbes (determined in chapter 3).  
6.1.1 Comet assay  
Comet is a well-known simple assay used to assess DNA damage caused by chemicals 
or other possible mutagenic treatments. The comet assay is also known as a single-cell 
gel (SCG) electrophoresis because it detects DNA damage caused within individual 
cells. The comet assay is a method of detecting DNA strands breakage (double, single, 
alkali-labile sites expressed as single strand breaks) in virtually any nucleated cell.  
Ostling and Johanson (1984) were the first to quantify DNA damage using the comet 
assay (Fairbairn et al., 1995). They used neutral conditions, which allowed the detection 
of only DNA double strands breaks. Later the assay was adapted under alkaline 
conditions by Singh (Anderson et al., 1998; Singh et al., 1988), which lead to a 
sensitive version of the assay that could assess both double and single strand DNA 
breaks as well as the alkali labile sites.  
The comet assay allows for the direct visualisation of DNA damage in individual cells. 
A small number of treated cells, suspended in a thin agarose gel on a microscope stage 
were lysed, electrophoresed and stained in situ with a fluorescent DNA binding dye 
(Fairbairn et al., 1995). The results of the test were based on the migration of relaxed 
and broken DNA fragments further than intact pieces of DNA when electric current is 
applied. The resulting images, (named for their appearance as comets) were measured to 
determine migration and “spread” and therefore the extent of the DNA damage 
(Fairbairn et al., 1995). The comet assay provides a direct determination of the extent of 
DNA damage in individual cells. The single cell gel assay has also been used to 
examine DNA damage and repair under a variety of experimental conditions (Collins et 
al., 1995; Fairbairn et al; 1995, McNair et al., 1997). This technique has proved to be 
valuable in discriminating the different mechanism involved in genotoxicity and DNA 
repair (Collins et al., 1995). 
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The comet assay possesses a number of advantages as compared to other genotoxicity 
tests. Significant advantages include its sensitivity for detecting low levels of DNA 
damage (Olive et al., 1990), the requirement for only small numbers of cells per sample, 
its ease of application and low cost, and the short time needed to perform the assay 
providing rapid production of data (Liao et al., 2009; Fairbairn et al, 1995). In addition 
this assay is flexible as it can be used to evaluate various types of DNA damage, and is 
readily modifiable for adaptation to a variety of experimental requirements (Liao et al., 
2009; Tice et al., 2000).  Therefore comet assay has been used in many studies to 
investigate DNA damage and repair by a variety of DNA-damaging agents. 
The comet has been previously used for successful screening of human lymphocytes 
obtained from large numbers human subjects to determine the extent of DNA damage 
occurrence with time and lifestyle (cigarettes smoked/day). (Betti et al., 1995). The 
alkaline comet assay has been previously applied as an effective screening assay for 
DNA damage induced by PDT on K562 cell line (McNair et al., 1997).  
The principle of the assay is based upon the ability of denatured, cleaved DNA 
fragments to migrate out of the nucleoid under the influence of an electric field, whereas 
undamaged DNA migrates slower and remains within the confines of the nucleoid when 
current is applied. Evaluation of the DNA “comet” tail shape and migration pattern 
allows for assessment of DNA damage. Olive et al. (1990) introduced the concept of 
tail moment measure; tail length and amounts of DNA in the tail as a measure of DNA 
migration. (Olive et al., 1990). 
Two main principles that determine the pattern of comet formation are the size of the 
DNA and the number of broken ends which may be attached to large pieces of DNA but 
which can still migrate a short distance from the comet head. The tail length initially 
increases with damage but reaches a maximum that is largely defined by the 
electrophoresis conditions, not the size of the fragments. At the low damage levels, 
stretching of the attached strands of DNA, rather than migration of individual pieces is 
likely to occur. With the increase in number of breaks, DNA pieces migrate freely into 
the tail of the comet, at the extreme (e.g. in apoptotic cells), the head and tail will be 
separated. The intensity of the fluorescence of the tail relative to the head provides 
information about the numbers of strand breaks. These concepts, stretching and 
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migration of separated strands are generally accepted to explain the DNA migration 
patterns observed in the comet assay (Collins et al., 1995, Fairbairn et al., 1995). 
Modifications of the comet assay can allow detection of DNA double-strand breaks, 
crosslinks, base damage and apoptotic nuclei enabling more information about the 
nature of the damage (Olive and Banáth, 2006). The limit of sensitivity of the assay is 
approximately 50 strand breaks per diploid mammalian cell (Olive and Banáth, 2006). 
The series of steps in the comet assay procedure are:  
1. cells mixed with low melting agarose at 37◦ C (Low melting (LM) agarose) 
2. immobilise cells on comet slide  
3. treats cells with lysis solution 
4. samples treated with alkali (unwinds and denatured DNA) 
5. samples stained with intercalated dye and visualised with epifluorescence 
microscopy following alkaline electrophoresis, which reveals DNA breaks 
6.1.2 DNA damage  
DNA damage could be defined as any modification of DNA that changes its sequence 
or coding properties such that it loses the normal information transfer fidelity (Swain 
and Rao, 2011). DNA damage can occur by two mechanisms by spontaneous damage 
caused by sources within a cell or damage caused by external sources such as chemicals 
and radiation (ultraviolet or ionizing radiation (X-rays, -rays, particles and cosmic 
rays). These substances may induce inter-strand and intra-strand cross-links, DNA–
protein cross-links, bulky DNA adducts, single strand breaks (SSBs) and double strand 
breaks (DSBs) (Swain and Rao, 2011). 
6.2 Aims of this chapter 
The purpose of the present study was to assess the in vitro genotoxicity of APDT and 
ECAS on lymphocytes using the comet assay and to determine repair of DNA damage 
following incubation after treatment.  
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6.3 Results  
In figure 6.1 the untreated lymphocytes shows undamaged DNA as it appears as round 
spots as the intact DNA does not migrate out of the cells and is confined to the nucleoid 
area. In contrast, figure 6.2 the positive control (100 M of hydrogen peroxide) shows 
cells with DNA damage that appear as fluorescent comets (migrating fragments of DNA 
the comet tail moving away from the nucleoid the comet head) with tails of DNA 
fragmentation  
Figure 6.3 shows the light control (cells exposed to light for 20 minutes total light dose 
11 Jcm
-2 
at light intensity of 9.4 mWcm
-2
. The image shows round spots because the 
DNA is intact showing that exposure of cells to only light does not damage the DNA.   
Similarly in figure 6.4, 6.5 and 6.6 shows the dark control (cells incubated with only 
MB (10 μg/ml) in the dark for 20 minutes) without recovery period, after 6 hours 
recovery period and 24 hours recovery period respectively. All the three images show 
no DNA damage as cells appears as round fluorescent spots.  
Figure 6.7 shows cells treated with APDT without incubation. It shows cells with 
damaged DNA that appear as fluorescent comets. In contrast the control (figure 6.4) 
where cells were incubated with only MB (10 μg/ml) in the dark without incubation 
shows cells with undamaged DNA that appears as round spots.  
The respective dark control (figure 6.5) shows no damaged DNA while cells incubated 
for 6 hours following APDT (figure 6.8) shows cells with damaged DNA that appear as 
fluorescent comets indicating DNA damage.  
Figure 6.9 shows cells incubated for 24 hours following APDT. It shows cells with 
damaged DNA that appear as fluorescent comets while the dark control (figure 6.6) 
cells that were incubated with only MB (10 μg/ml) in the dark for 20 minutes and 
incubated for 24 hours shows cells with undamaged DNA that appears as round spots.  
Figure 6.10 shows DNA damage measured immediately after ECAS treatment; figure 
6.11 and 6.12 shows a recovery period 6 hours and 24 hours respectively. These show 
no detectible damage which is similar to the negative controls (untreated).  
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Using the comet Assay IV single cell electrophoresis assay quantification software the 
tail moment was determined for each sample. The graph shows tail moment against type 
of treatment at different incubation time. Box plot graph shows the distribution of tail 
moment obtained for 50 cells for each treatment. Tail moment is a parameter which 
increases in proportion to the number of DNA strand breaks (Sparrow et al., 2003).  
Figure 6.13 shows the tail moment of cells exposed to APDT (MB concentration 10 
μg/ml and total light 11 Jcm-2 at light intensity of 9.4 mWcm-2) plotted against the 
incubation time following treatment. The positive control (H2O2) showed the highest 
mean value of tail moment. The untreated cells, light only and dark only showed very 
low mean tail moment. The magnitude of tail moment after APDT treatment was 
increased compared to the control. The magnitude of the tail moment was dependent on 
the incubation time.  24 hours shows the highest mean value of tail moment.  
The Exposure of cells to 5% v/v ECAS for 30 minutes (figure 6.14) immediately or 
following 6 hours or 24 hours incubation shows tail moment values similar to the 
control negative (the untreated cells) while the positive control (H2O2) was significantly 
greater compared to both the control and ECAS treated cells for all incubation times. 
The magnitude of tail moment was not dependent on the incubation time. 
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6.3.1 Comet images of APDT treated cells compared with untreated cells  
 
Figure 6-1 Comet image of lymphocytes not exposed to treatment (negative 
control). 
 
 
Figure 6-2 Comet image of lymphocytes treated with 100 M of hydrogen peroxide 
(positive control). 
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Figure 6-3 Comet image of lymphocytes exposed to light only (total light 11 J/cm
2
 
at light intensity of 9.4 mW/cm
2
) and no incubation after treatment.   
 
 
 
Figure 6-4 Comet image of lymphocytes exposed to MB in the dark (cells incubated 
with MB concentration 10 g/ml for 20 minutes) and no incubation after 
treatment.  
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Figure 6-5 Comet image of lymphocytes exposed to MB in the dark (incubated 
with MB concentration 10 g/ml for 20 minutes) and after treatment incubated for 
6 hours.  
 
 
Figure 6-6 Comet image of lymphocytes exposed to MB in dark (incubated with 
MB concentration 10 g/ml for 20 minutes) and after treatment incubated for 24 
hours.  
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Figure 6-7 Comet image of lymphocytes after APDT (MB concentration 10 g/ml 
and total light 11 J/cm
2
 at light intensity of 9.4 mW/cm
2
) and not inubated after 
treatment. 
 
 
Figure 6-8 Comet image of lymphocytes after APDT (MB concentration 10 g/ml 
and total light 11 J/cm
2
 at light intensity of 9.4 mW/cm
2
) and incubated for 6 hours 
after treatment.  
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Figure 6-9 Comet image of lymphoctes after APDT (MB concentration 10 μg/ml 
and total light 11 J/cm
2
 at light intensity of 9.4 mW/cm
2
) and incubated for 24 
hours after treatment.  
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6.3.2 Comet images of ECAS treated cells  
 
Figure 6-10 Comet image of lymphocytes treated with 5% ECAS for 30 minutes 
and without incubation after treatment. 
 
 
Figure 6-11 Comet image of lymphocytes treated with 5% ECAS for 30 minutes 
and incubated for 6 hours after treatment.  
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Figure 6-12 Comet image of cells treated with 5% ECAS for 30 minutes and 
incubated for 24 hours after treatment.  
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Figure 6-13 Box-Whiskers plot of data collected for each comet assay for 
lymphocytes (Jurkat cells) treated with APDT (MB concentration 10 g/ml and 
total light 11 Jcm
-2
  at light intensity 9.4 mWcm
-2
). The comet assay was 
performed, immediately after treatment (time, 0 h), 6 hours incubation after 
treatment (time 6 h) and 24 hours incubation after treatment (time 24 h). Control 
population for each treatment is shown side by side for comparison. (n=75). 
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Figure 6-14 Box-Whiskers plot of data collected for each comet assay for 
lymphocytes (Jurkat cells) treated with 5% v/v ECAS for 30 minutes. The negative 
control population for each treatment is shown side by side for comparison. The 
comet assay was performed, immediately after treatment (time, 0 h), 6 hours 
incubation after treatment (time 6 h) and 24 hours incubation after treatment 
(time 24 h). (n=75). 
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 6.4 Discussion  
This study was carried out to detect genotoxic effects of APDT and ECAS on 
lymphocytes (Jurkat cells) at doses previously shown (chapter 3) to effectively kill 
bacterial cells and doses that were shown to be non-cytotoxic to mammalian cells 
(chapter 5). The comet assay was employed to detect damage to DNA resulting after 
exposure of Jurkat cells to treatment (APDT or ECAS). The comet assay detects very 
small amount of damage to DNA (Olive and Banáth, 2006).  
Lymphocyte cells exposed to hydrogen peroxide showed very high level of DNA 
damage. The images captured after exposure to hydrogen peroxide (figure 6.9) showed 
a typical comet appearance confirming that the technique is capable of detecting DNA 
damage and this corresponds to very high tail moment measurement. This confirms that 
hydrogen peroxide damages the DNA and is genotoxic to lymphocytes. H2O2 is 
frequently used as a positive control in genotxicty studies (Zeina et al., 2003; 
Shimabukuro et al., 2011). Hydrogen peroxide is known to cause oxidative stress in 
mammalian cells which leads to  DNA damage (Benhusein et al., 2010). The extent of 
this damage is dependent on the concentration of H2O2 (Benhusein et al., 2010). 
Untreated (figure 6.8) cells and Light alone (figure 6.7) showed no visually detectable 
damage to DNA and also gave low tail moment. Dark control cells exposed to 10 g/ml 
MB alone showed no visual comet formation after immediate exposure or following 6 
or 24 hours incubation after treatment. This confirmed that MB alone in the dark does 
not damage the DNA and there are no delayed genotoxicity effects.  
Lymphocytes exposed to APDT (10 g/ml MB total light 11Jcm-2 at light intensity of 
9.4mWcm
-2
) and comet assay carried out immediately showed increased tail moment 
compared to respective dark control. Although APDT showed significantly higher tail 
moment compared to the respective controls it was not as high as the hydrogen peroxide 
at the concentration used, indicating that APDT of stated exposure time (20 min) causes 
less DNA damage compared to hydrogen peroxide. Comet assay has been used detect 
delayed DNA damage (e.g. apoptosis) or DNA repair following a recovery period 
(Olive et al., 1993). To determine the DNA damage recovery or delayed DNA damage 
to lymphocytes after APDT, the comet assay was carried out immediately after APDT 
or 6 h or 24 h incubation of cells. The mean tail moment was significantly different (p< 
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0.005) when comet assay was carried out immediately after treatment, 6 h or 24 h 
incubation after treatment. Comet assay carried out after APDT and following 24 h 
incubation showed the highest mean tail moment. The ability of the cells to repair the 
damage is dependent on the extent of DNA damage (Sparrow et al., 2003). The failure 
of the cells to repair following incubation therefore may indicate that the severity of 
damage to lymphocyte DNA.   
The Exposure of cells to 5% v/v ECAS for 30 minutes immediately or following  6 
hours or 24 hours  incubation  after treatment showed no  visual damage to DNA hence 
very low tail moment. The DNA damage after ECAS was very small therefore 
incubation after treatment did not show any significance. This shows that ECAS is not 
genotoxic to the cells and there was no delayed genotoxicity. Compared to APDT, 
ECAS resulted in considerably less damage to DNA.  
This significantly higher genotoxicity level of APDT compared to ECAS is very 
interesting. This difference may be due the difference in the predominant ROS involved 
in the mechanisms of these two treatments. APDT mechanism involves predominantly 
singlet oxygen while ECAS may be mainly hydroxyl radicals as discussed in chapter 4.   
Reactive oxygen species are known to induce chromosomal aberrations with high 
efficiency. It has been reported that MB photodynamic therapy (MB-PDT) might be 
expected to cause DNA damage, as MB is known to bind to DNA (Norden and Tjerneld 
1982). MB was shown to intercalate rapidly into DNA, predominantly binding to purine 
nucleotides resulting in significant oxidative DNA damage (Tuite and Kelly, 1995). It 
has been identified that singlet oxygen is able to react with DNA molecule resulting in 
the formation of 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) with toxic and 
mutagenic effects (Agnez-Lima et al., 2012). Singlet oxygen mediated damage may 
explain high DNA damage to the lymphocytes and inability of cells to repair the DNA 
damage. However, despite this evidence of in vitro DNA damage effects of MB plus 
light, this has not been reproduced in vivo (Wagner et al., 1995). MB mediated PDT 
caused DNA damage to human myeloid leukaemia cell line (K562). However, upon 
incubation for 4 hour post treatment at 37°C the DNA damage was repaired. (McNair et 
al., 1997). Singlet oxygen has a very limited diffusion distance 50m (Moan, 1990; Fu 
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et al., 2013). Therefore it is to be expected that the target for damage is likely to be 
restricted to sites close to the site of localisation of PS. 
One of the major concerns of using ECAS is the potential to cause DNA oxidation and 
genotoxicity. This study confirmed that ECAS at concentrations tested (5%v/v) is not 
genotoxic to lymphocytes. Previous studies also failed to show any genotoxicity of 
ECAS using in vitro mutagenicity tests, Ames test (Tusji et al., 1999) or the 
genotoxicity micronucleus test (Gutierrez, 2006; Thorn et al., 2012). Moreover, it was 
shown that when dermal fibroblast cells were exposed to neutralised ECAS it did not 
degrade nucleic acids or induce oxidative damage in dermal fibroblasts in vitro 
(Martínez-De Jesús et al., 2007). Therefore it can be concluded that together with the 
results of this study that ECAS does not target cell nuclei and does not induce damage 
to DNA (Martínez-De Jesús et al., 2007). These are very encouraging results and 
indicate that ECAS can be safely used to develop treatment protocols for various 
localised infections including more invasive systemic infections.   
This study (chapter 6) confirmed that lymphocytes incubated with 5% v/v ECAS for 30 
minutes do not incur significant damage to their DNA. In optimal treatment, it may not 
be necessary for such long exposure of mammalian cells, higher than that required for 
efficacious antibacterial effect for ECAS. This indicates 2 minutes required for 4 log 
reduction in bacterial number will not cause any safety issues to mammalian cells.  This 
indicates that ECAS may be safer to use in deep-seated tissue infections. 
This study showed that APDT is genotoxic to lymphocyte cells and the damage was not 
repaired following incubation up to 24 hours. APDT damage compared with ionizing 
radiation is likely to be relatively low, as the damage reported consists predominantly of 
oxidative damage to guanine leading to single-strand breaks or an alkali-labile site, 
which are likely to be relatively easily repaired and also are likely to be highly 
dependent on the treatment agents (Evans et al., 1997). Sparrow et al. (2003) reported 
that the repair of the DNA damage is dependent on the extent of DNA damage and may 
vary depending on the type of the cells. Therefore the lymphocytes may require more 
than 24 h incubation time to repair the damage.  
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A study carried out Zeina et al. (2003) to assess the DNA damage caused to 
keratinocytes by APDT mediated by MB showed no genotoxicity on keratinocytes. This 
indicates that lymphocytes are more sensitive to DNA damage and also, it was found 
(chapter 5) that APDT is more cytotoxic to lymphocytes compared to keratinocytes. The 
fact that keratinocytes are more resistant to genotoxicity levels than lymphocytes means 
that APDT may be more applicable for outer layers of skin infection rather than deep 
seated wound infections. Further studies may need to be carried out to optimise the 
APDT treatment.  
Although it is known that DNA damage is an important factor in cancer development, 
direct evidence linking DNA damage and cancer have not been established (Poulsen et 
al., 1998). There is no straightforward link between DNA modification and cancer 
initiation, most cells are repaired or killed and only small proportion of cells become 
cancerous (Noodt et al., 1993) Also long term exposure to the mutagen might be an 
important contributing factor in cancer development. US, FDA Guidelines for 
carcinogenicity testing of pharmaceuticals (CDER, 1996) indicate that all drugs 
expected for continuous clinical use for at least 6 months or more are required to 
undergo long-term carcinogenicity studies should be performed in rodents. APDT and 
ECAS may need short treatment times and may not be needed for long-term use 
therefore minimizing any potential risk.  
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Chapter 7:  Application of APDT and ECAS against biofilm 
Real time monitoring of metabolic activity in biofilms exposed 
to APDT and ECAS within an in vitro flat-bed perfusion 
biofilm model 
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7.1 Introduction  
In the first part of this thesis it was established that APDT and ECAS are both effective 
against the planktonic bacterial cultures. In recent years bacterial biofilms have been 
implicated in various non-healing wounds and chronic infections (Schierle et al., 2009). 
Furthermore biofilm has been frequently reported to dominate in infections associated 
with foreign-body (implants), cystic fibrosis (chronic bronchopneumonia), endocarditis, 
persistent otitis media, chronic osteomyelitis, infected prosthetic joints and intravenous 
catheters and stents (Høiby et al., 2011). According to National Institutes of Health 
(NIH) biofilms are responsible for more than 80% of infectious diseases in the body 
(Davies, 2003). Moreover biofilm infections are characterized by persistent 
inflammation and tissue damage (Høiby et al., 2011). These infections persist in spite of 
the innate and adaptive immune system and the inflammatory response of the host. 
Evidence supports the view that the biofilm mode of growth of bacteria lead to 
increased resistance to antimicrobial products compared to their “planktonic 
counterpart” making it difficult to eliminate biofilms (Costerton et al., 1999). The 
emergence of highly resistant bacteria to conventional antimicrobials and high tolerance 
of biofilms to disinfectant and antibiotic therapy clearly shows that new biofilm control 
strategies are required (Simões et al., 2010).   
 
In the literature there are reports on the effectiveness of various disinfectants and 
antimicrobial agents including ECAS (Liao et al., 2007) and APDT (Hamblin and 
Hassan, 2004), all based upon the results of tests carried out on planktonic bacteria. 
Such tests using planktonic cultures of micro-organisms have demonstrated the 
effectiveness of these agents; however these results will be unlikely to predict their 
potential effects in vivo. Biofilm growing bacteria differ from planktonic bacteria with 
respect to their genetic and biochemical properties and biofilm bacteria show enhanced 
tolerance to antimicrobial agents (Donlan and Costerton, 2002). It has been shown that 
the minimal inhibitory concentration (MIC) and minimal bactericidal concentration 
(MBC) of antibiotics required with biofilm-growing bacteria may be up to 100 to 1000-
fold higher than those needed for equivalent populations of free-floating counterpart 
planktonic bacteria (Davies 2003). Biofilm represents a far more realistic representation 
of bacterial behavior in the clinical settings (Costerton et al., 1999). Therefore biofilm 
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models may be more appropriate to evaluate the efficacy of a given antimicrobial agent 
than the currently used assays on planktonic bacteria. It is therefore essential to assess 
the in vitro efficacy of APDT and ECAS against bacteria growing in a biofilm mode 
using the most appropriate in vitro biofilm model in order to obtain clinically relevant 
information.  
 
It is known biofilms form in wound and it is detrimental for the recovery of the wound 
by delaying the recovery processes (Bjarnsholt et al., 2008). In excisional wounds of 
pigs the presence of S. aureus biofilms have been demonstrated and further showed that 
the planktonic bacteria recovered from the wounds were more susceptible to topical 
antimicrobial agents than the biofilm bacteria recovered from the same wounds (Davies 
2003). Microbial biofilms cause various oral conditions, including caries, periodontal 
and endodontic diseases, dental implant failures and oral malodor (Soukos and 
Goodson, 2000). APDT and ECAS proposed as topical methods with broad-spectrum 
disinfection may therefore have applications in these localized infections.  
 
As described in previous chapters the antimicrobial activity of both APDT and ECAS 
are dependent on highly reactive non-specific ROS (singlet oxygen and hydroxyl 
radical). Due to the high reactivity and non-specific activity of ROS, both APDT and 
ECAS may be active against the biofilm structure, causing general oxidative breakdown 
alongside cell killing (Wainwright and Crossley, 2004; Thorn et al., 2012). It has been 
demonstrated that APDT mediated by NMB caused both cell killing and the breakdown 
of EPS, while the antibiotic ampicillin showed little damage to the EPS (Wainwright et 
al., 2002). In Escherichia coli biofilms, extracellular matrix exposed to ECAS was 
removed (Thorn et al., 2012). It was also proposed that hydroxyl radicals present in 
ECAS may cause the collapse of the highly structured hydrated biofilm matrix by 
removing hydrogen ions (through oxidation), and exposing deeper biofilm cells to 
antimicrobial agents (Thorn et al., 2012; Marais and Brözel, 1999).  Such dual activity 
is not seen in conventional antibiotics (Wainwright et al., 2002). The mechanism of 
killing in APDT is non-specific and cytotoxic species damaged a variety of bacterial 
components and the development of resistance from repeated use is unlikely 
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(Wainwright and Crossley, 2004). Therefore non-specific ROS generating agents such 
as APDT and ECAS may be promising alternatives to treat biofilm infections.  
 
As discussed in the introduction (chapter 1) APDT has been shown to be effective 
against biofilms using various biofilm models (Lee et al., 2004; Beil et al., 2011).  The 
numbers of studies carried out are still limited and mainly focus on oral biofilm bacteria 
using different in vitro (batch culture or fluid-feed replacement within the same biofilm 
vessel) biofilm models (Zanin et al., 2005).  
 
When S. aureus biofilms treated with APDT using TBO PS a significant reduction in 
viability and disruption of the structure of biofilm was observed (Sharma et al., 2008).  
Another study showed the APDT using PS merocyanine 540 on S. aureus biofilms 
required higher light dose to inactivate compared to planktonic cultures (Lin et al., 
2004).  These studies concluded that the number of bacterial cells killed within a 
biofilm was considerably lower than what can be achieved when treating their 
planktonic counterparts and EPS may be one contributing factor for biofilm resistance. 
More evidence concerning the application APDT against biofilm is needed to 
understand the higher protection afforded by the biofilm mode of growth in order to 
improve APDT before it can be widely implemented in clinical settings. Also reliable in 
vitro biofilm models that closely represent the biofilm growth in vivo need to be tested 
to study effectiveness of APDT against the target biofilm organism.  
 
Several studies have confirmed that ECAS is effective in removing biofilms formed by 
different bacteria associated with different surfaces (Thorn et al., 2012). Similar to 
APDT it has been reported that ECAS exposure removed micro-organisms from tooth 
surfaces (Hata et al., 1996) indicating application of ECAS to target biofilms involved 
in oral cavity diseases. ECAS was found to effectively reduce Listeria monocytogenes 
biofilms  by 9 log10  after 5 min of treatment (Venkitanarayanan et al., 1999). ECAS 
activity has also been confirmed against clinically relevant species such as 
Staphylococcus aureus including, methicillin resistant S. aureus (MRSA), Enterococcus 
faecalis, E. coli, Acinetobacter baumannii (Thorn et al., 2012). These studies further 
support potential applications of ECAS against biofilm infections in healthcare settings. 
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However, the number of studies of ECAS against biofilms are limited and the studies 
carried out so far are mainly focused on bacteria growing on different surfaces such as 
cutting boards (Venkitanarayanan et al., 1999; Park et al., 2002) relevant to applications 
in food industry or in disinfection of medical equipment (endoscope) (Masuda et al., 
1995; Sakurai et al., 2002) Therefore further research is required to elucidate the kill 
kinetics and to develop optimised treatment protocols (Thorn et al., 2012).  
 
For studying biofilm a number of different in vitro biofilm models have been used (e.g. 
flow cells, continuous perfusion systems, microtitre plates). Most of the studies were 
carried out using models based on batch culture biofilm models. These finding from the 
studies were highly significant and showed that APDT may be effective against 
biofilms. However, these batch biofilm models and do not account for the dynamic 
growth environment in which biofilms grow in vivo (Thorn and Greenman, 2009).  
Batch culture models are simple and easy to set up and in some cases may be adequate 
for gaining understanding of microbial activities upon exposure to antimicrobial agents 
(Thorn and Greenman, 2009). The major limitations of batch culture biofilm model is 
that limited control of the whole physicochemical environment (number of cells, 
concentrations of substrates, nutrients, products, pH and oxygen tension) (Greenman et 
al., 2013). 
 In contrast to batch culture biofilm, open continuous flow biofilm models (biofilm 
model used in the current study) are not isolated from their surrounding environment 
and can therefore be more representative of biofilms growth in vivo (Thorn and 
Greenman, 2009). In these models nutrients can be continually supplied/ refreshed with 
additional nutrients, substrates and buffer of controlled composition and flow rate, so as 
to stabilize parameters such as microbial density (Thorn and Greenman, 2009). A novel 
continuous culture dynamic biofilm model for testing active surfaces was developed by 
Thorn et al. (2009) described as an in vitro flat-bed perfusion biofilm matrix model and 
used developed in order to test the efficacy of topical wound dressing. Mature steady-
state target species biofilms was reproducibly grown within the model and used to 
assess the antimicrobial efficacy of topical treatments, producing kill kinetic profiles 
that differentiate bactericidal from bacteriostatic effects (Thorn and Greenman, 2009). 
Moreover it is known that the low growth rate of its constituent cells may be one of the 
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resistance mechanisms of biofilm (Lewis, 2001).  In this biofilm model the growth rate 
can be controlled by changing the flow rate of nutrients into the system which changes 
the growth rate and therefore the number of cells in the eluted perfusate. Therefore the 
growth rate effect contributing to the resistance mechanisms may be studied using this 
model.  
This model with slight modifications has also been used to test the efficacy of 
biologically active anti-odour compounds (Saad et al., 2013; Greenman et al., 2013).  
Therefore in this thesis the most appropriate model was considered to be the  in vitro 
flat-bed perfusion systems and this was chosen to test APDT and ECAS activity against 
target bacterial biofilms.  
Even though many studies have been carried out to test APDT and ECAS in eliminating 
biofilms these studies focus on the end point bacterial reduction in the biofilm after 
treatment. Some of the studies only provided a qualitative description of APDT effects 
on the structure of natural oral plaque biofilms using techniques such as confocal laser 
scanning microscopy (CLSM) (Wood et al., 2006). So far no kill kinetics data is 
available on biofilms exposed to APDT or ECAS treatments.  In all the studies the 
biofilm was destroyed after treatment to enable colony count of the survivors. Therefore 
in the current study the bioluminescent organism was incorporated into the in vitro flat-
bed perfusion model to allow continuous monitoring of the biofilm after treatment 
exposure without disputing the biofilm, enabling metabolic activity of the biofilm to be 
monitored in real time.  
To model the closest conditions possible to that found in clinical conditions in vivo 
testing in animal models are performed. Bioluminescence imaging was used in these 
animal models to monitor the efficacy of APDT in real time (Hamblin et al., 2002; 
Hamblin et al., 2003). Due to the non-invasive nature of this technique, animals can be 
repeatedly imaged, considerably reducing the number of animals needed to carry out in 
vivo studies. This was a significant development towards reducing the number of live 
animals for scientific studies. However it is still preferable to find alternatives to the use 
of live animals in research. It was considered that the use in vitro flat-bed perfusion 
biofilm model will be very useful to test the efficacy of APDT without the need for 
testing in animal models to replace or more selectively use live animals.  
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7.2 Aims of the investigation 
The first aim of this chapter was to monitor the change in metabolic activity of 
bioluminescent bacteria growing in biofilms after APDT and ECAS exposure. The 
second aim was to assess whether the growth rate of biofilm contributes to susceptibility 
of biofilm to the treatments.  
7.3 Results  
Growth of bioluminescent E. coli Nissle 1917 pGLITE within the biofilm model 
Figure 7.1 shows the growth and development of bioluminescent E. coli Nissle 1917 
pGLITE within the  flat-bed perfusion biofilm model over 48 hours for  low growth rate 
(nutrient perfused at a flow rate of  (1 ml h
−1
). During the growth of E. coli Nissle 1917 
pGLITE the total matrix population (TMP) and eluate reduced during the first 8 hours.  
and after this  both TMP and eluate measurements were more or less remained 
unchanged for up to 48 h, indicating that the biofilm growth reaches quasi steady state 
from 24 h and remains in steady state for 48 h.  
 
The growth of bioluminescent E. coli Nissle 1917 pGLITE biofilm was monitored by 
both viable count methods (figure 7.1 a) and bioluminescence (figure 7.1 b). The viable 
count results largely correlated with that of bioluminescence. The bioluminescence also 
showed a decrease for the first 8 hours for the TMP, from 12 hours it showed an 
increase and reaches a steady state from 24 to 48 hours. The bioluminescence for the 
eluate showed increase at 8 hours and then a drop in bioluminescence at 12 hours. From 
12 to 24 hours the eluate bioluminescence increased and started reaching a steady state. 
By 24 hours the eluate levels of bioluminescence was steady and remain at steady levels 
up to 48 hours.  
 
Figure 7.2 shows the data from figure 7.1 of  E. coli Nissle 1917 pGLITE biofilm (low 
growth rate biofilm: flow rate of (1 ml h
−1
) in steady state of growth from 24 hours to 48 
hours. Both the viable count and bioluminescence method showed that by 24 hours the 
biofilm is in steady state and remained in steady state from 24 hours to 48 hours. This 
result shows both viable count and bioluminescence to give the same pattern of growth 
and shows correlation between bioluminescence and viable count.  
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Figure 7-1 Development of E. coli Nissle 1917 pGLITE biofilm from inoculation 
/colonization (t=0) to steady state growth (at nutrient flow rate of 1 ml/h) within an 
in vitro flat-bed perfusion biofilm model measured by (a) viable count of total 
matrix population (TMP) and eluate, and (b) bioluminescence of TMP and eluate, 
the biofilm sampled at every 4 hours up to 12 hours and then sampled at 24h, 36h 
and at 48h. Error bars show mean ± SD (n=3). 
(a) 
(b) 
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Figure 7-2 Steady state of E. coli Nissle 1917 pGLITE biofilm  monitored by (a) 
viable count (b) bioluminescence, of both total matrix population (TMP) and 
corresponding eluate (upper and lower values respectively shown for each graph). 
Error bars show means ± SD (n=3). 
 
(b) 
(a) 
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Figure 7.3 shows measurement of photon output by the E. coli Nissle 1917/pGLITE 
biofilm cells growing at 3 different growth rates. The growth rate was controlled by the 
flow of nutrient into the system. The fastest growth rate (nutrient flow rate set up as 
50ml/h) shows the fastest growth rate. It takes shorter time to reach the steady state of 
growth. The intermediate growth (nutrient flow rate set up as 15ml/h) rate shows that 
the growth rate is at an intermediate level in between low and faster rate. The low 
growth rate (nutrient flow rate set up as 1ml/h) shows that it takes the longest time to 
reach the steady state. This shows that bioluminescence allow differential growth rate to 
be monitored. From the graph it can be clearly seen that when the nutrient flow rate is 
set at three different rates the biofilm bacteria shows distinct bioluminescence output 
indicating different growth rates. The growth rate was calculated for each flow rate as 
shown in table 7.1 which shows that at the calculated growth rate was different for each 
flow rate. The fastest flow rate gave the highest growth rate per hour and with lowest 
flow rate lowest growth rate and intermediate flow rate gave growth rate in between the 
fastest and lowest flow rate.  
 
Growth rate calculation:   
The growth rates were calculated using the formula given below for biofilm grown up 
to 24 hours at low, intermediate and fast flow rate by measuring the total biofilm 
population  TMP (biofilm on: 1cm
2
 cellulose membrane) and eluate viable counts  
 
Growth rate ()= Rate of elution of cells (h-1) 
                              Total biofilm population 
 
 Table 7.1 Calculated specific growth rate h
-1
 at low, intermediate and fast rate of  E. 
coli Nissle 1917 pGLITE biofilm 
Flow rate   Growth rate (h
-1
) 
Low               (1 ml h
−1
) 0.34 
Intermediate  (15 ml h
−1
) 0.58 
Fast                (50 ml h
−1
) 0.98 
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Figure 7-3 Development of E. coli Nissle 1917 pGLITE biofilms (over first) 12 
hours and the start of steady state phase, for fast (50ml/h), intermediate (15ml/h)  
and slow (1ml/h) flow rates,  followed by bioluminescence output by the biofilm 
matrix (TMP photon count). (T=0 on the graph corresponds to inoculation of 
biofilm). Symbol represent mean ± SD (n=3). 
 
Figure 7.4 shows a control biofilm of E. coli Nissle 1917/pGLITE where a mock 
treatment with phosphate buffer solution (PBS) was carried out. The graph shows 
(unlike treatment with APDT and ECAS) that there is no significant reduction in photon 
count following the PBS treatment. It also shows that immediately following the PBS 
injection there was a slight drop in photon count and then a quick recovery to the level 
before treatment and thereafter the bioluminescence remained constant level for 30 
hours, showing that the bioluminescence remains stable for the duration of the 
experiment.  
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Figure 7-4 Showing the application of PBS (1ml) as a control treatment (negative 
control) to the surface of the E. coli Nissle 1917 pGLITE biofilm (intermediate 
growth rate) and bioluminescence monitored for up to 30 hours. (T=10 on the 
graph corresponds to the start of experiment on steady state biofilm following 
maturity at 16 h). Error bars show mean ± SD (n=3). 
 
Figure 7.5, figure 7.6 and figure 7.7 shows E. coli Nissle 1917/pGLITE biofilm at low, 
intermediate and fast growth rate respectively treated with ECAS. Each biofilm was 
treated with two treatments of ECAS: treatment 1 biofilm treated with 300 L of 5% v/v 
of ECAS and treatment 2 treated with 300 L of undiluted ECAS (100% ECAS) (for 
both treatments 300 l of ECAS was transferred on to the biofilm matrix 1cm2 cellulose 
membrane and nutrient supply stopped for 5 minutes). When ECAS treatment was 
applied on low growth rate biofilm (figure 7.5) and intermediate growth rate biofilm 
(figure 7.6) it shows only a slight increase in bioluminescence after each treatment and 
then light output remains steady. It was interesting to see an increase in light output 
after treatment instead of a drop in light output; these were in contrast to when the same 
treatment was carried out on a fast growth rate biofilm (figure 7.7). When the fast 
growth rate biofilm is exposed to ECAS there is nearly a one log drop in light output. 
However it shows a quick recovery and reaches slightly higher light output than the 
initial pretreatment level before light output returns to steady state. 
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Figure 7-5 Change in photon count by bioluminescent E. coli Nissle (low growth 
rate biofilm)  following ECAS treatment (300L) (treatment 1-5% v/v ECAS), 
(treatment 2-100% ECAS). (T=10 on the graph corresponds to the start of 
experiment on steady state biofilm following maturity at 16 h). Symbol represent 
mean ± SD (n=3). 
 
 
Figure 7-6 Change in photon count by bioluminescent E. coli Nissle (intermediate 
growth rate biofilm) following ECAS treatment (300L) (treatment 1- 5% v/v 
ECAS), (treatment 2- 100% ECAS). (T=10 on the graph corresponds to the start of 
experiment on steady state biofilm following maturity at 16 h).  Error bars show 
mean  ± SD (n=3). 
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Figure 7-7 Change in photon count by bioluminescent E. coli Nissle (fast growth 
rate biofilm) following ECAS treatment (300L) (treatment 1-5% v/v ECAS), 
(treatment 2-100% ECAS). (T=10 on the graph corresponds to the start of 
experiment on steady state biofilm following maturity at 16 h). Error bars show 
mean ± SD (n=3). 
 
 
Figure 7.8, 7.9 and 7.10 shows E. coli Nissle 1917/pGLITE biofilm at low, intermediate 
and fast growth rate respectively, treated with the APDT (treatment duration 30 
minutes) 100 g/ml MB and total light dose of 25.2 J/cm2 (light intensity 14.5mW/cm2). 
The treatment was repeated three times. The first treatment for low growth rate (figure 
7.8) shows that after the first APDT treatment it shows nearly 2.5 log drop in light 
output. However, light output starts to increase immediately after treatment and reaches 
the pre-treatment levels in 8 hours. After the recovery period the second treatment was 
applied. This shows a 1 log drop in light output and there was quick recovery. The third 
treatment was applied after 1-hour recovery period following the second treatment. 
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Following the third treatment there was a drop in light output by 2-log and immediate 
recovery to steady state in 5 hours.  
 
The treatment procedure was repeated for the intermediate (figure 7.9) and fast growth 
rate (figure 7.10). The graph shows the same general pattern in reduction in light output 
after treatments. However unlike the slow and intermediate growth rate biofilms, the 
faster growth rate biofilm recovers quickly (figure 7.10).   
 
Figure 7.11 shows comparisons of growth rate effects on the light output after exposure 
to APDT treatments.  It shows that the fastest growth rate biofilm is more resistant to 
treatment and shows quick recovery compared to low and intermediate. Low growth 
rate biofilm is the most sensitive to treatments since it takes longer for the biofilm to 
return to pretreatment light output levels. 
 
 
 
 
 
Figure 7-8 Change in photon count by bioluminescent E. coli Nissle biofilm (low 
growth rate) following APDT treatment with 100 g/ml MB (1 ml) and total light 
dose of 25.2 J/cm
2
 (light intensity 14.5mW/cm
2
)
 
 APDT treatment was repeated 3 
times shown by the arrow. Error bars show mean ± SD (n=3). 
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Figure 7-9 Change in photon count by bioluminescent E. coli Nissle biofilm 
(intermediate growth rate) following APDT treatment with 100 g/ml MB (1 ml) 
and total light dose dose of 25.2 J/cm
2
 (light intensity 14.5mW/cm
2
)
 
was repeated 3 
times shown by the arrow.  Error bars show mean ± SD (n=3). 
 
 
Figure 7-10 Change in photon count by bioluminescent E. coli Nissle biofilm (fast 
growth rate) following APDT treatment with 100 g/ml MB (1 ml) and total light 
dose of dose of 25.2 J/cm
2
 (light intensity 14.5mW/cm
2
).
 
APDT treatment was 
repeated 3 times shown by the arrow. Error bars show mean ± SD (n=3). 
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Figure 7-11 Showing the bioluminescence of E. coli Nissle 1917 biofilm as a 
function of recovery time in hours following APDT MB treatment for each biofilm 
compared to control (treated with PBS). Error bars show means ± SD (n=3). 
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7.4 Discussion 
In this study biofilms were grown within an in vitro flat-bed perfusion biofilm model to 
evaluvate APDT and ECAS efficacy agaisnt biofilm. The flat-bed perfusion biofilm was 
innoculated with a bioluminescent E. coli Nissle 1917. The media perfused into the 
system at three different flow rates low (1 ml h
−1
), intermediate (15 ml h
−1
) and fast (50 
ml h
−1
). When media continuously perfuses the matrix to feed the cells, the cells divide 
and produce daughter cells that are eluted from the matrix. In the case of low growth 
rate biofilm both the viable counts and bioluminescence was measured. The total matrix 
population (TMP) and detached cells removed from the matrix in the fluid flow (eluate) 
was measured by viable methods and bioluminescence, and showed that the biofilm 
density initially decreases due loosely bound cells detaching from the matrix and being 
removed through flow of fuid. After this period the cells colonised the matrix and the 
density steadily increases as the cells grow and replicate. Finally the biofilm reaches a 
quasi steady state around 16 hours as the maximum biofilm density is reached. The 
biofilm once in steady state will remain in steady state unless no change occurs in the 
biofilm growth environment. There was correlation between the viable count data and 
bioluminescence, Confiming that bioluminescene can be used to follow the growth of 
biofilm and that bioluminescence gives similar information as viable counts. The steady 
state was maintained 24 to 48 hours.  
 
When the growth of biofilm was continiuously followed only by bioluminescence 
output from innocluation to steady state, it showed that for low growth rate there was an 
initial reduction in bioluminescence as was seen with viable counts. Similarly for the 
fast and intermediate growth rate there was initial decrease in light output by the 
biofilm. This decrease may be due to cells detaching from the matrix which results in 
reduction in the cell density. Once cells start to colonise by adapting to the new 
environment they multiply and metabolic activity increases and consequectly, light 
output increases. The cells reach the maximum cell density and produce a maximum 
steady light output. It was shown that when the flow of media was low, cells take a 
longer time to reach steady state than intermediate and fast flow rates which take less 
time to reach steady state. This indicates that light production by the cell is dependent 
on the supply rate availability of nutrients. The flat-bed perfusion biofilm model 
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enabled the growth of steady state reproducable dynamic steady state biofilm growth. 
The growth of the biofilm was consistant with the studies carried out by Thorn and 
Greenman (2009), where the biofilm reached a mature steady state. However in the 
present study the biofilm reached steady state in a faster time (16 hours) of growth, this 
difference is due to different target organims and growth conditions. It was found in 
general that the pattern of growth was similar and the biofilm reached a mature steady 
state of growth, confirming that the mature target species biofilm could be used to study 
the efficacy and kill kinetics of APDT and ECAS.  
 
Biofilm grown in the in vitro flat-bed perfusion model was monitiored continuously by 
bioluminescence and once a steady state of growth is achieved, the model was used to 
study the efficacy of ECAS and APDT. ECAS was applied to biofilms at three different 
growth rates. ECAS was applied twice on each biofilm. In the first treatment 300l of 
5% v/v ECAS applied on the matrix and in the second treatment on the same biofilm,  
300l of undiluted ECAS (100%) was applied to the biofilm matrix. Slow and 
intermediate growth rate biofilms showed a slight increase in bioluminescence 
immediately upon treatment after both the treatments. Increasing the concentration of 
ECAS showed no increase in reduction of bioluminescence for these biofilms. 
However, when the fast growth rate biofilm was treated with ECAS, after the first 
treatment (300l of 5% v/v ECAS) there was a 1 log drop in bioluminescence but with 
the second treatment (undiluted ECAS (100%)) there was initial increases in 
bioluminescence and then a steady state light output which was slightly lower than the 
pretreatment steady state light output. These results indicate that the ECAS treatment 
employed is not a strongly effective against biofilm and its effects are dependent on the 
biofilm growth rate. The reduction in bioluminescence in the fast growth rate condition 
and the quick recovery means that ECAS has bacteriostatic rather than biocidal effects. 
Which means ECAS acts by reducing growth rate and inhibiting other cell functions 
(light output is closely dependent on the metabolic activity of the cells (Thorn et al., 
2007). Therefore removal of treatment immediately reversed the effects of ECAS and 
light output returns to normal. The slight increase upon treatment may be explained by 
ECAS killing cells on the top layer of the biofilm hence the nutrients per cell is 
increased thereby increases the growth rate of the biofilm (increasing light output) as 
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the biofilm get repopulated it returns to the original steady state of growth (John 
Greenman personal communication). The slightly low light output steady state after 
ECAS treatment means there was some effect on the metabolic activity of the biofilm 
cells. The high resistance of biofilm to ECAS may be explained by the ROS generated 
being competetively queched by the organic material of the extracellular matrix. It has 
been reported in the literature that ECAS activity is significantly reduced for planktonic 
culture in the presence of organic material (Robinson et al., 2011). Therefore the 
extracellular matrix of the biofilm may inhibit the interactions of ECAS with attached 
“mother layers” of  biofilm cells. This means that the biofilm may need to be perfused 
with a larger volume of ECAS to compensate for the inhibitory action of the 
extracellular matrix. In this study only 300l of ECAS was applied to the biofilm with 5 
minutes of application time (nutrient supply to the biofilm was stopped). Therefore 
ECAS concentration and volume need to be optimised. To confirm that extracellular 
polymer material rather than specific genes (a biofilm phenotype) contribute resistance 
to ECAS, bacterial cells dispersed from the biofilm and resuspended in suspension can 
be compared to an intact biofilm and non biofilm derived planktonic cells in suspension. 
If there is a difference in resistance then it may confirm that the extracellular polyer 
matrix or a change phenotype that may contribute to resitance of biofilm cells. In a 
study carried out to evaluvate the interaction of tobramycin with P. aeruginosa mucoid 
exoploysaccharide, it was shown that the dispersed biofilm cells were 15-times more 
susceptible to tobramycin than those in the intact biofilms (Hoyle and Costerton, 1991).  
 
When the biofilm was treated with APDT it showed that APDT was more effective 
compared to ECAS. After APDT the bioluminescence output was reduced by nearly 2 
log and it takes up to 8 hours for the cells to recover to steady state and again multiple 
treatments showed the same effect. The second treatment was carried out before the 
biofilm could recover to steady state. However, this did not show a significant increase 
in reduction in bioluminescence and there was quick recovery. Similarly the third 
APDT treatment showed reduction but showed quicker recovery than the first treatment 
(5 hours). The longer recovery time indicates that unlike ECAS treatment, APDT is 
biocidal. The biofilm population was reduced and takes longer time to recover to steady 
state levels. This indicates that even though APDT is able to reduce the biofilm 
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population to some extent, the remaining cells are able to regrow when supplied with 
fresh contionous media. Also it was found that APDT activity is dependent on the 
growth rate; with fast rate being the least sensitive and slow growth rate the most 
sensitive.  
 
There are several explanations for the lowered APDT activity towards bacterial biofilm 
cells. First, reduced susceptibility of APDT to biofilms compared to plantonic cultures 
may be due to the reduced ability of MB to penetrate the full depth of the biofilm 
preventing damage to the bacterial cell targets. Its has been suggested that the EPS traps 
the PS on the outside of the cell due to ionic or hydrophobic interactions (de Melo et al., 
2013). Second, it has been shown that MB are substrates of multidrug resistance pumps 
in bacteria (Tegos and Hamblin, 2006). Third, it has been shown that MB mediated 
APDT effects of on biofilm (dental plaque bacteria) were affected by the presence of 
serum proteins present in brain–heart infusion broth (Fontana et al., 2009).  
 
Many studies have shown incomplete destruction of bacteria in biofilm after APDT 
(Fontana et al., 2009; O’Neill et al., 2002) in agreement with the findings of the current 
study. APDT carried out on saliva-derived biofilms observed using confocal scanning 
laser microscopy revealed that photodestruction occurred predominantly in the outer 
layers of the biofilm (O’Neill et al., 2002). Therefore the reduced susceptibility of 
biofilms to APDT may be attributed to reduced penetration and retention of MB in the 
outer layer (Fontana et al., 2009; O’Neill et al., 2002). However, it has been shown that 
APDT mediated by cationic PS could overcome the protective effect of extracellular 
slime (Gad et al., 2004). Various studies have shown APDT to be particularly effective 
agasint Gram-positive biofilm bacteria using different PS (de Melo et al., 2013). It was 
also shown that APDT with MB reduced S. mutans and S. aureus biofilms by 2.81 log10 
and 3.29 log10  respectively (Pereira et al., 2011). Although MB was used to inactivate 
the biofilm, the target biofilm organims, concentration of MB, light dose and biofilm 
model were different, making it difficult to compare to the present study.  
 
Similarly, G-negative biofilm bacteria have also been shown to be sensitive to APDT 
(de Melo et al., 2013). P. aeruginosa biofilms were exposed to APDT using  20 mM δ-
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ALA  and 120 J/cm
2
 light dose which eradicated the biofilm, although after 24 hours 
biofilms appeared to re-form thereafter and reached 7.2 log10 CFU/ cm
2 
after 48 hours of 
re-growth  (Lee et al., 2004). In addition to killing of cells a desirable feature of both 
APDT (Wainwright et al., 2002) and ECAS (Thantsha and Cloete, 2006) are the ability 
of these agents to disrupt EPS via inducing oxidative damage of glucose and proteins, 
disrupting the biofilm stability.  
 
APDT has been used in the treatment of several localized infections in animal models 
(Dai et al., 2009; Demidova et al., 2005; Hamblin et al., 2002; Lambrechets et al., 
2005). Mice models with chronic biofilm infections caused by MRSA lux-
bioluminescent strain were treated with APDT (Dai et al., 2010). The bioluminescence 
signal disappeared when PS polyethylenimine chlorine (e6) (PEI-ce6) was topically 
applied to the infection followed by illumination with red light (up to 240 Jcm
-2
). 
However bioluminescence was observed after 24 h when bacteria regrow. There was 
accelerated wound healing (8.6 days) in comparison to the untreated infected wounds. It 
can be concluded that APDT has the potential to be an alternative treatment for 
localized infection. However the treatment needs to be optimized to reduce recurrence 
or regrowth of bacteria.   
 
It has been reported that the slow growing bacteria survive adverse conditions compared 
to fast replicating cells (Gilbert et al., 1990 ). Therefore a characteristic response by 
populations of replicating cells when in adverse environmental change is to reduce 
growth rate (Gilbert et al., 1990). Therefore another mechanism of the protection of 
bacterial biofilms from antimicrobial agents might be related to the existence of bacteria 
in a slow growing or starved state (Gilbert and Brown, 1995). In this study it was found 
that the susceptibility of biofilm is influenced by growth rate. Interestingly it was found 
that fast growth rate was more susceptible to APDT compared to low growth rate. In 
contrast ECAS showed the opposite effect.  
This study showed that growth rate is an important factor contributiong to a cells 
susceptibility to treatments. To the author’s knowledge it is the first time growth rate of 
biofilm and suceptibility to APDT and ECAS has been studied. To better understand the 
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growth rate effects of biofilm, further research need to be carried out where growth rate 
matched planktonic culture cells needs to be compared to growth rate matched biofilms.  
 
The biofilm model system incorporated with a target bioluminescent organism E. coli 
Nissle 1917 pGLITE allowed for non invasive in situ monitoring of biofilm growth and 
enabled continuous monitoring of the effects of APDT and ECAS without disrupting 
the biofilm. These data shows that APDT and ECAS has the potential to rapidly reduce 
bacterial load in the biofilm. However, the treatments need to be optimised to prevent 
recurrence or regrowth of bacteria. The model could be slightly modifed to incoporate 
serum to make it closer to the in vivo conditions. This system could then be used to 
assess the efficacy of new phtosenstizers before testing them in animal models to give 
clincally relevent data or  the model may be used as a replacement for animal model 
testing.  
 
In conclusion this study has shown that bioluminecene could be utilized as a tool in the 
study of APDT and ECAS and is a robust sytem to use in the study of biofilms to better 
understand the activity of these treatments in real time. This study has opened up 
several interesting avenues of research which could be carried out to understand 
efficacy of these treatments against biofilms which may lead to  applications of APDT 
and ECAS in clinical settings.  
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Chapter 8:  General Discussion 
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8.1 Discussion 
This study was carried out in order to compare the effects of ROS killing by APDT and 
ECAS and predict the likelihood that the chosen treatments will be effective at killing 
microbes without significant harm to mammalian cells. The overall aims of this thesis 
was to develop appropriate reproducible rapid assays for studying APDT and ECAS 
(ROS generating systems) for microbial cell killing (chapter 3), to carry out 
comparative mechanistic study of the two systems (chapter 4), to assess potential of 
these agents to cause cytotoxicity to mammalian cells (chapter 5) and to measure DNA 
damage after exposure of mammalian cells (lymphocytes) to a specified dose of 
treatment (chapter 6) and to study the effects of treatments when applied to bacteria in 
the form of biofilms using an in vitro flat-bed perfusion model incorporated with 
bioluminescent target organism (chapter 7).  
A rapid assay method was developed based on bioluminescent target organisms, 
allowing a comparison of the kill kinetics of APDT and ECAS (chapter 3). The assay 
was simple, rapid and sufficiently accurate to allow comparison of kill rates. It was 
found that viable count correlated closely with bioluminescence (r
2
 > 0.9) allowing 
replacement of the non-rapid viable count method with bioluminescence. 
Bioluminescence gave reproducible kill kinetic time plots for given conditions and it 
was found that compared to control, both APDT and ECAS at defined doses were 
effective in killing target organisms (>3 log10 reductions) in a reasonable time frame (5 
to 30 minutes). For both APDT and ECAS, there was dose dependent reduction in 
bioluminescence of the target organisms E. coli Nissle 1917-pGLITE and P. aeruginosa 
MCS5-lite.  
Viable count methods were used to evaluate the efficacy of Gram-positive species since 
bioluminescent Gram-positive organisms giving sufficient light output were not 
available. For S. aureus, it was found that MRSA was more resistant compared to the 
methicillin sensitive strain. MRSA is considered a major threat to public health due to 
growing antibiotic resistance (Spellberg et al., 2008). Using APDT, MRSA was reduced 
>3 log10 in 30 minutes confirming previous studies (Demidova et al., 2005) showing 
that both antibiotic resistant and non-resistant organisms could be targeted. The order of 
killing susceptibility (including non-lux targets) was S. aureus >> E. coli Nissle 1917 
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pGLITE > P. aeruginosa MCS5-lite > MRSA.  For ECAS (5% v/v), the antimicrobial 
activity against the E. coli Nissle 1917 pGLITE was several fold faster compared to 
APDT. At higher concentrations (10%, 25% and 50% v/v ECAS) the kill rate of target 
organism was very fast, reaching the limits of detection within 5 seconds. Compared to 
viable methods, the bioluminescence assay enabled accurate calculation of the kill rates 
of E. coli Nissle 1917 pGLITE, capturing initial kill rates even after exposure to fast 
acting agent.    
With regard to the study of killing mechanisms, the standardised bioluminescence assay 
was used with incorporation of singlet oxygen enhancer (D2O), and addition of general 
or specific scavengers of ROS (tryptophan, azide, DMTU, mannitol). Previous work 
reported in the literature suggested that APDT could involve both type-I (mainly 
hydroxyl radical) and type-II (mainly singlet oxygen) killing mechanisms. The analysis 
of results obtained by comparing kill rates in the presence or absence of D2O and 
scavengers showed that APDT generated singlet oxygen (type-II reaction) since killing 
was enhanced with D2O and strongly inhibited by tryptophan, but not strongly inhibited 
by the specific hydroxyl scavengers, mannitol and DMTU suggesting that hydroxyl 
radical interactions (type-I reactions) were minimum. In contrast, for ECAS, mixed 
ROS mechanisms were clearly involved since azide and tryptophan inhibited killing, 
but D2O had little effect suggesting little contribution if any from singlet oxygen. 
The use of fluorescent probes for ROS detection showed it to be a simple method in 
practice to determine ROS generation by APDT and ECAS. Overall the results using 
the fluorescence probes (SOSG, APF and HPF) in combination with specific 
scavengers, confirmed that the main ROS species produced in APDT are singlet oxygen 
(type II pathway) with a smaller contribution by hydroxyl radical (type I pathway). In 
contrast, ECAS inactivated SOSG and HPF but gave a clear fluorescence response with 
APF (inhibited by mannitol and DMSO), suggesting hydroxyl radical involvement with 
little or no singlet oxygen production with only slight increase with D2O and little 
inhibitory effect with azide. The main limitations of using fluorescent probes are their 
lack of selectivity towards one particular ROS (Kiesslich et al., 2013) but this problem 
was ameliorated by the addition of specific scavengers at specified concentrations and 
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use of these probes was thus able to determine the portion of fluorescence ascribed to 
the ROS under study.  
The regulatory authorities in Europe and the USA recommend that cytotoxicity, 
genotoxicity and carcinogenicity should be performed as a part of the application for 
marketing approval of pharmaceuticals. Both APDT and ECAS are effective at killing 
micro-organisms, thus they are both strong candidates for being used for treatment 
applications in vivo. In this case it is important to prove that they do not cause any side 
effects (cytotoxicity or genotoxicity) on host cells. For cytotoxicity, the concept of a 
protective index can be invoked. The protective index is a comparison of the amount of 
an agent or treatment that causes the therapeutic (antimicrobial) effect, to the amount 
that causes toxicity. Quantitatively, it is the ratio given by dividing the toxic dose by the 
therapeutic dose. A higher index is preferred since the therapeutic effect can be reached 
without eliciting damage to the host. Translated to in vitro testing, this would mean 
finding a dose that kills microbes effectively without damaging mammalian cells in 
culture. The data obtained in this thesis (chapters 5 and 6) suggests that for both APDT 
and ECAS, a level of treatment could be found whereby the kill rates of all the 
microbial test species were very much greater than those measured for mammalian 
cells, suggesting that a wide margin exists between an effective therapeutic dose and 
one that is likely to have cytotoxic or genotoxic effects on mammalian cells, suggesting 
that if applied in a clinical setting the treatments would have little damaging effects on 
the host. 
 
It has been reported (George and Kishen, 2007) that in vitro, Enterococcus faecalis was 
killed at a much faster rate than normal fibroblasts after APDT treatment.  In this study 
the rate of loss of fibroblast (measured as loss of mitochondrial activity in fibroblast 
cells) occurred at a mean rate constant of 0.08 min
-1
 which was significantly less 
compared to the kill rate of the Enterococcus (mean rate constant 1.01 min
-1
). Likewise, 
in this thesis, when E. coli Nissle 1917 pGLITE and keratinocytes were exposed to 
APDT simultaneously, the microbial kill rate was 0.15 log RLU min
-1
 and for 
keratinocytes was 0.012log cells min
-1
 showing that the bacterial cells were much more 
susceptible to APDT compared to mammalian cells. 
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In addition to cytotoxicity it is important to ensure that these putative treatments do not 
cause any genotoxic effects to mammalian cells. Previous studies have shown that 
APDT is not genotoxic to keratinocytes (Zeina et al., 2003). However, very few studies 
if any have reported on genotoxicity of these agents against lymphocytes in conditions 
relevant to APDT. Since both APDT and ECAS can be targeted to localised wound 
infections, and lymphocytes play an important role in wound healing (Schaffer and 
Barbul, 1998), it is important to determine that treatment is safe against these cells. For 
ECAS, the comet assay revealed only a very low level of genotoxicity towards 
lymphocytes whereas APDT showed a higher degree of DNA damage. However this 
was not as high as the positive control (100 M hydrogen peroxide). To test if the cells 
can repair the DNA damage after APDT, cells were incubated for 6 and 24 hours 
“recovery” time. However there was no reduction in tail moment as a measure of DNA 
damage; indeed, it appeared that DNA damage (increase in mean tail moment) was 
significantly increased (p<0.05) following the incubation period after treatment. These 
results indicate that some caution may need to be exercised when developing APDT 
protocols for deep seated wound infections where it is likely that lymphocytes are 
present and thus exposed to the treatment. In contrast, ECAS appears to be more 
favourable in terms of having lower potential damaging side effects towards 
mammalian cells.  
In many cases of microbial infection and disease, the target micro-organisms are 
growing in a biofilm state and biofilms are reported to be many times more resistant to 
biocidal treatment than their planktonic counterparts (Costerton et al., 1999). In this 
thesis (chapter 7), both ECAS and APDT were markedly less efficient at killing target 
cells when growing in biofilm mode even after multiple treatments, any of which would 
have caused a 3-log drop of bioluminescence in planktonic cells.  For biofilms, the 
treatments only produced short term bacteriocidal or bacteriostatic effects characterised 
by a reduction of light output but only for a few hours before a slow or fast recovery 
back to normal (baseline) levels, depending on the flow rate/growth rate of the system. 
Slow flow rate/growth rate was associated with slow recovery whilst fast flow 
rate/growth rate gave a much quicker recovery when exposed to APDT.  
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In this thesis it was found that an in vitro flat-bed perfusion biofilm model integrated 
with a bioluminescent strain (target biofilm) was a suitable system to measure APDT 
and ECAS against biofilm cells. This model enabled continuous monitoring of 
bioluminescence output without the need to disrupt the biofilm for analysis. Therefore 
this model may be particularly suitable to study newly developed PS against biofilms. 
This model may more closely represent in vivo conditions and thus help to reduce the 
use of animal models in research.  
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8.2 Conclusions and further study 
In conclusion this study showed that bioluminescence enabled accurate determinations 
of kill rates of target organisms after exposure to APDT and ECAS. The rapid assays 
enabled characterisation of the mechanisms of APDT and ECAS in terms of singlet 
oxygen and free radical mechanisms by using specific scavengers. This convenient 
simple assay approach together with specific ROS fluorescent probes was adequate in 
understanding the underlying mechanism of these agents and moreover was in 
agreement with the previously known mechanism of APDT. However for ECAS it was 
found that the mechanism was mainly hydroxyl radical rather than singlet oxygen. The 
ECAS mechanism appears to be more complex than previously thought. It was found 
that both agents were less damaging to mammalian cells (keratinocytes and 
lymphocytes) compared to bacterial cells. One possible reason for this observation 
could be the markedly different surface area to volume ratios possessed by eukaryotic 
and prokaryotic cells. Both APDT and ECAS are thought to damage membranes, and 
bacterial cells have much larger ratios of outer membrane to volume than do the much 
larger mammalian cells. A systematic study of species with increasing cell size (e.g. 
from small to large bacteria, small to large yeasts, and small to large mammalian cells) 
may support or rule out this hypothesis.  
 
With regard to genotoxicity of treatments, then APDT produce higher levels of DNA 
damage compared to ECAS on lymphocytes. Therefore ECAS may be safer to use in a 
clinical setting. However, both these treatments were found to be less effective against 
biofilms compared to planktonic cultures. Since biofilms pose a significant challenge in 
treating persistent infections with conventional antibiotics, further studies are required 
to improve the efficacy of any new treatments against biofilms. There may be a number 
of reasons for the high resistance of biofilms to treatments including; lack of agent 
penetration into the biofilm, changes in the cell phenotype when growing in biofilm 
mode (e.g. up-regulation of drug efflux systems), or most likely, high production rates 
of agent neutralising material (slime, capsular material, proteins and other polymers). 
With regard to living biofilms, it should be noted that higher growth rates of the 
attached cells will produce higher numbers of exfoliating daughter cells which will also 
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react, neutralise or protect the attached living mother layers within the inner parts of the 
biofilm from agents. More research will be required in order to study these mechanisms 
of biofilm resistance.   
Another important area that may require further investigation stems from the finding 
that APDT (in contrast with ECAS) could be genotoxic to lymphocytes.  One way of 
minimising the damage is to have PS immobilised or using APDT conjugated to 
specific antibodies. In this form, production of ROS is external to the cell, where it is 
much less likely to interact with intracellular DNA and genotoxic damage would be 
avoided.  
Indications for APDT and ECAS include the treatment of local, superficial skin and soft 
tissue infections or its use for the reduction of nosocomial colonization of the skin by 
multi-resistant bacteria. Topical treatments by conventional antimicrobial agents (e.g. 
antibiotics) can give rise to severe side effects such as allergic contact sensitization, 
development of resistance in the resident flora, or overgrowth of yeasts or 
superinfection by species resistant to the antibiotic (Fu et al., 2013). Therefore 
alternatives such as APDT and ECAS are required. One advantage of topically applied 
PS with subsequent irradiation is the locally limited action of the photodynamic effect. 
In contrast, ECAS reacts with organic material including target microbes, but is soon 
neutralised. Therefore the mode of application of ECAS is different from that of APDT. 
For ECAS, an infected wound would be bathed, rinsed or irrigated using copious 
amounts of ECAS, which can be produced in large volumes. Only further research can 
show the advantages of this approach.  
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Chemical structure of porfimer sodium (photofrin) 
